{"doc_id": 0, "doc": {"person_id": 115967211, "visit_occurrence_id": 51248592, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2012-10-19 00:00:00", "visit_end_datetime": "2012-10-19 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2011-05-09 12:40:00", "patient_last_visit_date": "2015-02-18 00:00:00", "end_obs_date": "2013-10-19", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 27, "cumulated_visit_num": 27, "cumulated_approximate_token_count": 12529, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-05-09 12:40:00, ended at 2011-05-09 19:32:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Headache\n- Blepharitis\n- Posttraumatic stress disorder\n- Visual disturbance\n- Keratitis\n- Myopia\n\n### Drug\n- hypromellose 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day.\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 0.5 cm to both eyes 2 times a day. For 5 days in each eye\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 08:00:34, ended at 2011-05-21 09:57:57\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-29 12:55:00, ended at 2011-05-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Finding of head and neck region\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-31 00:00:00, ended at 2011-05-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm of uncertain behavior of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:01:04, ended at 2011-06-14 17:43:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- atomoxetine 40 MG Oral Capsule, through Oral route, presumably until 2011-07-26. Instructions: take 40 mg by mouth 2 times a day.\n- aripiprazole 2 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 2 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:40:28, ended at 2011-06-14 17:43:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-06-14, presumably until 2011-07-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth as directed. Take 2 tablets every morning and 1 tablet every afternoon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-14 11:56:00, ended at 2011-06-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 76 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.03 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12 (microgram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 33 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-06-15 00:00:00, ended at 2011-06-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-15, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:44:00, ended at 2011-06-16 08:47:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Disorder of brain\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:48:00, ended at 2011-06-16 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-22 01:00:00, ended at 2011-06-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation\n\n### Condition\n- Finding of head and neck region\n- Benign neoplasm of pituitary gland and craniopharyngeal duct\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-22 10:30:48, ended at 2011-06-22 17:57:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 10 mg by mouth every bedtime.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2011-07-26. Instructions: 2 Puffs by Inhalation route as needed.\n- clonazepam 1 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 1 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-06-23 06:05:00, ended at 2011-07-26 14:23:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Base deficit in Blood: 1.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 366 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Prothrombin time (PT): N/A (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 39.0 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 94 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 51 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Osmolality of Serum or Plasma: 332 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.12 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: N/A (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.6 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 8 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78.6 (microgram per milliliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Osteoplasty of cranium with flap of bone\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computer assisted surgery with MR/MRA\n- Evaluation of speech, language, voice, communication, and/or auditory processing\n- Insertion of endotracheal tube\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Percutaneous endoscopic gastrostomy\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Other exploration and decompression of spinal canal\n- Evaluation of oral and pharyngeal swallowing function\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of venous blood by venipuncture\n- Venous catheterization, not elsewhere classified\n- Partial excision of pituitary gland by transsphenoidal approach\n- Computed tomography, head or brain; without contrast material\n- Controlled ventilation procedure and therapy, initiation and management\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Insertion of catheter into artery\n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n\n### Condition\n- Asthma\n- Cachexia\n- Disorder of nasal cavity\n- Disorder of pituitary gland\n- Obesity\n- Blind or low vision - both eyes\n- Diabetes insipidus\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Atelectasis\n- Episodic mood disorder\n- Pleural effusion\n- Visual disturbance\n- Acute respiratory failure\n- Finding of head and neck region\n- Panhypopituitarism\n- Abnormal findings on diagnostic imaging of skull and head\n- Bipolar affective disorder, currently manic, severe, with psychosis\n- Disturbance of consciousness\n- Hyperosmolality and or hypernatremia\n- Lung field abnormal\n- Malnutrition (calorie)\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Pulmonary congestion and hypostasis\n- Acquired hypothyroidism\n- Fever\n- Homonymous hemianopia\n- Anxiety state\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n- Disorder of posterior pituitary\n- Blindness AND/OR vision impairment level\n- Pneumonitis due to inhaled substance\n- Tobacco dependence syndrome\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-07-14, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 3 Tabs by mouth every morning.\n- hydrocortisone 100 MG Injection, started on 2011-06-23, presumably until 2011-07-04\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-06-24, presumably until 2011-07-07\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-07-12, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- desmopressin acetate 0.2 MG Oral Tablet, through Oral route, started on 2011-07-08, presumably until 2011-07-09\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 250 MG Oral Capsule, through Oral route, started on 2011-07-08, presumably until 2011-11-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth every bedtime.\n- levothyroxine sodium 0.2 MG Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-05\n- olanzapine 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-06-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2012-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-06-29, presumably until 2011-07-05\n- haloperidol 5 MG/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-05\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-24, presumably until 2011-06-30\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-18, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2011-06-24, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-07-01, presumably until 2011-07-06\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-07-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-07-07, presumably until 2011-07-21\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2011-07-03, presumably until 2011-07-03\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-06-29, presumably until 2011-07-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-06-28, presumably until 2011-06-30\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-06-23, presumably until 2011-06-23\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily before dinner.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-07-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- olanzapine 10 MG Injection, through Intramuscular route, started on 2011-06-24, presumably until 2011-06-30\n- hydrocortisone 20 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-06-30, presumably until 2011-07-03\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-01, presumably until 2011-07-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2011-07-15, presumably until 2011-07-15, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-03\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-07-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-06-27\n- cefepime 2000 MG Injection, through Intravenous route, started on 2011-06-27, presumably until 2011-07-07\n- atomoxetine 40 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-27. Instructions: take 40 mg by mouth 2 times a day.\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-28\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- lorazepam 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-06-26, presumably until 2011-06-28\n- desmopressin acetate 0.004 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-23, presumably until 2011-07-06\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-04\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- clonazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24. Instructions: take 1 mg by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-07-05, presumably until 2011-07-06\n- midazolam 1 MG/ML Injectable Solution, started on 2011-06-30, presumably until 2011-06-30\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-11. Instructions: take 2 mg by mouth Every Day.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2011-07-02, presumably until 2012-07-14, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every 2 hours.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2011-07-15\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-13 13:26:26, ended at 2011-08-13 14:48:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-13 17:32:00, ended at 2011-08-14 01:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Bipolar disorder\n- Neoplasm of uncertain behavior of pituitary gland\n- Visual disturbance\n- Postprocedural state finding\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2011-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:31, ended at 2011-09-13 12:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take  by mouth. 0.1 mg qhs, 0.05 mg in morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:48, ended at 2011-09-13 12:58:33\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 13:22:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.4 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 34 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-15 10:10:00, ended at 2011-11-15 14:42:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of pituitary gland\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:56:54, ended at 2011-11-15 15:37:29\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n- fluoxetine 20 MG Oral Capsule, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:57:10, ended at 2011-11-15 16:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-11-15 14:43:00, ended at 2011-11-16 15:45:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.23 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 57.3 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.0 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 28 (millimeter mercury column)\n- Body height: 5' 3\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 57 (nanogram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n\n### Condition\n- Edema\n- Seizure\n- Anxiety state\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Psychotic disorder\n- Acquired hypothyroidism\n- Blind or low vision - both eyes\n- Dysthymia\n- Low blood pressure\n- Panhypopituitarism\n- Insomnia\n- Diabetes insipidus\n- Hyperlipidemia\n- Visual disturbance\n- Cough\n- Disorder of pituitary gland\n- Failure to thrive\n- Heteronymous bilateral visual field defects\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 3 Tabs by mouth every morning.\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-01-03, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 250 MG Extended Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Cap by mouth 2 times a day.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth every bedtime.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-03 10:16:11, ended at 2012-01-03 11:43:09\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take 100 mcg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-03 11:51:00, ended at 2012-01-03 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-17 14:02:05, ended at 2012-04-17 17:12:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Adrenal cortical hypofunction\n- Disorder of pituitary gland\n- Diabetes insipidus\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route. Instructions: take 0.1 mg by mouth as directed. 0.05 mg po qAM, 0.1 mg po qhs \n- hydrocortisone 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth 2 times a day.  \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, presumably until 2015-02-17. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-17 15:50:00, ended at 2012-04-18 12:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prolactin [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: <0.01 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Blindness AND/OR vision impairment level\n- Diabetes insipidus\n- Disorder of nasal cavity\n- Disorder of visual pathways\n- Panhypopituitarism\n- Severe visual impairment\n- Essential hypertension\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-05-09 12:40:00, ended at 2011-05-09 19:32:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Headache\n- Blepharitis\n- Posttraumatic stress disorder\n- Visual disturbance\n- Keratitis\n- Myopia\n\n### Drug\n- hypromellose 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day.\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 0.5 cm to both eyes 2 times a day. For 5 days in each eye\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 08:00:34, ended at 2011-05-21 09:57:57\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-29 12:55:00, ended at 2011-05-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Finding of head and neck region\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-31 00:00:00, ended at 2011-05-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm of uncertain behavior of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:01:04, ended at 2011-06-14 17:43:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- atomoxetine 40 MG Oral Capsule, through Oral route, presumably until 2011-07-26. Instructions: take 40 mg by mouth 2 times a day.\n- aripiprazole 2 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 2 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:40:28, ended at 2011-06-14 17:43:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-06-14, presumably until 2011-07-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth as directed. Take 2 tablets every morning and 1 tablet every afternoon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-14 11:56:00, ended at 2011-06-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 76 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.03 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12 (microgram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 33 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-06-15 00:00:00, ended at 2011-06-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-15, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:44:00, ended at 2011-06-16 08:47:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Disorder of brain\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:48:00, ended at 2011-06-16 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-22 01:00:00, ended at 2011-06-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation\n\n### Condition\n- Finding of head and neck region\n- Benign neoplasm of pituitary gland and craniopharyngeal duct\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-22 10:30:48, ended at 2011-06-22 17:57:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 10 mg by mouth every bedtime.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2011-07-26. Instructions: 2 Puffs by Inhalation route as needed.\n- clonazepam 1 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 1 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-06-23 06:05:00, ended at 2011-07-26 14:23:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Base deficit in Blood: 1.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 366 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Prothrombin time (PT): N/A (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 39.0 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 94 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 51 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Osmolality of Serum or Plasma: 332 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.12 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: N/A (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.6 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 8 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78.6 (microgram per milliliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Osteoplasty of cranium with flap of bone\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computer assisted surgery with MR/MRA\n- Evaluation of speech, language, voice, communication, and/or auditory processing\n- Insertion of endotracheal tube\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Percutaneous endoscopic gastrostomy\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Other exploration and decompression of spinal canal\n- Evaluation of oral and pharyngeal swallowing function\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of venous blood by venipuncture\n- Venous catheterization, not elsewhere classified\n- Partial excision of pituitary gland by transsphenoidal approach\n- Computed tomography, head or brain; without contrast material\n- Controlled ventilation procedure and therapy, initiation and management\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Insertion of catheter into artery\n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n\n### Condition\n- Asthma\n- Cachexia\n- Disorder of nasal cavity\n- Disorder of pituitary gland\n- Obesity\n- Blind or low vision - both eyes\n- Diabetes insipidus\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Atelectasis\n- Episodic mood disorder\n- Pleural effusion\n- Visual disturbance\n- Acute respiratory failure\n- Finding of head and neck region\n- Panhypopituitarism\n- Abnormal findings on diagnostic imaging of skull and head\n- Bipolar affective disorder, currently manic, severe, with psychosis\n- Disturbance of consciousness\n- Hyperosmolality and or hypernatremia\n- Lung field abnormal\n- Malnutrition (calorie)\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Pulmonary congestion and hypostasis\n- Acquired hypothyroidism\n- Fever\n- Homonymous hemianopia\n- Anxiety state\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n- Disorder of posterior pituitary\n- Blindness AND/OR vision impairment level\n- Pneumonitis due to inhaled substance\n- Tobacco dependence syndrome\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-07-14, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 3 Tabs by mouth every morning.\n- hydrocortisone 100 MG Injection, started on 2011-06-23, presumably until 2011-07-04\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-06-24, presumably until 2011-07-07\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-07-12, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- desmopressin acetate 0.2 MG Oral Tablet, through Oral route, started on 2011-07-08, presumably until 2011-07-09\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 250 MG Oral Capsule, through Oral route, started on 2011-07-08, presumably until 2011-11-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth every bedtime.\n- levothyroxine sodium 0.2 MG Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-05\n- olanzapine 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-06-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2012-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-06-29, presumably until 2011-07-05\n- haloperidol 5 MG/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-05\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-24, presumably until 2011-06-30\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-18, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2011-06-24, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-07-01, presumably until 2011-07-06\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-07-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-07-07, presumably until 2011-07-21\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2011-07-03, presumably until 2011-07-03\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-06-29, presumably until 2011-07-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-06-28, presumably until 2011-06-30\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-06-23, presumably until 2011-06-23\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily before dinner.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-07-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- olanzapine 10 MG Injection, through Intramuscular route, started on 2011-06-24, presumably until 2011-06-30\n- hydrocortisone 20 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-06-30, presumably until 2011-07-03\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-01, presumably until 2011-07-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2011-07-15, presumably until 2011-07-15, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-03\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-07-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-06-27\n- cefepime 2000 MG Injection, through Intravenous route, started on 2011-06-27, presumably until 2011-07-07\n- atomoxetine 40 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-27. Instructions: take 40 mg by mouth 2 times a day.\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-28\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- lorazepam 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-06-26, presumably until 2011-06-28\n- desmopressin acetate 0.004 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-23, presumably until 2011-07-06\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-04\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- clonazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24. Instructions: take 1 mg by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-07-05, presumably until 2011-07-06\n- midazolam 1 MG/ML Injectable Solution, started on 2011-06-30, presumably until 2011-06-30\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-11. Instructions: take 2 mg by mouth Every Day.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2011-07-02, presumably until 2012-07-14, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every 2 hours.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2011-07-15\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-13 13:26:26, ended at 2011-08-13 14:48:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-13 17:32:00, ended at 2011-08-14 01:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Bipolar disorder\n- Neoplasm of uncertain behavior of pituitary gland\n- Visual disturbance\n- Postprocedural state finding\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2011-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:31, ended at 2011-09-13 12:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take  by mouth. 0.1 mg qhs, 0.05 mg in morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:48, ended at 2011-09-13 12:58:33\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 13:22:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.4 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 34 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-15 10:10:00, ended at 2011-11-15 14:42:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of pituitary gland\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:56:54, ended at 2011-11-15 15:37:29\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n- fluoxetine 20 MG Oral Capsule, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:57:10, ended at 2011-11-15 16:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-11-15 14:43:00, ended at 2011-11-16 15:45:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.23 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 57.3 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.0 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 28 (millimeter mercury column)\n- Body height: 5' 3\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 57 (nanogram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n\n### Condition\n- Edema\n- Seizure\n- Anxiety state\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Psychotic disorder\n- Acquired hypothyroidism\n- Blind or low vision - both eyes\n- Dysthymia\n- Low blood pressure\n- Panhypopituitarism\n- Insomnia\n- Diabetes insipidus\n- Hyperlipidemia\n- Visual disturbance\n- Cough\n- Disorder of pituitary gland\n- Failure to thrive\n- Heteronymous bilateral visual field defects\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 3 Tabs by mouth every morning.\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-01-03, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 250 MG Extended Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Cap by mouth 2 times a day.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth every bedtime.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-03 10:16:11, ended at 2012-01-03 11:43:09\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take 100 mcg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-03 11:51:00, ended at 2012-01-03 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-17 14:02:05, ended at 2012-04-17 17:12:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Adrenal cortical hypofunction\n- Disorder of pituitary gland\n- Diabetes insipidus\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route. Instructions: take 0.1 mg by mouth as directed. 0.05 mg po qAM, 0.1 mg po qhs \n- hydrocortisone 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth 2 times a day.  \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, presumably until 2015-02-17. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-17 15:50:00, ended at 2012-04-18 12:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prolactin [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: <0.01 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Blindness AND/OR vision impairment level\n- Diabetes insipidus\n- Disorder of nasal cavity\n- Disorder of visual pathways\n- Panhypopituitarism\n- Severe visual impairment\n- Essential hypertension\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e162d0a191d016a0fc6e7d0027afeb800783fe539f5b769d774b71f4ea97370c", "prompt_hash": "b579407dd8a83334f6ae5c217ad7fa080504c7a97784477648f5072ed0dbfa3e", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967545, "visit_occurrence_id": 168111161, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2020-10-28 00:00:00", "visit_end_datetime": "2020-10-28 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 91, "patient_first_visit_date": "2017-08-08 00:00:00", "patient_last_visit_date": "2021-12-21 10:38:54", "end_obs_date": "2021-10-28", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 43, "cumulated_visit_num": 43, "cumulated_approximate_token_count": 10330, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-08 00:00:00, ended at 2017-08-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-08 13:48:42, ended at 2017-08-08 15:19:30\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Disorder of kidney and/or ureter\n- Sleep apnea\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (40 mg total) by mouth daily\n- atorvastatin 80 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth daily\n- rivaroxaban 20 MG Oral Tablet, started on 2017-05-14, presumably until 2017-05-14, with intended 1 refill(s). Instructions: every day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-08 15:32:00, ended at 2017-08-08 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.50 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 10:56:00, ended at 2017-09-25 13:48:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-09-25, presumably until 2017-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 13:49:00, ended at 2017-09-25 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 08:01:39, ended at 2017-11-12 08:54:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.32\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic fibrosis\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 12:31:12, ended at 2017-11-12 14:23:32\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Urogenital finding\n- Primary diagnosis: Hydronephrosis\n- Acute renal failure syndrome\n- Chronic kidney disease stage 3\n- Urinary tract obstruction\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-15 00:00:00, ended at 2017-11-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-27 00:00:00, ended at 2017-11-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Acute non-ST segment elevation myocardial infarction\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-12 07:14:00, ended at 2017-12-12 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.08 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 208 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-12 07:56:19, ended at 2017-12-12 09:36:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thromboembolism of vein\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 07:20:00, ended at 2017-12-28 07:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.8 (percent)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 09:30:00, ended at 2017-12-28 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 67 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, started on 2018-01-10, presumably until 2018-02-06, with intended 0 refill(s). Instructions: One syringe subcu 01/15/2018 q 12 hours.  Last syringe 01/16/2018 in am.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 09:57:45, ended at 2018-01-10 12:06:21\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-10 12:13:00, ended at 2018-01-10 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.39 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.1 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 164 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney and/or ureter\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 13:00:12, ended at 2018-01-10 14:06:34\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; renal procedures, including upper one-third of ureter, or donor nephrectomy\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hydronephrosis\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- cefazolin 1000 MG Injection, started on 2018-01-17, presumably until 2018-01-17\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- ketamine 100 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- iothalamic acid, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- iothalamate, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 06:01:00, ended at 2018-01-20 13:20:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.05 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -2.9 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 178.0 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Carbon dioxide [Partial pressure] in Arterial blood: 38.5 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 145 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Ultrasonic guidance, intraoperative\n- Resection of Right Kidney, Percutaneous Endoscopic Approach\n- Excision of Right Kidney, Percutaneous Endoscopic Approach, Diagnostic\n- Laparoscopy, surgical; pyeloplasty\n- Cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service\n- Robotic Assisted Procedure of Trunk Region, Percutaneous Endoscopic Approach\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Laparoscopy, surgical; nephrectomy, including partial ureterectomy\n\n### Condition\n- Aortocoronary bypass graft present\n- Coagulation factor deficiency syndrome\n- Hydronephrosis\n- Anesthesia of skin\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Uncomplicated asthma\n- Obstructive sleep apnea syndrome\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic kidney disease stage 3\n- Old myocardial infarction\n- Chronic kidney disease due to hypertension\n- Illness\n- Primary malignant neoplasm of kidney\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2018-01-17, presumably until 2018-01-20\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-01-20, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-01-17, presumably until 2018-01-18\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-19\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-02-03 00:00:00, ended at 2018-02-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of urinary system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-06 00:00:00, ended at 2018-02-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cellulitis of abdominal wall\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-02-06, presumably until 2018-02-13, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 09:57:06, ended at 2018-02-06 12:47:03\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney, NOS\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 13:02:00, ended at 2018-02-06 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.26 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.34 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cellulitis of abdominal wall\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 14:24:01, ended at 2018-02-06 14:57:17\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:13:00, ended at 2018-05-08 07:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:14:00, ended at 2018-05-08 10:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 10:14:00, ended at 2018-05-08 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-08 10:31:15, ended at 2018-05-08 12:28:13\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:05:00, ended at 2018-12-26 07:20:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.83 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.3 (percent)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Absent kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-26 09:41:30, ended at 2018-12-26 10:32:44\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-30 00:00:00, ended at 2019-09-30 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-25 06:59:00, ended at 2019-12-25 06:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Non-toxic multinodular goiter\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-08 00:00:00, ended at 2017-08-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-08 13:48:42, ended at 2017-08-08 15:19:30\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Disorder of kidney and/or ureter\n- Sleep apnea\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (40 mg total) by mouth daily\n- atorvastatin 80 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth daily\n- rivaroxaban 20 MG Oral Tablet, started on 2017-05-14, presumably until 2017-05-14, with intended 1 refill(s). Instructions: every day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-08 15:32:00, ended at 2017-08-08 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.50 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 10:56:00, ended at 2017-09-25 13:48:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Kidney imaging morphology; with vascular flow and function, single study, with pharmacological intervention (eg, angiotensin converting enzyme inhibitor and/or diuretic)\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-09-25, presumably until 2017-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-25 13:49:00, ended at 2017-09-25 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 08:01:39, ended at 2017-11-12 08:54:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.32\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic fibrosis\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-12 12:31:12, ended at 2017-11-12 14:23:32\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Urogenital finding\n- Primary diagnosis: Hydronephrosis\n- Acute renal failure syndrome\n- Chronic kidney disease stage 3\n- Urinary tract obstruction\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-15 00:00:00, ended at 2017-11-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-27 00:00:00, ended at 2017-11-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Acute non-ST segment elevation myocardial infarction\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-12 07:14:00, ended at 2017-12-12 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.08 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 208 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-12 07:56:19, ended at 2017-12-12 09:36:26\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thromboembolism of vein\n- Primary diagnosis: Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 07:20:00, ended at 2017-12-28 07:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.8 (percent)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-28 09:30:00, ended at 2017-12-28 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 67 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Impaired fasting glycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-10 00:00:00, ended at 2018-01-10 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Resistance to activated protein C due to Factor V Leiden\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, started on 2018-01-10, presumably until 2018-02-06, with intended 0 refill(s). Instructions: One syringe subcu 01/15/2018 q 12 hours.  Last syringe 01/16/2018 in am.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 09:57:45, ended at 2018-01-10 12:06:21\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-10 12:13:00, ended at 2018-01-10 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Prothrombin time (PT): 15.3 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.39 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.1 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 164 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney and/or ureter\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-10 13:00:12, ended at 2018-01-10 14:06:34\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; renal procedures, including upper one-third of ureter, or donor nephrectomy\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Hydronephrosis\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- cefazolin 1000 MG Injection, started on 2018-01-17, presumably until 2018-01-17\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-01-17, presumably until 2018-01-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- ketamine 100 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-01-17 00:00:00, ended at 2018-01-17 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2018-01-17, presumably until 2018-01-17\n- iothalamic acid, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2018-01-17, presumably until 2018-01-17\n- iothalamate, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-01-17 06:01:00, ended at 2018-01-20 13:20:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.05 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Body height: 5' 7\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -2.9 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 178.0 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Carbon dioxide [Partial pressure] in Arterial blood: 38.5 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 145 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Ultrasonic guidance, intraoperative\n- Resection of Right Kidney, Percutaneous Endoscopic Approach\n- Excision of Right Kidney, Percutaneous Endoscopic Approach, Diagnostic\n- Laparoscopy, surgical; pyeloplasty\n- Cystourethroscopy, with ureteral catheterization, with or without irrigation, instillation, or ureteropyelography, exclusive of radiologic service\n- Robotic Assisted Procedure of Trunk Region, Percutaneous Endoscopic Approach\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Laparoscopy, surgical; nephrectomy, including partial ureterectomy\n\n### Condition\n- Aortocoronary bypass graft present\n- Coagulation factor deficiency syndrome\n- Hydronephrosis\n- Anesthesia of skin\n- Disorder of kidney and/or ureter\n- Hyperlipidemia\n- Uncomplicated asthma\n- Obstructive sleep apnea syndrome\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic kidney disease stage 3\n- Old myocardial infarction\n- Chronic kidney disease due to hypertension\n- Illness\n- Primary malignant neoplasm of kidney\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2018-01-17, presumably until 2018-01-20\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-01-20, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2018-01-17, presumably until 2018-01-18\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-17\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-01-17, presumably until 2018-02-06, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-19\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-01-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-01-17, presumably until 2018-01-19\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2018-01-17, presumably until 2018-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-02-03 00:00:00, ended at 2018-02-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of urinary system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-06 00:00:00, ended at 2018-02-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cellulitis of abdominal wall\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-02-06, presumably until 2018-02-13, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 09:57:06, ended at 2018-02-06 12:47:03\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.929\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney, NOS\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-06 13:02:00, ended at 2018-02-06 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.26 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.34 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cellulitis of abdominal wall\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-06 14:24:01, ended at 2018-02-06 14:57:17\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:13:00, ended at 2018-05-08 07:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 07:14:00, ended at 2018-05-08 10:13:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-08 10:14:00, ended at 2018-05-08 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-08 10:31:15, ended at 2018-05-08 12:28:13\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of kidney\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:05:00, ended at 2018-12-26 07:20:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.83 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.3 (percent)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.33 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-26 07:21:00, ended at 2018-12-26 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n- Absent kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-26 09:41:30, ended at 2018-12-26 10:32:44\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.93\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-30 00:00:00, ended at 2019-09-30 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-25 06:59:00, ended at 2019-12-25 06:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Non-toxic multinodular goiter\n- Absent kidney\n- Acquired absence of organ\n- Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of kidney\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c7f2e67e959f3f68ead2d889c2f719e43217c79c5dd92f832286f7421c6d6d8e", "prompt_hash": "57a8805bd92f7eb20e91b6c8727aa1840b96f34dc2deb3ae4dd39eaf5bd14bf1", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115967769, "visit_occurrence_id": 159320772, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2020-05-17 00:00:00", "visit_end_datetime": "2020-05-17 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n", "approximate_token_count": 123, "patient_first_visit_date": "2012-03-31 14:46:00", "patient_last_visit_date": "2023-02-06 10:56:09", "end_obs_date": "2021-05-17", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 129, "cumulated_visit_num": 129, "cumulated_approximate_token_count": 24713, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "158c09c66bbc2808a3e20c763d96a3c5eed1be8e0ff71a701fa5d42ab1404da8", "prompt_hash": "ea909e77d798efcf0dd2a490062bbec9224fc81410602069fa048c28cdb9e4bf", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115967856, "visit_occurrence_id": 39958617, "death_date": "2020-06-30", "visit_concept_name": "Office Visit", "visit_start_datetime": "2010-06-29 12:56:24", "visit_end_datetime": "2010-06-29 14:41:45", "visit_length_in_hours": 1.7558333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2010-06-29 12:56:24, ended at 2010-06-29 14:41:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 83, "patient_first_visit_date": "2008-02-17 00:00:00", "patient_last_visit_date": "2018-10-23 10:43:00", "end_obs_date": "2011-06-29", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 18, "cumulated_visit_num": 18, "cumulated_approximate_token_count": 6821, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-02-17 00:00:00, ended at 2008-02-17 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-10 00:00:00, ended at 2008-03-10 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 32 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.62 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.75 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-24 00:00:00, ended at 2008-03-24 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 350 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-22 11:30:15, ended at 2009-09-22 13:22:26\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-22 12:07:00, ended at 2009-09-22 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-23 15:01:05, ended at 2009-09-23 15:48:43\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 15:57:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 328 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary cardiomyopathy\n- Osteoarthritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-19 14:30:00, ended at 2009-10-19 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-19 00:00:00, ended at 2009-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint derangement\n- Primary diagnosis: Disorder of hip joint\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2010-05-18, with quantity of 8.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-06 12:42:36, ended at 2009-12-06 13:53:39\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-16 13:06:25, ended at 2010-03-16 15:37:46\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 14:16:00, ended at 2010-03-16 16:16:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; complete, minimum of 3 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Aseptic necrosis of bone\n- Mechanical complication of internal joint prosthesis\n- Congenital subluxation of hip\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-20 00:00:00, ended at 2010-03-20 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-03-20, presumably until 2010-09-16. Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-02 11:55:20, ended at 2010-05-02 14:14:25\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-02 14:21:00, ended at 2010-05-02 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 139 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Joint derangement\n- Disorder of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-05-15 12:48:00, ended at 2010-05-18 09:50:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 113 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Bone graft\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Revision of total hip replacement\n- Radiologic examination, pelvis; 1 or 2 views\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n\n### Condition\n- Chronic hepatitis C\n- Mitral valve disorder\n- Primary cardiomyopathy\n- Asthma\n- Essential hypertension\n- Joint derangement\n- Periprosthetic osteolysis\n- Prosthetic joint dislocation\n- Prosthetic joint loosening\n- Disorder of hip joint\n- Bone marrow transplant present\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous gluconate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous fumarate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous ascorbate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron,peptonized, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous succinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous bisglycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cysteine glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous aspartate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ammonium ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- soy protein-iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-15\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- ferrous carbonate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-17\n- ferrous glycine sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- folic acid, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-17, presumably until 2013-06-11, with quantity of 11.0, with intended 0 refill(s). Instructions: 40 mg by SUBCUTANEOUS route daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-16\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron succinyl milk protein complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron-dextran complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- teferrol, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-05-16, presumably until 2011-05-17, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- ferrous asparto glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cacodylate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous oxalate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- iron sucrose, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron carbonyl, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous lactate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous chloride, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-16, presumably until 2010-05-18\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-11-13, with quantity of 90.0, with intended 0 refill(s). Instructions: take 2-4 Tabs by mouth every 4 hours as needed \n- iron sorbitex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous phosphate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2013-06-11. Instructions: take by mouth 2 times a day. \n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-05-15, presumably until 2010-05-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-30 15:08:36, ended at 2010-05-30 16:33:38\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-29 12:56:24, ended at 2010-06-29 14:41:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-02-17 00:00:00, ended at 2008-02-17 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-10 00:00:00, ended at 2008-03-10 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 32 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.62 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.75 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-24 00:00:00, ended at 2008-03-24 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 45 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 350 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-22 11:30:15, ended at 2009-09-22 13:22:26\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-22 12:07:00, ended at 2009-09-22 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-23 15:01:05, ended at 2009-09-23 15:48:43\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 15:57:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 328 (thousand per microliter)\n- Prothrombin time (PT): 13.1 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary cardiomyopathy\n- Osteoarthritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-19 14:30:00, ended at 2009-10-19 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-19 00:00:00, ended at 2009-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint derangement\n- Primary diagnosis: Disorder of hip joint\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2009-11-19, presumably until 2010-05-18, with quantity of 8.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-06 12:42:36, ended at 2009-12-06 13:53:39\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-16 13:06:25, ended at 2010-03-16 15:37:46\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-16 14:16:00, ended at 2010-03-16 16:16:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, pelvis; complete, minimum of 3 views\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n\n### Condition\n- Aseptic necrosis of bone\n- Mechanical complication of internal joint prosthesis\n- Congenital subluxation of hip\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-20 00:00:00, ended at 2010-03-20 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-03-20, presumably until 2010-09-16. Instructions: take 1 Tab by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-02 11:55:20, ended at 2010-05-02 14:14:25\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-02 14:21:00, ended at 2010-05-02 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 139 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Joint derangement\n- Disorder of hip joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-05-15 12:48:00, ended at 2010-05-18 09:50:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.09 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 113 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Bone graft\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Revision of total hip replacement\n- Radiologic examination, pelvis; 1 or 2 views\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n\n### Condition\n- Chronic hepatitis C\n- Mitral valve disorder\n- Primary cardiomyopathy\n- Asthma\n- Essential hypertension\n- Joint derangement\n- Periprosthetic osteolysis\n- Prosthetic joint dislocation\n- Prosthetic joint loosening\n- Disorder of hip joint\n- Bone marrow transplant present\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous gluconate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous fumarate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous ascorbate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron,peptonized, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous succinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous bisglycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cysteine glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous aspartate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ammonium ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- soy protein-iron complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-15\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- ferrous carbonate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-17\n- ferrous glycine sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- folic acid, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-17, presumably until 2013-06-11, with quantity of 11.0, with intended 0 refill(s). Instructions: 40 mg by SUBCUTANEOUS route daily. \n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2010-05-15, presumably until 2010-05-16\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron succinyl milk protein complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron-dextran complex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- teferrol, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-05-16, presumably until 2011-05-17, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- ferrous asparto glycinate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous cacodylate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-05-15, presumably until 2010-05-16\n- iron, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous oxalate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-05-17, presumably until 2010-05-17\n- iron sucrose, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous sulfate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- iron carbonyl, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous lactate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous chloride, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-16\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2010-05-16, presumably until 2010-05-18\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-11-13, with quantity of 90.0, with intended 0 refill(s). Instructions: take 2-4 Tabs by mouth every 4 hours as needed \n- iron sorbitex, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- ferrous phosphate, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2013-06-11. Instructions: take by mouth 2 times a day. \n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2010-05-16, presumably until 2010-05-18\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-05-15, presumably until 2010-05-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-30 15:08:36, ended at 2010-05-30 16:33:38\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hip joint\n- Primary diagnosis: Joint derangement\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-29 12:56:24, ended at 2010-06-29 14:41:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Prosthetic arthroplasty of hip\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "095fe041e500853f219d348b65c98524582f08082258c7c0c31568cc8cd4998c", "prompt_hash": "bccd03e6c8849fee2378b3204dd1d94625720b0652c409df0f9de1ddf870a6df", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115968035, "visit_occurrence_id": 174248134, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-02-07 00:00:00", "visit_end_datetime": "2021-02-07 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 82, "patient_first_visit_date": "2012-02-25 00:00:00", "patient_last_visit_date": "2023-01-06 00:00:00", "end_obs_date": "2022-02-07", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 69, "cumulated_visit_num": 69, "cumulated_approximate_token_count": 11418, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5a54a251c8fab7ff4520c8d2bb85622cc73b5c225566671138e0a6db41926e31", "prompt_hash": "f72dc52f06d9c7d27bcec3f90cff874775b2621d4ddc067f131284f5b56ccc7d", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 5, "doc": {"person_id": 115968945, "visit_occurrence_id": 41847305, "death_date": null, "visit_concept_name": "Emergency Room and Inpatient Visit", "visit_start_datetime": "2010-11-30 16:02:00", "visit_end_datetime": "2010-12-05 11:55:00", "visit_length_in_hours": 115.88333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n", "approximate_token_count": 2316, "patient_first_visit_date": "2008-07-01 02:25:00", "patient_last_visit_date": "2013-11-26 07:55:00", "end_obs_date": "2011-12-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 50, "cumulated_visit_num": 50, "cumulated_approximate_token_count": 16603, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d8c873cd38fa139f2c72860e17bbaed4ce73aaeda7054f32e1a655755b2f4620", "prompt_hash": "dee3d177e9de2c2909d8aa8367a7093699bd810c416f8c2698ac57c27c091dbb", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115969466, "visit_occurrence_id": 173590087, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-01-27 00:00:00", "visit_end_datetime": "2021-01-27 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-27 00:00:00, ended at 2021-01-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-27, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n", "approximate_token_count": 137, "patient_first_visit_date": "2014-03-21 01:58:00", "patient_last_visit_date": "2023-02-02 00:00:00", "end_obs_date": "2022-01-27", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 1, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 379, "cumulated_visit_num": 379, "cumulated_approximate_token_count": 81213, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-21 01:58:00, ended at 2014-03-29 16:27:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 338 (milligram per deciliter)\n- Osmolality of Urine: 574 (milliosmole per kilogram)\n- Thrombin time: 15.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.31 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.25 (milli-international unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Prothrombin time (PT): 16.0 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 357 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 94 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12.4 (microgram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Magnetic resonance angiography, head; without contrast material(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Radiologic examination, chest; single view, frontal\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Hospital discharge day management; more than 30 minutes\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n- Nerve conduction studies; 5-6 studies\n- Occupational therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Magnetic resonance angiography, neck; without contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Lumbar puncture\n- Open biopsy of cranial or peripheral nerve or ganglion\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Collection of venous blood by venipuncture\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Open biopsy of soft tissue\n- Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and prepari\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Acute renal failure syndrome\n- Arteritis\n- Diffuse cerebrovascular disease\n- Acquired deformity of ankle AND/OR foot\n- Altered mental status\n- Congestive heart failure\n- Disorder of brain\n- Eosinophil count raised\n- Eruption\n- Hyperkalemia\n- Cardiomegaly\n- Cerebral ischemia\n- Disorder of lower extremity\n- Disorder of posterior pituitary\n- Granulomatosis with polyangiitis\n- Hypo-osmolality and or hyponatremia\n- Polyarteritis nodosa\n- Primary diagnosis: Visual field defect\n- Disorder of skeletal muscle\n- Essential hypertension\n- Primary cardiomyopathy\n- Anemia in chronic kidney disease\n- First degree atrioventricular block\n- Renal function tests abnormal\n- Spontaneous ecchymosis\n- Organic mental disorder\n- Abnormal findings on diagnostic imaging of skull and head\n- Backache\n- Cardiomyopathy associated with another disorder\n- Chronic diastolic heart failure\n- Chronic kidney disease\n- Disorder of nervous system\n- Herpes simplex without complication\n- Electrocardiogram abnormal\n- Mononeuritis\n- Subarachnoid hemorrhage\n\n### Drug\n- ramipril 5 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-21\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 3 mL by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing.\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2023-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2014-03-22, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route daily.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 40 mg by Intravenous route daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed (pain or fever).\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-21, presumably until 2014-03-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-24, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-03-23, presumably until 2015-03-29, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 12 hours as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, through Subcutaneous route, started on 2014-03-21, presumably until 2014-05-14, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 8 hours.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-03-23, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 1 Singhal by mouth every bedtime.\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-03-27, presumably until 2014-03-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-03-24\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-10-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2014-03-29, presumably until 2014-03-29\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-03-26, presumably until 2014-03-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-03-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-03-26, presumably until 2014-03-26\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Muscle weakness\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2014-03-25, presumably until 2014-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-25, presumably until 2014-03-25\n- midazolam 1 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:06:18, ended at 2014-04-09 16:27:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-24 11:44:00, ended at 2014-04-24 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-04-24, presumably until 2014-04-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-24 15:16:36, ended at 2014-04-24 15:16:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-14 00:00:00, ended at 2014-05-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 2.1EF(MOD-sp4) (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-14 09:16:31, ended at 2014-05-14 10:23:33\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2014-09-04, with intended 6 refill(s). Instructions: take 4 Tabs by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2015-01-06, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 09:30:00, ended at 2014-05-14 10:28:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n\n### Condition\n- Localized swelling, mass and lump, trunk\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 10:29:00, ended at 2014-05-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 92.5 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.17 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-27 11:59:00, ended at 2014-05-27 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-27, presumably until 2014-05-27\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-27 12:40:23, ended at 2014-05-27 12:41:49\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-06-11 00:00:00, ended at 2014-06-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arteritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 09:44:00, ended at 2014-06-26 10:55:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.65 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ulcerative colitis\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 10:56:00, ended at 2014-06-26 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.488\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-06-26, presumably until 2014-06-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-26 12:33:34, ended at 2014-06-26 12:34:17\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 3 refill(s). Instructions: take 40 mg by mouth daily.\n- prednisone 5 MG Oral Tablet, started on 2014-06-26, presumably until 2014-07-31, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- cyclophosphamide 25 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-08-01, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily.\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 09:56:00, ended at 2014-07-31 11:17:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 34 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Cataract\n- Presbyopia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-31 10:22:03, ended at 2014-07-31 11:10:54\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 11:18:00, ended at 2014-07-31 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 10 (milligram per gram)\n- Albumin [Mass/volume] in Urine: 10 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-05 09:30:00, ended at 2014-08-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-05, presumably until 2014-08-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-05 14:28:42, ended at 2014-08-05 17:01:53\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arteritis\n- Inflammatory and toxic neuropathy\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-18 00:00:00, ended at 2014-08-18 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-08-18, presumably until 2014-09-04, with intended 3 refill(s). Instructions: take 2 tablets by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-04 00:00:00, ended at 2014-09-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-09-04, presumably until 2014-11-11, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 10 MG Oral Tablet, started on 2014-09-04, presumably until 2014-11-06, with intended 6 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-22 00:00:00, ended at 2014-09-22 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-14 11:53:00, ended at 2014-10-14 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 17 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.90 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cataract\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-14 15:17:41, ended at 2014-10-14 16:01:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Ma..., through Intramuscular route, started on 2014-10-14, presumably until 2014-10-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, presumably until 2014-11-11, with intended 0 refill(s). Instructions: take  by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-04 00:00:00, ended at 2014-11-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myocardial infarction of anterior wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 12:34:00, ended at 2014-11-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte sedimentation rate: 13 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.23 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 9 (milligram per gram)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-05 13:51:43, ended at 2014-11-05 14:20:57\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation\n\n### Condition\n- Primary diagnosis: Cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Taper as instructed by MD.\n- prednisone 5 MG Oral Tablet, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-11-10 00:00:00, ended at 2014-11-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin sulfates, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- cefazolin 1000 MG Injection, started on 2014-11-10, presumably until 2014-11-10\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-11-10, presumably until 2014-11-10\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-10 11:50:00, ended at 2014-11-10 14:31:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n- Aspiration of cataract by phacoemulsification\n\n### Condition\n- Visual field defect\n- Hypermetropia\n- Presbyopia\n- Cataract\n- Asthma\n- Gastroesophageal reflux disease\n- Age related macular degeneration\n- Cardiac arrhythmia\n- Chronic kidney disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-11 13:56:14, ended at 2014-11-11 14:39:52\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-11-11, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-18 10:24:00, ended at 2014-11-18 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 19 (milligram per gram)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils [#/volume] in Blood by Automated count: 7.61 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 331 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Urine: 11 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin sulfates, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- cefazolin 1000 MG Injection, started on 2014-12-15, presumably until 2014-12-15\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-12-15, presumably until 2014-12-15\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 11:18:00, ended at 2014-12-15 14:40:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Aspiration of cataract by phacoemulsification\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n\n### Condition\n- Asthma\n- Chronic kidney disease\n- Cataract\n- Heart failure\n- Disorder of kidney and/or ureter\n- Granulomatosis with polyangiitis\n- Age related macular degeneration\n- Allergic disposition\n- Chronic sinusitis\n- Allergic rhinitis\n- Gastroesophageal reflux disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-12-15, presumably until 2014-12-15\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-24 12:07:00, ended at 2014-12-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.76 (thousand per microliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 09:29:01, ended at 2015-01-06 10:29:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 11:18:21, ended at 2015-01-06 12:06:39\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Age related macular degeneration\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-01-06, presumably until 2015-04-30, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 1 MG Oral Tablet, started on 2015-01-06, presumably until 2015-05-05, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- prednisone 5 MG Oral Tablet, started on 2015-01-06, presumably until 2015-03-27, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2016-10-20, with intended 0 refill(s). Instructions: take 6.25 mg by mouth 2 times a day with meals \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-10 00:00:00, ended at 2015-02-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 10:04:24, ended at 2015-02-10 12:34:34\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n\n### Condition\n- Eruption\n- Primary diagnosis: Chronic rhinitis\n- Chronic sinusitis\n- Asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 14:51:30, ended at 2015-02-10 16:38:58\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Chronic rhinitis\n- Eruption\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 16:11:09, ended at 2015-02-10 17:15:16\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-03 00:00:00, ended at 2015-03-03 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 09:01:58, ended at 2015-03-03 10:32:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 11 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 11:10:19, ended at 2015-03-03 13:37:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Granulomatosis with polyangiitis\n- IgE-mediated allergic asthma\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-03-03, presumably until 2015-05-05, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-03 12:47:00, ended at 2015-03-03 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Acute myocardial infarction of anterior wall\n- Cerebral infarction due to embolism of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 15:08:13, ended at 2015-03-03 16:51:51\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-04-16, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-27 00:00:00, ended at 2015-03-27 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2015-03-31, presumably until 2015-08-25, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2015-04-17, presumably until 2015-04-17, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-30 00:00:00, ended at 2015-04-30 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-04-30, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-05-05 00:00:00, ended at 2015-05-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-05 09:35:00, ended at 2015-05-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 18 (milligram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 129.70 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.98 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-05 10:09:27, ended at 2015-05-05 10:55:28\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- potassium chloride 25 MEQ Effervescent Oral Tablet, through Oral route, started on 2015-05-05, presumably until 2016-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-24 10:42:00, ended at 2015-06-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.64 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 32.50 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 12:52:33, ended at 2015-06-24 14:33:10\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 14:50:21, ended at 2015-06-24 15:40:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-06-24, presumably until 2015-08-25, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-07-07 00:00:00, ended at 2015-07-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 10:22:00, ended at 2015-07-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 79.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n- Chronic sinusitis\n- Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-21 13:38:44, ended at 2015-07-21 14:47:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-07-21, presumably until 2016-05-19, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- cephalexin 500 MG Oral Capsule, through Oral route, presumably until 2015-07-21, with intended 0 refill(s). Instructions: take by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-25 10:45:00, ended at 2015-08-25 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Creatinine [Mass/volume] in Urine: 55.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.85 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of muscle\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 11:35:10, ended at 2015-08-25 12:35:45\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n- Asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-08-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 14:05:22, ended at 2015-08-25 15:02:39\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.04 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Disorder of muscle\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-04-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, started on 2015-08-25, presumably until 2015-12-23, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-26 00:00:00, ended at 2015-08-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-28 00:00:00, ended at 2015-09-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-12 00:00:00, ended at 2015-11-12 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-18 10:21:00, ended at 2015-11-18 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 168 (picogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 120.7 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.83 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-18 11:04:02, ended at 2015-11-18 11:46:02\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-23 10:30:00, ended at 2015-12-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 123.8 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.64 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of bone\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-23 11:24:15, ended at 2015-12-23 11:52:17\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-01-05 00:00:00, ended at 2016-01-05 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 14:12:49, ended at 2016-02-04 16:12:30\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 16:10:44, ended at 2016-02-04 16:53:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, presumably until 2019-04-30, with intended 0 refill(s). Instructions: take 20 mEq by mouth 2 times a day Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-19 00:00:00, ended at 2016-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-20 11:37:00, ended at 2016-04-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 59.99 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.40 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 292 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-20 12:00:20, ended at 2016-04-20 12:18:01\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2016-04-20, presumably until 2016-09-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 1 MG Oral Tablet, started on 2016-04-20, presumably until 2016-09-19, with intended 2 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-29 00:00:00, ended at 2016-04-29 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-05-18 00:00:00, ended at 2016-05-18 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 10:46:24, ended at 2016-05-19 12:06:35\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 60 minutes\n\n### Condition\n- No conditions.\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, started on 2016-05-19, presumably until 2017-04-12, with intended 0 refill(s). Instructions: Take 2 tablets by mouth initially then 1 tablet by mouth following each loose stool. Not to exceed 8 tablets per day\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 1,440 Units into a muscle One Time\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n- typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily Take one tablet daily, starting 1-2 days prior to travel to malarious area. Continue daily while in malarious area and for 7 days after leaving area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 13:25:31, ended at 2016-05-19 14:01:55\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2016-05-19, presumably until 2016-10-10, with intended 6 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- fexofenadine hydrochloride 180 MG Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-09 00:00:00, ended at 2016-06-09 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-09 15:45:46, ended at 2016-06-09 16:14:23\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypokalemia\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-13 00:00:00, ended at 2016-06-13 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-14 00:00:00, ended at 2016-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-14 12:20:00, ended at 2016-07-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Urine: 32.09 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-14 14:04:01, ended at 2016-07-14 14:32:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-09-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-10-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-08-09 00:00:00, ended at 2016-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-06 00:00:00, ended at 2016-09-06 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-15 00:00:00, ended at 2016-09-15 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-15, presumably until 2016-09-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-16 00:00:00, ended at 2016-09-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 24 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 199 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 21 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10635 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Protein [Mass/volume] in Urine: 5 (milligram per deciliter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Basophils [#/volume] in Blood by Automated count: 0 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 445 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 208 (milligram per gram of creatinine)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 2.0 (calculated)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.13 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 421 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Essential hypertension\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-09-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-20 00:00:00, ended at 2016-09-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-09-20, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-28 00:00:00, ended at 2016-09-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-28, presumably until 2017-01-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-30 00:00:00, ended at 2016-09-30 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-10 00:00:00, ended at 2016-10-10 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-10-10, presumably until 2017-01-19, with intended 3 refill(s). Instructions: SPRAY 1 SPRAY NASALLY 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-20 12:33:00, ended at 2016-10-20 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 18.05 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.39 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-20 14:20:04, ended at 2016-10-20 14:56:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-11 00:00:00, ended at 2016-11-11 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-11-14, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-14 11:39:00, ended at 2016-12-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 10.31 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-14 14:17:25, ended at 2016-12-14 15:07:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 10:48:04, ended at 2017-01-19 10:48:30\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Inhalation, started on 2017-01-19, presumably until 2017-12-26, with intended 3 refill(s). Instructions: 1 Spray by Inhalation route 2 times a day as needed (rhinitis)\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-01-19, presumably until 2017-07-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 14:07:24, ended at 2017-01-19 14:50:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: Take 4mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-07 00:00:00, ended at 2017-02-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-09 00:00:00, ended at 2017-02-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-02-14, presumably until 2017-03-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 11:18:15, ended at 2017-02-09 12:28:04\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.913\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 12:38:08, ended at 2017-02-09 13:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-14 00:00:00, ended at 2017-02-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-22 00:00:00, ended at 2017-02-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-02-23, presumably until 2017-02-23, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-21 00:00:00, ended at 2017-03-21 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-03-21, presumably until 2017-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-12 10:51:00, ended at 2017-04-12 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 26.74 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Erythrocyte sedimentation rate: 14 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.02 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Osteoporosis\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 11:17:25, ended at 2017-04-12 12:11:15\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2017-04-12, presumably until 2018-01-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2017-01-04, presumably until 2017-08-10, with intended 0 refill(s). Instructions:   </br>1 Puff Aerosol, INH, BID, 6 gm, 0, Maintenance\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 14:58:04, ended at 2017-04-12 15:24:37\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-04-12, presumably until 2017-07-17, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-04-12, presumably until 2017-09-05, with intended 3 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-24 00:00:00, ended at 2017-05-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-31 00:00:00, ended at 2017-05-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- levalbuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2017-05-31, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 3 mL by Nebulization route 4 times a day as needed\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2017-05-31, presumably until 2018-02-01, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-07 00:00:00, ended at 2017-06-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-06-07, presumably until 2018-06-07, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY DR\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-07-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily Or as directed by MD.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-12, presumably until 2017-09-05, with intended 0 refill(s). Instructions: Take as directed by MD for tapering\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-13, presumably until 2017-06-13, with intended 6 refill(s). Instructions: TAKE 4 TABLETS ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 12:56:20, ended at 2017-06-15 15:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 14:25:08, ended at 2017-06-15 15:08:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Exacerbation of mild persistent asthma\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-16 00:00:00, ended at 2017-06-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-22 00:00:00, ended at 2017-06-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-06-22, presumably until 2017-06-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-07-06, presumably until 2017-12-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-07-17, presumably until 2017-09-05, with intended 0 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-07-17, presumably until 2017-07-18, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-07-18, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-02 00:00:00, ended at 2017-08-02 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-10 11:38:00, ended at 2017-08-10 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 11.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-10 13:51:08, ended at 2017-08-10 15:20:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2017-01-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: 1 Cris Burt, Oliver, every 12 hours, PRN, as needed for pain, 0, Maintenance\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-08-10, presumably until 2017-12-26, with intended 11 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2019-10-22, with intended 0 refill(s). Instructions: take 3.125 mg by mouth daily as needed\n- citalopram 10 MG Oral Tablet, through Oral route, presumably until 2019-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-22 00:00:00, ended at 2017-08-22 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-08-22, presumably until 2018-08-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-24 15:25:49, ended at 2017-08-24 16:47:09\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nose and accessory sinuses; not otherwise specified\n\n### Condition\n- Heart failure\n- Transient cerebral ischemia\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- cefazolin 1000 MG Injection, started on 2017-08-25, presumably until 2017-08-25\n- remifentanil 2 MG Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein dilaurate, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 05:47:00, ended at 2017-08-25 12:19:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Replacement of Nasal Septum with Autologous Tissue Substitute, Open Approach\n- Submucous resection inferior turbinate, partial or complete, any method\n- Excision of Nasal Turbinate, Percutaneous Approach\n- Nasal/sinus endoscopy, surgical, with frontal sinus exploration, including removal of tissue from frontal sinus, when performed\n- Nasal/sinus endoscopy, surgical, with maxillary antrostomy\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Computer Assisted Procedure of Head and Neck Region\n- Excision of Right Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Ethmoid Sinus, Percutaneous Endoscopic Approach\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Nasal/sinus endoscopy, surgical, with sphenoidotomy\n- Repair Right Maxillary Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Frontal Sinus, Percutaneous Endoscopic Approach\n- Repair Left Maxillary Sinus, Percutaneous Endoscopic Approach\n- Septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft\n- Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior)\n- Excision of Left Frontal Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Ethmoid Sinus, Percutaneous Endoscopic Approach\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Degenerative disorder of macula\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n- Osteoporosis\n- Seasonal allergic rhinitis\n- Presbyopia\n- Allergic rhinitis\n- Disorder of nasal cavity\n- Chronic sinusitis\n- Disorder of kidney and/or ureter\n- Essential hypertension\n- Heart failure\n- Uncomplicated asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-05 12:31:57, ended at 2017-09-05 13:01:26\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2017-09-05, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-05 15:21:00, ended at 2017-09-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of nasal cavity\n- Allergic rhinitis due to animal dander\n- Disorder of bone\n- Chronic sinusitis\n- Osteoporosis\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-28 13:12:56, ended at 2017-09-28 14:17:14\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or debridement (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-12 11:00:00, ended at 2017-10-12 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 332 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 24.94 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 11:34:28, ended at 2017-10-12 12:34:37\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 13:54:53, ended at 2017-10-12 15:07:57\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n- Allergic rhinitis due to pollen\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-10-12, presumably until 2017-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 15:15:57, ended at 2017-10-12 16:10:38\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-19 00:00:00, ended at 2017-10-19 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Acute asthma\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-10-19, presumably until 2017-12-26, with intended 0 refill(s). Instructions: Take 20 mg PO Qday x 7 days, then 10 mg PO Qday x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-02 12:54:42, ended at 2017-11-02 13:31:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 12:07:41, ended at 2017-12-26 12:43:08\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated mild persistent asthma\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-10-09, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-02-01, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2018-10-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-12-26, presumably until 2019-01-01, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2019-03-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 13:09:03, ended at 2017-12-26 14:24:20\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:27:00, ended at 2017-12-26 14:49:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 51.71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 19 (kilounit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:50:00, ended at 2017-12-26 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperparathyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 12:55:22, ended at 2018-01-04 13:29:56\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 15:01:13, ended at 2018-01-04 16:10:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 11:22:54, ended at 2018-02-01 12:51:04\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic maxillary sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-02-01, presumably until 2018-09-06, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2018-02-01, presumably until 2018-09-06, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 13:32:31, ended at 2018-02-01 14:52:49\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Mononeuritis multiplex\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-10 00:00:00, ended at 2018-03-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-03-12, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 10:25:18, ended at 2018-03-21 10:50:18\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-21 11:12:00, ended at 2018-03-21 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.30 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Urine: <5.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 60.51 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.13 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 16 (kilounit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 182 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis\n- Hyperparathyroidism\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 11:22:44, ended at 2018-03-21 12:13:39\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-24 10:49:00, ended at 2018-04-24 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Chronic sinusitis\n- Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-24 14:54:36, ended at 2018-04-24 16:30:41\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-26 13:43:37, ended at 2018-06-26 14:46:12\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-04 00:00:00, ended at 2018-07-04 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-07-12, presumably until 2018-07-12, with intended 0 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 14:18:37, ended at 2018-07-19 14:45:47\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 15:26:30, ended at 2018-07-19 16:01:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Allergic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-14 11:59:13, ended at 2018-08-14 13:15:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe, started on 2018-09-05, presumably until 2018-09-05, with intended 0 refill(s). Instructions: LA:[000000]:05/18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-06 12:58:46, ended at 2018-09-06 14:41:57\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2019-03-20, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning with breakfast Takes 2-3 a day for pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-06 14:15:00, ended at 2018-09-06 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Cerebral infarction\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-10-09, presumably until 2019-01-31, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 10:40:45, ended at 2018-10-11 11:28:07\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Acute upper respiratory infection\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 12:08:12, ended at 2018-10-11 12:34:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 14:10:39, ended at 2018-10-11 14:36:43\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-18, presumably until 2018-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-24 00:00:00, ended at 2018-10-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2018-10-29, presumably until 2019-01-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 14 days\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-12-13, presumably until 2019-12-13, with intended 1 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 11:00:00, ended at 2018-12-12 14:56:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Chronic kidney disease\n- Cerebral infarction\n- Anemia in chronic kidney disease\n- Valvular endocarditis\n- Visual field defect\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 14:57:00, ended at 2018-12-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 13.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.1 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 88.78 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 152 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.93 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 108.0 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 259 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 10:43:30, ended at 2019-01-01 12:48:12\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic pansinusitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2019-01-01, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-01-01, presumably until 2019-04-04, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 12:52:22, ended at 2019-01-01 15:15:25\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Uncomplicated asthma\n- Chronic sinusitis\n- Primary diagnosis: Loss of sense of smell\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, started on 2019-01-01, presumably until 2019-03-20, with intended 11 refill(s). Instructions: Use 1 ampule as directed BID.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-24 14:46:39, ended at 2019-01-24 15:22:41\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-01-29, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-06-18, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-02-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-29 00:00:00, ended at 2019-01-29 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-29, presumably until 2019-08-13, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-31 00:00:00, ended at 2019-01-31 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-01-31, presumably until 2020-03-02, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-12 15:03:19, ended at 2019-02-12 16:29:50\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphonia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 11:37:58, ended at 2019-03-07 12:21:35\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Chronic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- fexofenadine hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-03-07, presumably until 2019-05-13, with intended 11 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-07-29, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 15:33:11, ended at 2019-03-07 17:03:08\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-19 12:17:38, ended at 2019-03-19 14:02:29\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n- Disorder of the larynx\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2019-03-19, presumably until 2019-05-13, with intended 3 refill(s). Instructions: take 5 mL by mouth 4 times a day\n- fluconazole 150 MG Oral Tablet, started on 2019-03-19, presumably until 2019-03-20, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 4 days if symptoms persist.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, head; without contrast material(s)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Hypertrophic condition of skin\n- Essential hypertension\n- Osteoporosis\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- gadobenate, through Intravenous route, started on 2019-03-20, presumably until 2019-03-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 09:56:33, ended at 2019-03-20 10:25:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2019-03-20, presumably until 2020-03-04, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 13:31:38, ended at 2019-03-20 15:07:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypertrophic condition of skin\n- Primary diagnosis: Pain in right foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-20, presumably until 2019-03-20, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-27, presumably until 2019-03-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-04 11:42:40, ended at 2019-04-04 12:33:34\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-04 14:09:00, ended at 2019-04-04 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.17 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 30.13 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 5.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-24 00:00:00, ended at 2019-04-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-05-01, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 12:05:26, ended at 2019-04-30 15:57:31\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm\n\n### Condition\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 13:14:52, ended at 2019-04-30 14:18:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n- Dysphonia\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n- Neoplastic disease of uncertain behavior\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-13 10:55:27, ended at 2019-05-13 12:12:51\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olopatadine 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-05-08, presumably until 2019-05-08, with intended 0 refill(s). Instructions: Instill 1 drop to both eyes as needed\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-05-13, presumably until 2019-05-13, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2019-04-14, presumably until 2019-05-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:15:00, ended at 2019-05-13 12:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Tailor's bunion\n- Pain in right foot\n- Talipes planus\n- Acquired hallux varus\n- Essential hypertension\n- Pain in left foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:30:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-15 00:00:00, ended at 2019-05-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-05-15, presumably until 2020-05-11, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-18 10:57:51, ended at 2019-06-18 12:08:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-06-18, presumably until 2019-10-09, with intended 3 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n- gabapentin 100 MG Oral Capsule, through Oral route, presumably until 2019-08-13, with intended 0 refill(s). Instructions: take 100 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-09 11:00:00, ended at 2019-07-09 11:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-17 00:00:00, ended at 2019-07-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-07-29, presumably until 2019-12-25, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-13 10:36:00, ended at 2019-08-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 26.70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <4.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bunion\n- Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Chronic pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 13:18:06, ended at 2019-08-13 13:37:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Primary diagnosis: Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2019-09-20, with intended 2 refill(s). Instructions: take 1 Tab (50 mg total) by mouth as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 14:05:12, ended at 2019-08-13 14:51:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2020-02-04, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2019-08-26, presumably until 2019-08-27, with intended 2 refill(s). Instructions: take 2 Tabs (2,000 mg total) by mouth 2 times a day for 1 day PRN cold sores\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-05 00:00:00, ended at 2019-09-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 09:26:05, ended at 2019-09-12 14:45:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, started on 2019-08-30, presumably until 2019-09-13, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 11:31:14, ended at 2019-09-12 13:11:07\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Eosinophilic asthma\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-13 07:30:00, ended at 2019-09-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Supraventricular tachycardia\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-20 00:00:00, ended at 2019-09-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-09-20, presumably until 2019-10-25, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every bedtime as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 20 Tabs by mouth every day\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-09-23, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-09 00:00:00, ended at 2019-10-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 08:15:00, ended at 2019-10-09 11:14:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone length studies (orthoroentgenogram, scanogram)\n\n### Condition\n- Osteoarthritis of knee\n- Acquired genu valgum\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 08:55:12, ended at 2019-10-09 09:27:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-10-09, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 11:15:00, ended at 2019-10-09 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Osteoporosis\n- Disorder of bone\n- Pain in thoracic spine\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Pain of left knee region\n- Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 15:03:15, ended at 2019-10-09 15:53:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in thoracic spine\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-21 00:00:00, ended at 2019-10-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2019-10-22, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-25 00:00:00, ended at 2019-10-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-10-28, presumably until 2019-12-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-28 00:00:00, ended at 2019-10-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-04 00:00:00, ended at 2019-11-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 09:50:06, ended at 2019-11-05 10:25:56\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 11:12:09, ended at 2019-11-05 12:04:23\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Uncomplicated severe persistent asthma\n- Chronic rhinitis\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 12:22:32, ended at 2019-11-05 14:38:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 13:22:35, ended at 2019-11-05 14:31:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-05 13:50:00, ended at 2019-11-05 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 15 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.10 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-08 00:00:00, ended at 2019-11-08 08:07:41\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-25, presumably until 2019-12-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-02 00:00:00, ended at 2019-12-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-05, presumably until 2019-12-10, with intended 1 refill(s). Instructions: 3 mL (1.25 mg total) by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing (cough)\n- prednisone 5 MG Oral Tablet, started on 2019-12-05, presumably until 2020-02-04, with intended 0 refill(s). Instructions: Take 10 mg x 1 week, then 5 mg x 1 week\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-12-05, presumably until 2020-02-20, with intended 2 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-05 00:00:00, ended at 2019-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-12-05, presumably until 2020-01-22, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2019-12-10, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 1 Dose by Injection route every 4 hours as needed Use as directed\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-10, presumably until 2020-01-09, with intended 1 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 08:59:06, ended at 2019-12-11 09:45:31\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute bronchitis\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-11 10:29:00, ended at 2019-12-11 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Melanocytic nevus of trunk\n- Acute sinusitis\n- Disorder of immune function\n- Hyperpigmentation of skin\n- Melanocytic nevus of lower limb\n- Temporomandibular joint disorder\n- Scar conditions and fibrosis of skin\n- Essential hypertension\n- Acute bronchitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Melanocytic nevus of upper limb\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 12:17:22, ended at 2019-12-11 13:40:55\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Scar conditions and fibrosis of skin\n- Hyperpigmentation of skin\n- Primary diagnosis: Melanocytic nevus of lower limb\n- Disorder of immune function\n- Primary diagnosis: Melanocytic nevus of trunk\n- Primary diagnosis: Melanocytic nevus of upper limb\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-19 00:00:00, ended at 2019-12-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2019-12-25, presumably until 2020-10-06, with intended 10 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-01-22, presumably until 2020-02-29, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Eosinophilic asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-01-22, presumably until 2020-07-21, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-04 09:13:00, ended at 2020-02-04 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 6.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 39.80 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 73.8 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 09:50:25, ended at 2020-02-04 10:17:09\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 10:45:37, ended at 2020-02-04 12:08:30\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Joint pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 12:20:34, ended at 2020-02-04 13:04:58\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-05-19, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reduced mobility\n- Primary diagnosis: Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed fracture of lower leg\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 12:15:00, ended at 2020-02-20 13:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed bimalleolar fracture\n- Closed fracture of lower leg\n- Arthralgia of the ankle and/or foot\n- Closed fracture of fibula\n- Closed fracture of medial malleolus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 13:42:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; 2 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-21 00:00:00, ended at 2020-02-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nonunion of fracture\n- Primary diagnosis: Closed bimalleolar fracture\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2020-02-21, presumably until 2020-02-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (for pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of deltoid ligament of ankle\n- Sprain of ankle\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- cefazolin 1000 MG Injection, started on 2020-02-27, presumably until 2020-02-27\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- ketamine 100 MG/ML Injectable Solution, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Open treatment of distal fibular fracture (lateral malleolus), includes internal fixation, when performed\n- Manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated\n- Open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of ankle\n- Sprain of deltoid ligament of ankle\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 07:19:00, ended at 2020-02-29 13:20:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Left ventricular Ejection fraction: 61.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n\n### Procedure\n- Repair Right Ankle Bursa and Ligament, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Reposition Right Fibula with Internal Fixation Device, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n\n### Condition\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Pain\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated asthma\n- Essential hypertension\n- First degree atrioventricular block\n- Illness\n- Persistent pain following procedure\n- Chronic systolic heart failure\n- Gastroesophageal reflux disease without esophagitis\n- Closed fracture of lower leg\n- Sprain of deltoid ligament of ankle\n- Electrocardiogram abnormal\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2020-02-28, presumably until 2020-02-29\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-02-27, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 2 Caps (200 mg total) by mouth 2 times a day as needed for Constipation\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-28\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-02-29, presumably until 2020-02-29\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 1 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily as needed\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 1 Tab (650 mg total) by mouth every 6 hours\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-02-27, presumably until 2020-02-28\n- carboxymethylcellulose sodium 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2020-02-28, presumably until 2020-02-29\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-04-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed for Pain\n- 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2020-02-29, presumably until 2020-02-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-04 00:00:00, ended at 2020-03-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2021-05-21, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-10 09:00:00, ended at 2020-03-10 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of medial malleolus\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 10:41:24, ended at 2020-04-07 12:14:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic pansinusitis\n- Primary diagnosis: Eosinophilic asthma\n- Chronic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 12:40:59, ended at 2020-04-07 13:56:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-12-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-10-23, with intended 0 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-07 13:56:18, ended at 2020-04-07 13:56:28\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Loss of consciousness\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-13 00:00:00, ended at 2020-04-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-04-28, presumably until 2020-05-26, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-23 09:50:00, ended at 2020-04-23 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Tailor's bunion\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Arthralgia of the ankle and/or foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-09 00:00:00, ended at 2020-05-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-05-11, presumably until 2020-08-11, with intended 2 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-15 00:00:00, ended at 2020-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 00:00:00, ended at 2020-05-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-05-19, presumably until 2020-12-23, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-05-26, presumably until 2020-06-02, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-05-25, presumably until 2020-06-01, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-26 00:00:00, ended at 2020-05-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-01 00:00:00, ended at 2020-06-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-01, presumably until 2020-06-16, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-02 00:00:00, ended at 2020-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-06-02, presumably until 2020-07-13, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 09:23:00, ended at 2020-06-16 15:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Late effect of fracture of lower extremities\n- Melanocytic nevus\n- Postoperative state\n- Closed bimalleolar fracture\n- Supraventricular tachycardia\n- Arthralgia of the ankle and/or foot\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 11:49:33, ended at 2020-06-16 13:26:49\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-16, presumably until 2020-06-25, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-16, presumably until 2020-06-18, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2020-06-16, presumably until 2020-06-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 13:05:45, ended at 2020-06-16 15:41:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Melanocytic nevus\n- Primary diagnosis: Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 14:48:32, ended at 2020-06-16 15:36:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 15:42:00, ended at 2020-06-16 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.12 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Creatinine [Mass/volume] in Urine: 77.29 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-17 00:00:00, ended at 2020-06-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-18 00:00:00, ended at 2020-06-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-18, presumably until 2020-08-21, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-19 00:00:00, ended at 2020-06-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, started on 2020-06-19, presumably until 2021-11-19, with intended 0 refill(s). Instructions: USE ONE VIAL BY INHALATION ROUTE EVERY 4 HOURS AS NEEDED FOR COUGH/WHEEZE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-08-20, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-07-07, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Primary diagnosis: Bacterial infectious disease\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-07-02, presumably until 2020-08-27, with intended 1 refill(s). Instructions: Apply to affected areas BID x 5-7 days until improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-07 11:06:14, ended at 2020-07-07 16:16:38\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-07-07, presumably until 2020-08-17, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- prednisone 5 MG Oral Tablet, started on 2020-07-07, presumably until 2020-07-09, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-07-07, presumably until 2020-11-03, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-09, presumably until 2020-07-21, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-10 00:00:00, ended at 2020-07-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-07-13, presumably until 2020-10-23, with intended 2 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 12:46:03, ended at 2020-07-14 13:10:35\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Recurrent acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute pansinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-10-06, with intended 11 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-08-13, with intended 0 refill(s). Instructions: 30 mg x 7 days, 20 mg x 7 days, 10 mg x 7 days, 5 mg x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-10 00:00:00, ended at 2020-08-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-11, presumably until 2021-01-26, with intended 0 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-13 11:05:59, ended at 2020-08-13 15:45:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2020-08-13, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-17 00:00:00, ended at 2020-08-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-17, presumably until 2020-08-20, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-20, presumably until 2021-05-21, with intended 1 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-18 00:00:00, ended at 2020-08-18 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-20 00:00:00, ended at 2020-08-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-20, presumably until 2020-08-21, with intended 0 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-08-20 10:05:43, ended at 2020-08-20 11:13:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n- Spasm\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Blood chemistry abnormal\n- Primary diagnosis: Disorder of bone\n- Lymphocytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-20 10:45:00, ended at 2020-08-20 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Metatarsalgia\n- Pain in right foot\n- Postoperative state\n- Closed bimalleolar fracture\n- Closed fracture of lateral malleolus\n- Acquired hallux varus\n- Hammer toe\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-21 00:00:00, ended at 2020-08-21 08:04:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Eosinophilic asthma\n- Primary diagnosis: Insomnia\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 M..., through Intramuscular route, started on 2020-08-21, presumably until 2020-08-21, with intended 0 refill(s). Instructions: inject into a muscle\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-08-21, with intended 12 refill(s). Instructions: take 1 Tab (3 mg total) by mouth every bedtime as needed (insomnia)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-21 00:00:00, ended at 2020-08-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-21, presumably until 2020-12-07, with intended 3 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-24 00:00:00, ended at 2020-08-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-24 00:00:00, ended at 2020-08-24 10:20:37\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Candidiasis of mouth\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-08-27, presumably until 2020-12-07, with intended 0 refill(s). Instructions: APPLY TO THE AFFECTED AREA(S) TWICE DAILY FOR 5 TO 7 DAYS UNTIL IMPROVED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-08 11:04:53, ended at 2020-09-08 12:09:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphocytopenia\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-10 11:26:40, ended at 2020-09-10 13:35:18\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Primary diagnosis: Tailor's bunion\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-17 00:00:00, ended at 2020-09-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-09-17, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open bimalleolar fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-23 00:00:00, ended at 2020-09-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-23 11:15:00, ended at 2020-09-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Dysphonia\n- Pain in right foot\n- Chronic pansinusitis\n- Disorder of bone\n- Spasm\n- Lymphocytopenia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-24 00:00:00, ended at 2020-09-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-24 08:30:00, ended at 2020-09-24 12:10:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Ostectomy, partial excision, fifth metatarsal head (bunionette) (separate procedure)\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n- Osteoporosis\n- Tailor's bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-09-24, presumably until 2020-09-24\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tailor's bunion\n- Pain in right foot\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-25, presumably until 2020-09-26, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-26 00:00:00, ended at 2020-09-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Tailor's bunion\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-26, presumably until 2020-10-08, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-10-06, presumably until 2021-02-09, with intended 3 refill(s). Instructions: Take by mouth every bedtime\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2020-10-06, presumably until 2021-07-05, with intended 3 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-08 09:35:08, ended at 2020-10-08 10:27:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Candidiasis of mouth\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Acute exacerbation of chronic obstructive airways disease\n\n### Drug\n- prednisone 1 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 4 mg x 7 days, then 3 mg x 7 days, 2 mg x 7 days, 1 mg x 7 days\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2020-10-13, presumably until 2020-10-15, with intended 3 refill(s). Instructions: 1 Plunkett (18 mcg total) by Inhalation route daily\n- fluconazole 150 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 72 hour if not improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clotrimazole 10 MG Oral Lozenge, through Oral route, started on 2020-10-09, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Lozenge (10 mg total) by mouth 5 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-13 00:00:00, ended at 2020-10-13 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n- Chronic kidney disease\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-23, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-23 00:00:00, ended at 2020-10-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-02, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 09:51:00, ended at 2020-10-26 12:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Postoperative state\n- Metatarsal bone fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-26 09:51:03, ended at 2020-10-26 12:26:39\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n- Primary diagnosis: Postoperative state\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 13:00:00, ended at 2020-10-26 14:02:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 3\n- Pain in right foot\n- Postoperative state\n- Uncomplicated severe persistent asthma\n- Tailor's bunion\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 14:03:00, ended at 2020-10-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 147 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 97.0 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 27 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 32 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.05 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-27 12:43:28, ended at 2020-10-27 13:54:28\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-03 15:51:11, ended at 2020-11-03 16:43:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-11-03, presumably until 2021-01-25, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-11-10 13:09:35, ended at 2020-11-10 14:05:34\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Chronic kidney disease stage 3A\n- Essential hypertension\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-20 00:00:00, ended at 2020-11-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-23 00:00:00, ended at 2020-11-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-11-23, presumably until 2021-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-25 00:00:00, ended at 2020-11-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-07 00:00:00, ended at 2020-12-07 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2020-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth every day\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2021-11-19, with intended 12 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-12-08 11:45:37, ended at 2020-12-08 12:18:16\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Cellulitis\n- Chronic sinusitis\n- Chronic obstructive lung disease\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2020-12-08, presumably until 2020-12-18, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-14 08:30:00, ended at 2020-12-14 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Dysphonia\n- Hammer toe\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Metatarsal bone fracture\n- Closed bimalleolar fracture\n- Metatarsalgia\n- Acquired hallux varus\n- Pain in right foot\n- Postoperative state\n- Tailor's bunion\n- Chronic frontal sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-15 00:00:00, ended at 2020-12-15 12:19:53\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-12-15, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2020-12-23, presumably until 2021-01-06, with intended 0 refill(s). Instructions: TAKE TWO TABLETS BY MOUTH DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, started on 2020-12-23, presumably until 2022-01-20, with intended 12 refill(s). Instructions: TAKE 1 TABLET (20MEQ) BY MOUT HEVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-01 00:00:00, ended at 2021-01-01 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2021-01-05, presumably until 2021-02-08, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN, APPOINTMENT NEEDED BEFORE NEXT REFILL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-02 00:00:00, ended at 2021-01-02 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2021-01-04, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-04 00:00:00, ended at 2021-01-04 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-04, presumably until 2021-02-09, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 00:00:00, ended at 2021-01-06 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-15, with intended 0 refill(s). Instructions: take 1.5 Tabs (75 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-25 00:00:00, ended at 2021-01-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-25, presumably until 2021-01-27, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-26 08:44:00, ended at 2021-01-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 20.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.11 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 89.00 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.22 (milligram per milligram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Hammer toe\n- Metatarsalgia\n- Non-rheumatic aortic sclerosis\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 09:16:50, ended at 2021-01-26 10:35:10\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic aortic sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 10:42:23, ended at 2021-01-26 12:24:26\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated severe persistent asthma\n- Osteoporosis\n- Non-rheumatic aortic sclerosis\n- Uncomplicated moderate persistent asthma\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-27 00:00:00, ended at 2021-01-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-27, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-21 01:58:00, ended at 2014-03-29 16:27:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 338 (milligram per deciliter)\n- Osmolality of Urine: 574 (milliosmole per kilogram)\n- Thrombin time: 15.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 229 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.31 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.25 (milli-international unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Prothrombin time (PT): 16.0 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 357 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 94 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12.4 (microgram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Magnetic resonance angiography, head; without contrast material(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Radiologic examination, chest; single view, frontal\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n- Hospital discharge day management; more than 30 minutes\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n- Nerve conduction studies; 5-6 studies\n- Occupational therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Magnetic resonance angiography, neck; without contrast material(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Lumbar puncture\n- Open biopsy of cranial or peripheral nerve or ganglion\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Collection of venous blood by venipuncture\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Open biopsy of soft tissue\n- Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and prepari\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Acute renal failure syndrome\n- Arteritis\n- Diffuse cerebrovascular disease\n- Acquired deformity of ankle AND/OR foot\n- Altered mental status\n- Congestive heart failure\n- Disorder of brain\n- Eosinophil count raised\n- Eruption\n- Hyperkalemia\n- Cardiomegaly\n- Cerebral ischemia\n- Disorder of lower extremity\n- Disorder of posterior pituitary\n- Granulomatosis with polyangiitis\n- Hypo-osmolality and or hyponatremia\n- Polyarteritis nodosa\n- Primary diagnosis: Visual field defect\n- Disorder of skeletal muscle\n- Essential hypertension\n- Primary cardiomyopathy\n- Anemia in chronic kidney disease\n- First degree atrioventricular block\n- Renal function tests abnormal\n- Spontaneous ecchymosis\n- Organic mental disorder\n- Abnormal findings on diagnostic imaging of skull and head\n- Backache\n- Cardiomyopathy associated with another disorder\n- Chronic diastolic heart failure\n- Chronic kidney disease\n- Disorder of nervous system\n- Herpes simplex without complication\n- Electrocardiogram abnormal\n- Mononeuritis\n- Subarachnoid hemorrhage\n\n### Drug\n- ramipril 5 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-21\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 3 mL by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing.\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2023-01-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2014-03-22, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route daily.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-05-14, with intended 0 refill(s). Instructions: 40 mg by Intravenous route daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-03-22, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed (pain or fever).\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-21, presumably until 2014-03-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-03-24, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-23\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-03-23, presumably until 2015-03-29, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 12 hours as needed.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, through Subcutaneous route, started on 2014-03-21, presumably until 2014-05-14, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 8 hours.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-03-23, presumably until 2014-07-31, with intended 0 refill(s). Instructions: take 1 Singhal by mouth every bedtime.\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-03-27, presumably until 2014-03-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-03-24\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-03-24, presumably until 2014-10-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2014-03-25, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2014-03-29, presumably until 2014-03-29\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-03-26, presumably until 2014-03-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-23, presumably until 2014-03-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-03-26, presumably until 2014-03-26\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2014-03-29, presumably until 2014-05-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-03-21, presumably until 2014-03-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-03-25 00:00:00, ended at 2014-03-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nerves, muscles, tendons, and fascia of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Muscle weakness\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2014-03-25, presumably until 2014-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-25, presumably until 2014-03-25\n- midazolam 1 MG/ML Injectable Solution, started on 2014-03-25, presumably until 2014-03-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:06:18, ended at 2014-04-09 16:27:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-24 11:44:00, ended at 2014-04-24 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-04-24, presumably until 2014-04-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-04-24, presumably until 2014-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-24 15:16:36, ended at 2014-04-24 15:16:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-14 00:00:00, ended at 2014-05-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 2.1EF(MOD-sp4) (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-14 09:16:31, ended at 2014-05-14 10:23:33\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2014-09-04, with intended 6 refill(s). Instructions: take 4 Tabs by mouth daily.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2014-05-14, presumably until 2015-01-06, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 09:30:00, ended at 2014-05-14 10:28:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n\n### Condition\n- Localized swelling, mass and lump, trunk\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-14 10:29:00, ended at 2014-05-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 92.5 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.17 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-27 11:59:00, ended at 2014-05-27 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-27, presumably until 2014-05-27\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-05-27, presumably until 2014-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-27 12:40:23, ended at 2014-05-27 12:41:49\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-06-11 00:00:00, ended at 2014-06-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arteritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 09:44:00, ended at 2014-06-26 10:55:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.65 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ulcerative colitis\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-26 10:56:00, ended at 2014-06-26 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.488\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-06-26, presumably until 2014-06-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-26 12:33:34, ended at 2014-06-26 12:34:17\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Ulcerative colitis\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 3 refill(s). Instructions: take 40 mg by mouth daily.\n- prednisone 5 MG Oral Tablet, started on 2014-06-26, presumably until 2014-07-31, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- cyclophosphamide 25 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-08-01, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily.\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2014-06-26, presumably until 2014-10-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 09:56:00, ended at 2014-07-31 11:17:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 34 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Cataract\n- Presbyopia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-31 10:22:03, ended at 2014-07-31 11:10:54\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-31 11:18:00, ended at 2014-07-31 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 10 (milligram per gram)\n- Albumin [Mass/volume] in Urine: 10 (milligram per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-05 09:30:00, ended at 2014-08-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-05, presumably until 2014-08-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-08-05, presumably until 2014-08-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-05 14:28:42, ended at 2014-08-05 17:01:53\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arteritis\n- Inflammatory and toxic neuropathy\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-18 00:00:00, ended at 2014-08-18 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-08-18, presumably until 2014-09-04, with intended 3 refill(s). Instructions: take 2 tablets by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-04 00:00:00, ended at 2014-09-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-09-04, presumably until 2014-11-11, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 10 MG Oral Tablet, started on 2014-09-04, presumably until 2014-11-06, with intended 6 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-22 00:00:00, ended at 2014-09-22 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-14 11:53:00, ended at 2014-10-14 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 17 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.90 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cataract\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-14 15:17:41, ended at 2014-10-14 16:01:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Ma..., through Intramuscular route, started on 2014-10-14, presumably until 2014-10-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, presumably until 2014-11-11, with intended 0 refill(s). Instructions: take  by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-04 00:00:00, ended at 2014-11-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myocardial infarction of anterior wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 12:34:00, ended at 2014-11-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte sedimentation rate: 13 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.23 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 9 (milligram per gram)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-05 13:51:43, ended at 2014-11-05 14:20:57\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation\n\n### Condition\n- Primary diagnosis: Cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Taper as instructed by MD.\n- prednisone 5 MG Oral Tablet, started on 2014-11-06, presumably until 2015-01-06, with intended 3 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-11-10 00:00:00, ended at 2014-11-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin sulfates, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- cefazolin 1000 MG Injection, started on 2014-11-10, presumably until 2014-11-10\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-11-10, presumably until 2014-11-10\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-10 11:50:00, ended at 2014-11-10 14:31:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n- Aspiration of cataract by phacoemulsification\n\n### Condition\n- Visual field defect\n- Hypermetropia\n- Presbyopia\n- Cataract\n- Asthma\n- Gastroesophageal reflux disease\n- Age related macular degeneration\n- Cardiac arrhythmia\n- Chronic kidney disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-11-10, presumably until 2014-11-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-11 13:56:14, ended at 2014-11-11 14:39:52\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2014-11-11, presumably until 2015-01-06, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-18 10:24:00, ended at 2014-11-18 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 19 (milligram per gram)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils [#/volume] in Blood by Automated count: 7.61 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 331 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Urine: 11 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hyaluronate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin sulfates, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- chondroitin 4-sulfate, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- cefazolin 1000 MG Injection, started on 2014-12-15, presumably until 2014-12-15\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-12-15, presumably until 2014-12-15\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-15 11:18:00, ended at 2014-12-15 14:40:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Aspiration of cataract by phacoemulsification\n- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation\n- One stage extracapsular extraction of lens and insertion of prosthetic intraocular lens\n\n### Condition\n- Asthma\n- Chronic kidney disease\n- Cataract\n- Heart failure\n- Disorder of kidney and/or ureter\n- Granulomatosis with polyangiitis\n- Age related macular degeneration\n- Allergic disposition\n- Chronic sinusitis\n- Allergic rhinitis\n- Gastroesophageal reflux disease\n\n### Drug\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-12-15, presumably until 2014-12-15\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-12-15, presumably until 2014-12-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-12-24 00:00:00, ended at 2014-12-24 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-24 12:07:00, ended at 2014-12-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.76 (thousand per microliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Age related macular degeneration\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 09:29:01, ended at 2015-01-06 10:29:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-06 11:18:21, ended at 2015-01-06 12:06:39\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Age related macular degeneration\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-01-06, presumably until 2015-04-30, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- prednisone 1 MG Oral Tablet, started on 2015-01-06, presumably until 2015-05-05, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- prednisone 5 MG Oral Tablet, started on 2015-01-06, presumably until 2015-03-27, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2016-10-20, with intended 0 refill(s). Instructions: take 6.25 mg by mouth 2 times a day with meals \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-10 00:00:00, ended at 2015-02-10 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 10:04:24, ended at 2015-02-10 12:34:34\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n\n### Condition\n- Eruption\n- Primary diagnosis: Chronic rhinitis\n- Chronic sinusitis\n- Asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 14:51:30, ended at 2015-02-10 16:38:58\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Chronic rhinitis\n- Eruption\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-10 16:11:09, ended at 2015-02-10 17:15:16\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-03 00:00:00, ended at 2015-03-03 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 09:01:58, ended at 2015-03-03 10:32:17\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 11 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Age related macular degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 11:10:19, ended at 2015-03-03 13:37:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Granulomatosis with polyangiitis\n- IgE-mediated allergic asthma\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-03-03, presumably until 2015-05-05, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-03 12:47:00, ended at 2015-03-03 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Acute myocardial infarction of anterior wall\n- Cerebral infarction due to embolism of cerebral arteries\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-03 15:08:13, ended at 2015-03-03 16:51:51\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-04-16, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-03-27 00:00:00, ended at 2015-03-27 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2015-03-31, presumably until 2015-08-25, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-17 00:00:00, ended at 2015-04-17 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2015-04-17, presumably until 2015-04-17, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-30 00:00:00, ended at 2015-04-30 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-04-30, presumably until 2015-06-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-05-05 00:00:00, ended at 2015-05-05 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-05 09:35:00, ended at 2015-05-05 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 18 (milligram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 129.70 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 21 - 50 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.73 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.98 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypokalemia\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-05 10:09:27, ended at 2015-05-05 10:55:28\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- potassium chloride 25 MEQ Effervescent Oral Tablet, through Oral route, started on 2015-05-05, presumably until 2016-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-24 10:42:00, ended at 2015-06-24 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.64 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 32.50 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 12:52:33, ended at 2015-06-24 14:33:10\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-24 14:50:21, ended at 2015-06-24 15:40:13\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n- Allergic rhinitis due to animal hair and dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-06-24, presumably until 2015-08-25, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-07-07 00:00:00, ended at 2015-07-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-21 10:22:00, ended at 2015-07-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 79.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Granulomatosis with polyangiitis\n- Chronic sinusitis\n- Chronic kidney disease stage 1\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-21 13:38:44, ended at 2015-07-21 14:47:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-07-21, presumably until 2016-05-19, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- cephalexin 500 MG Oral Capsule, through Oral route, presumably until 2015-07-21, with intended 0 refill(s). Instructions: take by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-25 10:45:00, ended at 2015-08-25 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Creatinine [Mass/volume] in Urine: 55.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.85 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of muscle\n- Allergic rhinitis due to animal hair and dander\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 11:35:10, ended at 2015-08-25 12:35:45\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n- Asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-08-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-25 14:05:22, ended at 2015-08-25 15:02:39\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.04 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Allergic rhinitis due to animal hair and dander\n- Primary diagnosis: Disorder of muscle\n- Granulomatosis with polyangiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2016-04-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, started on 2015-08-25, presumably until 2015-12-23, with intended 1 refill(s). Instructions: Taper as prescribed by MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-26 00:00:00, ended at 2015-08-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Granulomatosis with polyangiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-28 00:00:00, ended at 2015-09-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-12 00:00:00, ended at 2015-11-12 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-11-17 00:00:00, ended at 2015-11-17 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-18 10:21:00, ended at 2015-11-18 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 168 (picogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 120.7 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.83 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-18 11:04:02, ended at 2015-11-18 11:46:02\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-23 10:30:00, ended at 2015-12-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: <0.10 (milligram per milligram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 123.8 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.64 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of bone\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-23 11:24:15, ended at 2015-12-23 11:52:17\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-01-05 00:00:00, ended at 2016-01-05 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 14:12:49, ended at 2016-02-04 16:12:30\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 16:10:44, ended at 2016-02-04 16:53:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, presumably until 2019-04-30, with intended 0 refill(s). Instructions: take 20 mEq by mouth 2 times a day Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-04-19 00:00:00, ended at 2016-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-20 11:37:00, ended at 2016-04-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 59.99 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.40 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 292 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-20 12:00:20, ended at 2016-04-20 12:18:01\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2016-04-20, presumably until 2016-09-20, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 1 MG Oral Tablet, started on 2016-04-20, presumably until 2016-09-19, with intended 2 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-29 00:00:00, ended at 2016-04-29 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-05-18 00:00:00, ended at 2016-05-18 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 10:46:24, ended at 2016-05-19 12:06:35\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 60 minutes\n\n### Condition\n- No conditions.\n\n### Drug\n- loperamide hydrochloride 2 MG Oral Capsule, started on 2016-05-19, presumably until 2017-04-12, with intended 0 refill(s). Instructions: Take 2 tablets by mouth initially then 1 tablet by mouth following each loose stool. Not to exceed 8 tablets per day\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 1,440 Units into a muscle One Time\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n- typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution, through Intramuscular route, started on 2016-05-19, presumably until 2016-05-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily Take one tablet daily, starting 1-2 days prior to travel to malarious area. Continue daily while in malarious area and for 7 days after leaving area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-19 13:25:31, ended at 2016-05-19 14:01:55\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2016-05-19, presumably until 2016-10-10, with intended 6 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- fexofenadine hydrochloride 180 MG Oral Tablet, through Oral route, presumably until 2018-09-06, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-09 00:00:00, ended at 2016-06-09 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-09 15:45:46, ended at 2016-06-09 16:14:23\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypokalemia\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-13 00:00:00, ended at 2016-06-13 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-14 00:00:00, ended at 2016-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-14 12:20:00, ended at 2016-07-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Urine: 32.09 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-14 14:04:01, ended at 2016-07-14 14:32:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-09-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2016-07-14, presumably until 2016-10-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-08-09 00:00:00, ended at 2016-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-06 00:00:00, ended at 2016-09-06 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-15 00:00:00, ended at 2016-09-15 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-15, presumably until 2016-09-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-16 00:00:00, ended at 2016-09-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 24 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 199 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 21 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10635 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Protein [Mass/volume] in Urine: 5 (milligram per deciliter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Basophils [#/volume] in Blood by Automated count: 0 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 445 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 208 (milligram per gram of creatinine)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 2.0 (calculated)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.13 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 421 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.9 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-19 00:00:00, ended at 2016-09-19 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Essential hypertension\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-09-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-20 00:00:00, ended at 2016-09-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-09-20, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-09-28 00:00:00, ended at 2016-09-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2016-09-28, presumably until 2017-01-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-30 00:00:00, ended at 2016-09-30 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-10 00:00:00, ended at 2016-10-10 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-10-10, presumably until 2017-01-19, with intended 3 refill(s). Instructions: SPRAY 1 SPRAY NASALLY 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-20 12:33:00, ended at 2016-10-20 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 296 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 18.05 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.39 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-20 14:20:04, ended at 2016-10-20 14:56:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-11 00:00:00, ended at 2016-11-11 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2016-11-14, presumably until 2017-01-19, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-14 11:39:00, ended at 2016-12-14 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 10.31 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-14 14:17:25, ended at 2016-12-14 15:07:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 10:48:04, ended at 2017-01-19 10:48:30\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- olopatadine hydrochloride 0.665 MG/ACTUAT Metered Dose Nasal Spray, through Inhalation, started on 2017-01-19, presumably until 2017-12-26, with intended 3 refill(s). Instructions: 1 Spray by Inhalation route 2 times a day as needed (rhinitis)\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-01-19, presumably until 2017-07-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 14:07:24, ended at 2017-01-19 14:50:33\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-01-19, presumably until 2017-04-12, with intended 3 refill(s). Instructions: Take 4mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-07 00:00:00, ended at 2017-02-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-09 00:00:00, ended at 2017-02-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-02-14, presumably until 2017-03-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 11:18:15, ended at 2017-02-09 12:28:04\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.913\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 12:38:08, ended at 2017-02-09 13:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-02-14 00:00:00, ended at 2017-02-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-22 00:00:00, ended at 2017-02-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-02-23, presumably until 2017-02-23, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-21 00:00:00, ended at 2017-03-21 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-03-21, presumably until 2017-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-12 10:51:00, ended at 2017-04-12 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 26.74 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Erythrocyte sedimentation rate: 14 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 10.02 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Osteoporosis\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 11:17:25, ended at 2017-04-12 12:11:15\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2017-04-12, presumably until 2018-01-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2017-01-04, presumably until 2017-08-10, with intended 0 refill(s). Instructions:   </br>1 Puff Aerosol, INH, BID, 6 gm, 0, Maintenance\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-12 14:58:04, ended at 2017-04-12 15:24:37\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-04-12, presumably until 2017-07-17, with intended 1 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n- prednisone 1 MG Oral Tablet, started on 2017-04-12, presumably until 2017-09-05, with intended 3 refill(s). Instructions: Take 3mg PO daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-24 00:00:00, ended at 2017-05-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-31 00:00:00, ended at 2017-05-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- levalbuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2017-05-31, presumably until 2017-12-26, with intended 0 refill(s). Instructions: 3 mL by Nebulization route 4 times a day as needed\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2017-05-31, presumably until 2018-02-01, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-07 00:00:00, ended at 2017-06-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-06-07, presumably until 2018-06-07, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY DR\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-07-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily Or as directed by MD.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-12, presumably until 2017-09-05, with intended 0 refill(s). Instructions: Take as directed by MD for tapering\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-12 00:00:00, ended at 2017-06-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-06-13, presumably until 2017-06-13, with intended 6 refill(s). Instructions: TAKE 4 TABLETS ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 12:56:20, ended at 2017-06-15 15:15:34\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-15 14:25:08, ended at 2017-06-15 15:08:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Exacerbation of mild persistent asthma\n- Allergic rhinitis due to pollen\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-16 00:00:00, ended at 2017-06-16 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-22 00:00:00, ended at 2017-06-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2017-06-22, presumably until 2017-06-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-07-06, presumably until 2017-12-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2017-07-17, presumably until 2017-09-05, with intended 0 refill(s). Instructions: TAKE 2 TABS BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, started on 2017-07-17, presumably until 2017-07-18, with intended 1 refill(s). Instructions: TAPER AS PRESCRIBED BY MD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-07-18, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-02 00:00:00, ended at 2017-08-02 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-10 11:38:00, ended at 2017-08-10 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 11.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-10 13:51:08, ended at 2017-08-10 15:20:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2017-01-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: 1 Cris Burt, Oliver, every 12 hours, PRN, as needed for pain, 0, Maintenance\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-08-10, presumably until 2017-12-26, with intended 11 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2019-10-22, with intended 0 refill(s). Instructions: take 3.125 mg by mouth daily as needed\n- citalopram 10 MG Oral Tablet, through Oral route, presumably until 2019-03-07, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-22 00:00:00, ended at 2017-08-22 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-08-22, presumably until 2018-08-22, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-24 15:25:49, ended at 2017-08-24 16:47:09\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on nose and accessory sinuses; not otherwise specified\n\n### Condition\n- Heart failure\n- Transient cerebral ischemia\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- cefazolin 1000 MG Injection, started on 2017-08-25, presumably until 2017-08-25\n- remifentanil 2 MG Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-25, presumably until 2017-08-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-25 00:00:00, ended at 2017-08-25 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein dilaurate, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-25, presumably until 2017-08-25\n- fluorescein, through Intraocular route, started on 2017-08-25, presumably until 2017-08-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-25 05:47:00, ended at 2017-08-25 12:19:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Replacement of Nasal Septum with Autologous Tissue Substitute, Open Approach\n- Submucous resection inferior turbinate, partial or complete, any method\n- Excision of Nasal Turbinate, Percutaneous Approach\n- Nasal/sinus endoscopy, surgical, with frontal sinus exploration, including removal of tissue from frontal sinus, when performed\n- Nasal/sinus endoscopy, surgical, with maxillary antrostomy\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Computer Assisted Procedure of Head and Neck Region\n- Excision of Right Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Ethmoid Sinus, Percutaneous Endoscopic Approach\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Nasal/sinus endoscopy, surgical, with sphenoidotomy\n- Repair Right Maxillary Sinus, Percutaneous Endoscopic Approach\n- Excision of Left Sphenoid Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Frontal Sinus, Percutaneous Endoscopic Approach\n- Repair Left Maxillary Sinus, Percutaneous Endoscopic Approach\n- Septoplasty or submucous resection, with or without cartilage scoring, contouring or replacement with graft\n- Nasal/sinus endoscopy, surgical with ethmoidectomy; total (anterior and posterior)\n- Excision of Left Frontal Sinus, Percutaneous Endoscopic Approach\n- Excision of Right Ethmoid Sinus, Percutaneous Endoscopic Approach\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Degenerative disorder of macula\n- Deviated nasal septum\n- Hypertrophy of nasal turbinates\n- Osteoporosis\n- Seasonal allergic rhinitis\n- Presbyopia\n- Allergic rhinitis\n- Disorder of nasal cavity\n- Chronic sinusitis\n- Disorder of kidney and/or ureter\n- Essential hypertension\n- Heart failure\n- Uncomplicated asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-05 12:31:57, ended at 2017-09-05 13:01:26\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to animal dander\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2017-09-05, presumably until 2018-01-04, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-05 15:21:00, ended at 2017-09-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of nasal cavity\n- Allergic rhinitis due to animal dander\n- Disorder of bone\n- Chronic sinusitis\n- Osteoporosis\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-28 13:12:56, ended at 2017-09-28 14:17:14\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or debridement (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-10 00:00:00, ended at 2017-10-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-12 11:00:00, ended at 2017-10-12 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 332 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 24.94 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 300 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 11:34:28, ended at 2017-10-12 12:34:37\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 3\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Hypo-osmolality and or hyponatremia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 13:54:53, ended at 2017-10-12 15:07:57\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n- Allergic rhinitis due to pollen\n- Chronic maxillary sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-10-12, presumably until 2017-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-12 15:15:57, ended at 2017-10-12 16:10:38\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-19 00:00:00, ended at 2017-10-19 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Acute asthma\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-10-19, presumably until 2017-12-26, with intended 0 refill(s). Instructions: Take 20 mg PO Qday x 7 days, then 10 mg PO Qday x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-02 12:54:42, ended at 2017-11-02 13:31:24\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Disorder of nasal cavity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 12:07:41, ended at 2017-12-26 12:43:08\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated mild persistent asthma\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-10-09, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-12-26, presumably until 2018-02-01, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2018-10-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-12-26, presumably until 2019-01-01, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-12-26, presumably until 2019-03-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-26 13:09:03, ended at 2017-12-26 14:24:20\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:27:00, ended at 2017-12-26 14:49:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 51.71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 19 (kilounit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-12-26 14:50:00, ended at 2017-12-26 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Uncomplicated asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-01-03, presumably until 2018-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-03 00:00:00, ended at 2018-01-03 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperparathyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 12:55:22, ended at 2018-01-04 13:29:56\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-04 15:01:13, ended at 2018-01-04 16:10:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-01-04, presumably until 2018-03-21, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 11:22:54, ended at 2018-02-01 12:51:04\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Allergic rhinitis due to pollen\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic maxillary sinusitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n\n### Drug\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-02-01, presumably until 2018-09-06, with intended 3 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2018-02-01, presumably until 2018-09-06, with intended 1 refill(s). Instructions: 2 mL by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 13:32:31, ended at 2018-02-01 14:52:49\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Mononeuritis multiplex\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-10 00:00:00, ended at 2018-03-10 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2018-03-12, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 10:25:18, ended at 2018-03-21 10:50:18\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n- Allergic rhinitis due to animal dander\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-03-21, presumably until 2018-07-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-21 11:12:00, ended at 2018-03-21 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.30 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Urine: <5.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.27 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 60.51 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 8 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 49 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.13 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- IgE [Units/volume] in Serum or Plasma by Immunoassay: 16 (kilounit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 182 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Osteoporosis\n- Allergic rhinitis\n- Hyperparathyroidism\n- Allergic rhinitis due to animal dander\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-21 11:22:44, ended at 2018-03-21 12:13:39\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-24 10:49:00, ended at 2018-04-24 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Chronic sinusitis\n- Chronic maxillary sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-24 14:54:36, ended at 2018-04-24 16:30:41\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Primary diagnosis: Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-26 13:43:37, ended at 2018-06-26 14:46:12\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-04 00:00:00, ended at 2018-07-04 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-07-12, presumably until 2018-07-12, with intended 0 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 14:18:37, ended at 2018-07-19 14:45:47\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-10-11, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-19 15:26:30, ended at 2018-07-19 16:01:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Allergic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-14 11:59:13, ended at 2018-08-14 13:15:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe, started on 2018-09-05, presumably until 2018-09-05, with intended 0 refill(s). Instructions: LA:[000000]:05/18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-06 12:58:46, ended at 2018-09-06 14:41:57\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cerebral infarction\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2019-03-20, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning with breakfast Takes 2-3 a day for pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-06 14:15:00, ended at 2018-09-06 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Cerebral infarction\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-08, presumably until 2018-10-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Anemia in chronic kidney disease\n- Primary diagnosis: Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-10-09, presumably until 2019-01-31, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 10:40:45, ended at 2018-10-11 11:28:07\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Allergic rhinitis\n- Primary diagnosis: Exacerbation of mild persistent asthma\n- Acute upper respiratory infection\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 12:08:12, ended at 2018-10-11 12:34:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-11 14:10:39, ended at 2018-10-11 14:36:43\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-10-11, presumably until 2019-01-24, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-18, presumably until 2018-10-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-24 00:00:00, ended at 2018-10-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2018-10-29, presumably until 2019-01-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 14 days\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-01, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2018-12-13, presumably until 2019-12-13, with intended 1 refill(s). Instructions: TAKE 2 TABLETS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 11:00:00, ended at 2018-12-12 14:56:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Chronic kidney disease\n- Cerebral infarction\n- Anemia in chronic kidney disease\n- Valvular endocarditis\n- Visual field defect\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-12 14:57:00, ended at 2018-12-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 13.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.1 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 88.78 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 152 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.93 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 108.0 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 259 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 10:43:30, ended at 2019-01-01 12:48:12\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic pansinusitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2019-01-01, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-01-01, presumably until 2019-04-04, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-01 12:52:22, ended at 2019-01-01 15:15:25\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure)\n\n### Condition\n- Uncomplicated asthma\n- Chronic sinusitis\n- Primary diagnosis: Loss of sense of smell\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, started on 2019-01-01, presumably until 2019-03-20, with intended 11 refill(s). Instructions: Use 1 ampule as directed BID.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-24 14:46:39, ended at 2019-01-24 15:22:41\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-01-29, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-06-18, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-01-24, presumably until 2019-02-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-29 00:00:00, ended at 2019-01-29 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-01-29, presumably until 2019-08-13, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-31 00:00:00, ended at 2019-01-31 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-01-31, presumably until 2020-03-02, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-12 15:03:19, ended at 2019-02-12 16:29:50\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphonia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 11:37:58, ended at 2019-03-07 12:21:35\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Chronic rhinitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- fexofenadine hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-03-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-03-07, presumably until 2019-05-13, with intended 11 refill(s). Instructions: 1 Spray by Nasal route 2 times a day Use in each nostril as directed\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-03-07, presumably until 2019-07-29, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-07 15:33:11, ended at 2019-03-07 17:03:08\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-19 12:17:38, ended at 2019-03-19 14:02:29\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n- Disorder of the larynx\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2019-03-19, presumably until 2019-05-13, with intended 3 refill(s). Instructions: take 5 mL by mouth 4 times a day\n- fluconazole 150 MG Oral Tablet, started on 2019-03-19, presumably until 2019-03-20, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 4 days if symptoms persist.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, head; without contrast material(s)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 07:23:00, ended at 2019-03-20 15:22:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Hypertrophic condition of skin\n- Essential hypertension\n- Osteoporosis\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- gadobenate, through Intravenous route, started on 2019-03-20, presumably until 2019-03-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 09:56:33, ended at 2019-03-20 10:25:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2019-03-20, presumably until 2020-03-04, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-20 13:31:38, ended at 2019-03-20 15:07:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypertrophic condition of skin\n- Primary diagnosis: Pain in right foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-20, presumably until 2019-03-20, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 15:23:00, ended at 2019-03-20 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-26 00:00:00, ended at 2019-03-26 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-27, presumably until 2019-03-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-04 11:42:40, ended at 2019-04-04 12:33:34\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-04 14:09:00, ended at 2019-04-04 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.63 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.17 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 30.13 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 5.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-24 00:00:00, ended at 2019-04-24 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-05-01, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 12:05:26, ended at 2019-04-30 15:57:31\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 1.0 cm\n\n### Condition\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-30 13:14:52, ended at 2019-04-30 14:18:49\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.81\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n- Dysphonia\n- Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n- Neoplastic disease of uncertain behavior\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-13 10:55:27, ended at 2019-05-13 12:12:51\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- olopatadine 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-05-08, presumably until 2019-05-08, with intended 0 refill(s). Instructions: Instill 1 drop to both eyes as needed\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-05-13, presumably until 2019-05-13, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2019-04-14, presumably until 2019-05-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:15:00, ended at 2019-05-13 12:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Tailor's bunion\n- Pain in right foot\n- Talipes planus\n- Acquired hallux varus\n- Essential hypertension\n- Pain in left foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 12:30:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Localized, primary osteoarthritis of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-15 00:00:00, ended at 2019-05-15 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-05-15, presumably until 2020-05-11, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-18 10:57:51, ended at 2019-06-18 12:08:03\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-06-18, presumably until 2019-10-09, with intended 3 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n- gabapentin 100 MG Oral Capsule, through Oral route, presumably until 2019-08-13, with intended 0 refill(s). Instructions: take 100 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-09 11:00:00, ended at 2019-07-09 11:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-17 00:00:00, ended at 2019-07-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-07-29, presumably until 2019-12-25, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-13 10:36:00, ended at 2019-08-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 26.70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: <4.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Bunion\n- Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Chronic pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 13:18:06, ended at 2019-08-13 13:37:04\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Primary diagnosis: Follicular cysts of skin and subcutaneous tissue\n- Low back pain\n- Pain of left knee region\n- Bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2019-09-20, with intended 2 refill(s). Instructions: take 1 Tab (50 mg total) by mouth as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-13 14:05:12, ended at 2019-08-13 14:51:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2019-08-13, presumably until 2020-02-04, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2019-08-26, presumably until 2019-08-27, with intended 2 refill(s). Instructions: take 2 Tabs (2,000 mg total) by mouth 2 times a day for 1 day PRN cold sores\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-05 00:00:00, ended at 2019-09-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 09:26:05, ended at 2019-09-12 14:45:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- valacyclovir 1000 MG Oral Tablet, started on 2019-08-30, presumably until 2019-09-13, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-12 11:31:14, ended at 2019-09-12 13:11:07\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Eosinophilic asthma\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-13 07:30:00, ended at 2019-09-13 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Supraventricular tachycardia\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-20 00:00:00, ended at 2019-09-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-09-20, presumably until 2019-10-25, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every bedtime as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 20 Tabs by mouth every day\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2019-09-23, presumably until 2019-09-23, with intended 12 refill(s). Instructions: take 1 Packet (20 mEq total) by mouth daily Every other day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-09 00:00:00, ended at 2019-10-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 08:15:00, ended at 2019-10-09 11:14:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone length studies (orthoroentgenogram, scanogram)\n\n### Condition\n- Osteoarthritis of knee\n- Acquired genu valgum\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 08:55:12, ended at 2019-10-09 09:27:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2019-10-09, presumably until 2020-02-04, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-09 11:15:00, ended at 2019-10-09 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Osteoporosis\n- Disorder of bone\n- Pain in thoracic spine\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Pain of left knee region\n- Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-09 15:03:15, ended at 2019-10-09 15:53:45\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in thoracic spine\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-21 00:00:00, ended at 2019-10-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2019-10-22, presumably until 2020-04-07, with intended 12 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-25 00:00:00, ended at 2019-10-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-10-28, presumably until 2019-12-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-28 00:00:00, ended at 2019-10-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-04 00:00:00, ended at 2019-11-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 09:50:06, ended at 2019-11-05 10:25:56\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 11:12:09, ended at 2019-11-05 12:04:23\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Uncomplicated severe persistent asthma\n- Chronic rhinitis\n- Primary diagnosis: Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 12:22:32, ended at 2019-11-05 14:38:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-05 13:22:35, ended at 2019-11-05 14:31:38\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-05 13:50:00, ended at 2019-11-05 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 15 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.10 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-08 00:00:00, ended at 2019-11-08 08:07:41\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-25, presumably until 2019-12-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-02 00:00:00, ended at 2019-12-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.417 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-05, presumably until 2019-12-10, with intended 1 refill(s). Instructions: 3 mL (1.25 mg total) by Nebulization route every 4 hours as needed for Bronchospasm/Wheezing (cough)\n- prednisone 5 MG Oral Tablet, started on 2019-12-05, presumably until 2020-02-04, with intended 0 refill(s). Instructions: Take 10 mg x 1 week, then 5 mg x 1 week\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-12-05, presumably until 2020-02-20, with intended 2 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-05 00:00:00, ended at 2019-12-05 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2019-12-05, presumably until 2020-01-22, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- 125 ML sodium chloride 9 MG/ML Prefilled Syringe, started on 2019-12-10, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 1 Dose by Injection route every 4 hours as needed Use as directed\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2019-12-10, presumably until 2020-01-09, with intended 1 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 08:59:06, ended at 2019-12-11 09:45:31\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute bronchitis\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-11 10:29:00, ended at 2019-12-11 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Melanocytic nevus of trunk\n- Acute sinusitis\n- Disorder of immune function\n- Hyperpigmentation of skin\n- Melanocytic nevus of lower limb\n- Temporomandibular joint disorder\n- Scar conditions and fibrosis of skin\n- Essential hypertension\n- Acute bronchitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n- Melanocytic nevus of upper limb\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-11 12:17:22, ended at 2019-12-11 13:40:55\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Scar conditions and fibrosis of skin\n- Hyperpigmentation of skin\n- Primary diagnosis: Melanocytic nevus of lower limb\n- Disorder of immune function\n- Primary diagnosis: Melanocytic nevus of trunk\n- Primary diagnosis: Melanocytic nevus of upper limb\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-19 00:00:00, ended at 2019-12-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-25 00:00:00, ended at 2019-12-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n\n### Drug\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2019-12-25, presumably until 2020-10-06, with intended 10 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-01-22, presumably until 2020-02-29, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Eosinophilic asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-01-22, presumably until 2020-07-21, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-04 09:13:00, ended at 2020-02-04 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 20 (milligram per gram)\n- Basophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 6.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 39.80 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Erythrocyte sedimentation rate: 5 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 73.8 (picogram per milliliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.15 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.08 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Dysphonia\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 09:50:25, ended at 2020-02-04 10:17:09\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Dysphonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 10:45:37, ended at 2020-02-04 12:08:30\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Joint pain\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-04 12:20:34, ended at 2020-02-04 13:04:58\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-04, presumably until 2020-05-19, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reduced mobility\n- Primary diagnosis: Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed fracture of lower leg\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 12:15:00, ended at 2020-02-20 13:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed bimalleolar fracture\n- Closed fracture of lower leg\n- Arthralgia of the ankle and/or foot\n- Closed fracture of fibula\n- Closed fracture of medial malleolus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 13:42:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; 2 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Closed fracture of lower leg\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-21 00:00:00, ended at 2020-02-21 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nonunion of fracture\n- Primary diagnosis: Closed bimalleolar fracture\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2020-02-21, presumably until 2020-02-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (for pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; not otherwise specified\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of deltoid ligament of ankle\n- Sprain of ankle\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- cefazolin 1000 MG Injection, started on 2020-02-27, presumably until 2020-02-27\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- ketamine 100 MG/ML Injectable Solution, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2020-02-27, presumably until 2020-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Open treatment of distal fibular fracture (lateral malleolus), includes internal fixation, when performed\n- Manual application of stress performed by physician or other qualified health care professional for joint radiography, including contralateral joint if indicated\n- Open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed\n\n### Condition\n- Closed fracture of lateral malleolus\n- Sprain of ankle\n- Sprain of deltoid ligament of ankle\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-02-27 07:19:00, ended at 2020-02-29 13:20:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Left ventricular Ejection fraction: 61.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.03 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n\n### Procedure\n- Repair Right Ankle Bursa and Ligament, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Reposition Right Fibula with Internal Fixation Device, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Collection of venous blood by venipuncture\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n\n### Condition\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Pain\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated asthma\n- Essential hypertension\n- First degree atrioventricular block\n- Illness\n- Persistent pain following procedure\n- Chronic systolic heart failure\n- Gastroesophageal reflux disease without esophagitis\n- Closed fracture of lower leg\n- Sprain of deltoid ligament of ankle\n- Electrocardiogram abnormal\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2020-02-28, presumably until 2020-02-29\n- calcium carbonate 625 MG / cholecalciferol 125 UNT Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-02-27, presumably until 2020-02-27\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-02-27, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 2 Caps (200 mg total) by mouth 2 times a day as needed for Constipation\n- montelukast 10 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-28\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-02-29, presumably until 2020-02-29\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 1 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily as needed\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-03-10, with intended 0 refill(s). Instructions: take 1 Tab (650 mg total) by mouth every 6 hours\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2020-02-28, presumably until 2020-02-29\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-02-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-02-27, presumably until 2020-02-28\n- carboxymethylcellulose sodium 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2020-02-28, presumably until 2020-02-29\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-02-27, presumably until 2020-04-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed for Pain\n- 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2020-02-29, presumably until 2020-02-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-04 00:00:00, ended at 2020-03-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2020-03-04, presumably until 2021-05-21, with intended 3 refill(s). Instructions: take 1 Tab (70 mg total) by mouth every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-10 09:00:00, ended at 2020-03-10 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of medial malleolus\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 10:41:24, ended at 2020-04-07 12:14:11\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic pansinusitis\n- Primary diagnosis: Eosinophilic asthma\n- Chronic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-04-07 12:40:59, ended at 2020-04-07 13:56:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-12-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2020-04-07, presumably until 2020-10-23, with intended 0 refill(s). Instructions: take 1 Tab (3.125 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-07 13:56:18, ended at 2020-04-07 13:56:28\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; recording (includes connection and initial recording)\n- External electrocardiographic recording for more than 48 hours up to 21 days by continuous rhythm recording and storage; review and interpretation\n\n### Condition\n- Loss of consciousness\n- Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-13 00:00:00, ended at 2020-04-13 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-04-28, presumably until 2020-05-26, with intended 0 refill(s). Instructions: TAKE ONE TABLET ORALLY DAILY AT BEDTIME AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-23 09:50:00, ended at 2020-04-23 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Closed fracture of lateral malleolus\n- Tailor's bunion\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Closed bimalleolar fracture\n- Arthralgia of the ankle and/or foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-09 00:00:00, ended at 2020-05-09 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-05-11, presumably until 2020-08-11, with intended 2 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-15 00:00:00, ended at 2020-05-15 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Closed bimalleolar fracture\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-19 00:00:00, ended at 2020-05-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2020-05-19, presumably until 2020-12-23, with intended 1 refill(s). Instructions: take 2 Tabs (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-24 00:00:00, ended at 2020-05-24 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-05-26, presumably until 2020-06-02, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-05-25, presumably until 2020-06-01, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-26 00:00:00, ended at 2020-05-26 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-27 00:00:00, ended at 2020-05-27 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-01 00:00:00, ended at 2020-06-01 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-01, presumably until 2020-06-16, with intended 5 refill(s). Instructions: 0.5 mL (2.5 mg total) by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-02 00:00:00, ended at 2020-06-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-06-02, presumably until 2020-07-13, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-04 00:00:00, ended at 2020-06-04 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 09:23:00, ended at 2020-06-16 15:41:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Eosinophilic asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Late effect of fracture of lower extremities\n- Melanocytic nevus\n- Postoperative state\n- Closed bimalleolar fracture\n- Supraventricular tachycardia\n- Arthralgia of the ankle and/or foot\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 11:49:33, ended at 2020-06-16 13:26:49\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-16, presumably until 2020-06-25, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-16, presumably until 2020-06-18, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2020-06-16, presumably until 2020-06-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 13:05:45, ended at 2020-06-16 15:41:51\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Melanocytic nevus\n- Primary diagnosis: Supraventricular tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-06-16 14:48:32, ended at 2020-06-16 15:36:44\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-16 15:42:00, ended at 2020-06-16 23:59:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine collected for unspecified duration: 9.0 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.12 (milligram per milligram)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Creatinine [Mass/volume] in Urine: 77.29 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-17 00:00:00, ended at 2020-06-17 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-18 00:00:00, ended at 2020-06-18 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nasal cavity\n\n### Drug\n- mupirocin 0.02 MG/MG Nasal Ointment, through Nasal route, started on 2020-06-18, presumably until 2020-08-21, with intended 0 refill(s). Instructions: by Nasal route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-19 00:00:00, ended at 2020-06-19 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, started on 2020-06-19, presumably until 2021-11-19, with intended 0 refill(s). Instructions: USE ONE VIAL BY INHALATION ROUTE EVERY 4 HOURS AS NEEDED FOR COUGH/WHEEZE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-08-20, with intended 3 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-25 00:00:00, ended at 2020-06-25 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-06-25, presumably until 2020-07-07, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Primary diagnosis: Bacterial infectious disease\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-07-02, presumably until 2020-08-27, with intended 1 refill(s). Instructions: Apply to affected areas BID x 5-7 days until improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-02 00:00:00, ended at 2020-07-02 00:00:00\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-07 11:06:14, ended at 2020-07-07 16:16:38\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated mild persistent asthma\n- Primary diagnosis: Eosinophilic asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-07-07, presumably until 2020-08-17, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- prednisone 5 MG Oral Tablet, started on 2020-07-07, presumably until 2020-07-09, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-07-07, presumably until 2020-11-03, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-09, presumably until 2020-07-21, with intended 0 refill(s). Instructions: Take 20 mg by mouth x 5 days, 15 mg x 5 days, 10 mg x 5 days, 5 mg x 5 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-10 00:00:00, ended at 2020-07-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-07-13, presumably until 2020-10-23, with intended 2 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 12:46:03, ended at 2020-07-14 13:10:35\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Recurrent acute sinusitis\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Acute pansinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-10-06, with intended 11 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2020-07-21, presumably until 2020-08-13, with intended 0 refill(s). Instructions: 30 mg x 7 days, 20 mg x 7 days, 10 mg x 7 days, 5 mg x 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-10 00:00:00, ended at 2020-08-10 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-11, presumably until 2021-01-26, with intended 0 refill(s). Instructions: INHALE TWO PUFFS BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-13 11:05:59, ended at 2020-08-13 15:45:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eosinophilic asthma\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2020-08-13, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-17 00:00:00, ended at 2020-08-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated severe persistent asthma\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-17, presumably until 2020-08-20, with intended 0 refill(s). Instructions: 3 mL by Nebulization route as needed\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2020-08-20, presumably until 2021-05-21, with intended 1 refill(s). Instructions: 3 mL by Inhalation route every 6 hours as needed (cough/wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-18 00:00:00, ended at 2020-08-18 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-20 00:00:00, ended at 2020-08-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-20, presumably until 2020-08-21, with intended 0 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-08-20 10:05:43, ended at 2020-08-20 11:13:04\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pansinusitis\n- Spasm\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Blood chemistry abnormal\n- Primary diagnosis: Disorder of bone\n- Lymphocytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-20 10:45:00, ended at 2020-08-20 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Arthralgia of the ankle and/or foot\n- Metatarsalgia\n- Pain in right foot\n- Postoperative state\n- Closed bimalleolar fracture\n- Closed fracture of lateral malleolus\n- Acquired hallux varus\n- Hammer toe\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-21 00:00:00, ended at 2020-08-21 08:04:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Eosinophilic asthma\n- Primary diagnosis: Insomnia\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 M..., through Intramuscular route, started on 2020-08-21, presumably until 2020-08-21, with intended 0 refill(s). Instructions: inject into a muscle\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-08-21, with intended 12 refill(s). Instructions: take 1 Tab (3 mg total) by mouth every bedtime as needed (insomnia)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-21 00:00:00, ended at 2020-08-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 9 MG/ML Inhalation Solution, started on 2020-08-21, presumably until 2020-12-07, with intended 3 refill(s). Instructions: 3mL mixed with budesonide by inhalation route BID PRN cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-24 00:00:00, ended at 2020-08-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-24 00:00:00, ended at 2020-08-24 10:20:37\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Candidiasis of mouth\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-26 00:00:00, ended at 2020-08-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-08-27, presumably until 2020-12-07, with intended 0 refill(s). Instructions: APPLY TO THE AFFECTED AREA(S) TWICE DAILY FOR 5 TO 7 DAYS UNTIL IMPROVED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-08 11:04:53, ended at 2020-09-08 12:09:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lymphocytopenia\n- Uncomplicated severe persistent asthma\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-10 11:26:40, ended at 2020-09-10 13:35:18\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Primary diagnosis: Tailor's bunion\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-17 00:00:00, ended at 2020-09-17 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-09-17, presumably until 2020-12-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open bimalleolar fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-23 00:00:00, ended at 2020-09-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-23 11:15:00, ended at 2020-09-23 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, maxillofacial area; without contrast material\n\n### Condition\n- Dysphonia\n- Pain in right foot\n- Chronic pansinusitis\n- Disorder of bone\n- Spasm\n- Lymphocytopenia\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Tailor's bunion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-09-24 00:00:00, ended at 2020-09-24 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-09-24, presumably until 2020-09-24\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-24 08:30:00, ended at 2020-09-24 12:10:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Ostectomy, partial excision, fifth metatarsal head (bunionette) (separate procedure)\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Pain in right foot\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Eosinophilic asthma\n- Osteoporosis\n- Tailor's bunion\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-09-24, presumably until 2020-09-24\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-24, presumably until 2020-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tailor's bunion\n- Pain in right foot\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-25, presumably until 2020-09-26, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-26 00:00:00, ended at 2020-09-26 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Tailor's bunion\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-09-26, presumably until 2020-10-08, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n- Uncomplicated mild persistent asthma\n\n### Drug\n- montelukast 10 MG Oral Tablet, started on 2020-10-06, presumably until 2021-02-09, with intended 3 refill(s). Instructions: Take by mouth every bedtime\n- levocetirizine dihydrochloride 5 MG Oral Tablet, started on 2020-10-06, presumably until 2021-07-05, with intended 3 refill(s). Instructions: TAKE ONE TABLET (5MG) BY MOUTH ONE TIME DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-08 09:35:08, ended at 2020-10-08 10:27:46\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Candidiasis of mouth\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Acute exacerbation of chronic obstructive airways disease\n\n### Drug\n- prednisone 1 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 4 mg x 7 days, then 3 mg x 7 days, 2 mg x 7 days, 1 mg x 7 days\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2020-10-13, presumably until 2020-10-15, with intended 3 refill(s). Instructions: 1 Plunkett (18 mcg total) by Inhalation route daily\n- fluconazole 150 MG Oral Tablet, started on 2020-10-08, presumably until 2020-12-07, with intended 0 refill(s). Instructions: 150mg orally once and may repeat one tablet in 72 hour if not improved\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clotrimazole 10 MG Oral Lozenge, through Oral route, started on 2020-10-09, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Lozenge (10 mg total) by mouth 5 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-13 00:00:00, ended at 2020-10-13 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative disorder of macula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n- Chronic kidney disease\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Primary diagnosis: Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-22 00:00:00, ended at 2020-10-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-23, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-23 00:00:00, ended at 2020-10-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 3.125 MG Oral Tablet, started on 2020-10-23, presumably until 2020-11-02, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 09:51:00, ended at 2020-10-26 12:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in right foot\n- Postoperative state\n- Metatarsal bone fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-26 09:51:03, ended at 2020-10-26 12:26:39\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tailor's bunion\n- Primary diagnosis: Postoperative state\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 13:00:00, ended at 2020-10-26 14:02:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 3\n- Pain in right foot\n- Postoperative state\n- Uncomplicated severe persistent asthma\n- Tailor's bunion\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-26 14:03:00, ended at 2020-10-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 147 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 97.0 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 27 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 32 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.05 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic kidney disease stage 3\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-27 12:43:28, ended at 2020-10-27 13:54:28\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-03 15:51:11, ended at 2020-11-03 16:43:27\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic sinusitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2020-11-03, presumably until 2021-01-25, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-11-10 13:09:35, ended at 2020-11-10 14:05:34\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease\n- Chronic kidney disease stage 3A\n- Essential hypertension\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-20 00:00:00, ended at 2020-11-20 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-23 00:00:00, ended at 2020-11-23 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2020-11-23, presumably until 2021-11-23, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-25 00:00:00, ended at 2020-11-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in right foot\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-07 00:00:00, ended at 2020-12-07 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2020-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth every day\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2020-12-07, presumably until 2021-11-19, with intended 12 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-12-08 11:45:37, ended at 2020-12-08 12:18:16\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Primary diagnosis: Uncomplicated severe persistent asthma\n- Cellulitis\n- Chronic sinusitis\n- Chronic obstructive lung disease\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2020-12-08, presumably until 2020-12-18, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-14 08:30:00, ended at 2020-12-14 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Dysphonia\n- Hammer toe\n- Chronic sinusitis\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Metatarsal bone fracture\n- Closed bimalleolar fracture\n- Metatarsalgia\n- Acquired hallux varus\n- Pain in right foot\n- Postoperative state\n- Tailor's bunion\n- Chronic frontal sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-15 00:00:00, ended at 2020-12-15 12:19:53\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-12-15, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, started on 2020-12-23, presumably until 2021-01-06, with intended 0 refill(s). Instructions: TAKE TWO TABLETS BY MOUTH DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-22 00:00:00, ended at 2020-12-22 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 20 MEQ Extended Release Oral Tablet, started on 2020-12-23, presumably until 2022-01-20, with intended 12 refill(s). Instructions: TAKE 1 TABLET (20MEQ) BY MOUT HEVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-01 00:00:00, ended at 2021-01-01 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2021-01-05, presumably until 2021-02-08, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH AT BEDTIME AS NEEDED FOR PAIN, APPOINTMENT NEEDED BEFORE NEXT REFILL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-02 00:00:00, ended at 2021-01-02 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2021-01-04, presumably until 2021-01-04, with intended 0 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-04 00:00:00, ended at 2021-01-04 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2021-01-04, presumably until 2021-02-09, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 00:00:00, ended at 2021-01-06 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n\n### Drug\n- azathioprine 50 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-15, with intended 0 refill(s). Instructions: take 1.5 Tabs (75 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-25 00:00:00, ended at 2021-01-25 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-25, presumably until 2021-01-27, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-01-26 08:44:00, ended at 2021-01-26 23:59:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 20.0 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.11 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 89.00 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.22 (milligram per milligram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary disease due to allergic granulomatosis angiitis\n- Acquired hallux varus\n- Hammer toe\n- Metatarsalgia\n- Non-rheumatic aortic sclerosis\n- Localized, primary osteoarthritis of the ankle and/or foot\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 09:16:50, ended at 2021-01-26 10:35:10\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic aortic sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-01-26 10:42:23, ended at 2021-01-26 12:24:26\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary disease due to allergic granulomatosis angiitis\n- Uncomplicated severe persistent asthma\n- Osteoporosis\n- Non-rheumatic aortic sclerosis\n- Uncomplicated moderate persistent asthma\n- Chronic sinusitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-27 00:00:00, ended at 2021-01-27 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Uncomplicated moderate persistent asthma\n\n### Drug\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2021-01-27, presumably until 2021-02-09, with intended 1 refill(s). Instructions: 2 mL (0.5 mg total) by Inhalation route 2 times a day\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "b683f88bc101cd0b5ef4926f40a5b15e4ec57da197b188dcddb595d1e2eee06b", "prompt_hash": "f31bd40bb5ec4d3c4a8430f25ccf2a1fb57fcc038b004c527fd38759f49389ff", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
{"doc_id": 7, "doc": {"person_id": 115970074, "visit_occurrence_id": 42887392, "death_date": "2014-01-03", "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2011-03-27 00:00:00", "visit_end_datetime": "2011-03-27 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-27 00:00:00, ended at 2011-03-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 88, "patient_first_visit_date": "2009-07-11 00:00:00", "patient_last_visit_date": "2013-12-29 14:19:00", "end_obs_date": "2012-03-26", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 54, "cumulated_visit_num": 54, "cumulated_approximate_token_count": 11793, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-11 00:00:00, ended at 2009-07-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Venous varices\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-13 00:00:00, ended at 2009-07-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Venous varices\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-17 00:00:00, ended at 2009-07-17 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-04 00:00:00, ended at 2009-08-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-08-04, presumably until 2009-10-04, with quantity of 10.0, with intended 1 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-22 00:00:00, ended at 2009-08-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-22 00:00:00, ended at 2009-08-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-08-22 15:30:00, ended at 2009-08-23 12:23:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 48.7 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Prothrombin time (PT): 30.9 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Body height: 5' 7.992\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-23\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-22\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-23\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2009-12-27. Instructions: take 100 mg by mouth as needed \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-22\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-22. Instructions: take 5 mg by mouth every bedtime as needed \n- alendronic acid 35 MG Oral Tablet, through Oral route, presumably until 2009-08-31. Instructions: take 35 mg by mouth as directed. Every Wed\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-08-23, presumably until 2009-08-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-08-22, presumably until 2009-08-23\n- aspirin 81 MG Oral Tablet, through Oral route, presumably until 2011-11-13. Instructions: take 81 mg by mouth daily. \n- 10 ML furosemide 10 MG/ML Injection, started on 2009-08-22, presumably until 2009-08-22\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, presumably until 2012-07-11. Instructions: take 2.5 mg by mouth as directed. 1 days a week\n- ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet, through Oral route, presumably until 2010-03-26. Instructions: take 2.5 Tabs by mouth daily. Femhrt 2.5 mg once q am\n- diphenhydramine hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2012-07-24. Instructions: take 50 mg by mouth as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-08-23, presumably until 2009-08-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-08-22 16:20:29, ended at 2009-08-22 18:55:55\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-31 00:00:00, ended at 2009-08-31 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.3 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Prothrombin time (PT): 14.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-01 05:28:00, ended at 2009-09-01 16:35:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Varicose veins of lower extremity with inflammation\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2009-09-01, presumably until 2010-02-28, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-10-04 00:00:00, ended at 2009-10-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-10-04, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours. Replace previous order for Atrovent to HFA inhaler \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-04 11:13:37, ended at 2009-10-04 14:56:15\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2009-10-04, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 2 Sprays by Nasal route daily. \n- 100 ACTUAT flunisolide 0.25 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-10-04, presumably until 2010-10-04, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day. \n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-10-04, presumably until 2009-10-04, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours. \n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2009-10-04, presumably until 2010-10-04, with intended 6 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-10-05 00:00:00, ended at 2009-10-05 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-05 12:54:47, ended at 2009-10-05 14:23:56\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-05 14:29:00, ended at 2009-10-05 14:48:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-05 14:49:00, ended at 2009-10-05 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; review and interpretation by a physician \n\n### Condition\n- Conduction disorder of the heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-10-06 00:00:00, ended at 2009-10-06 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Atrial fibrillation\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-25 05:51:00, ended at 2009-10-25 09:07:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Blood: 9.0 (millimole per liter)\n- Body height: 5' 10\" (inch (US))\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n\n### Procedure\n- Other electric countershock of heart\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-10-25, presumably until 2009-10-25\n- dronedarone 400 MG Oral Tablet, through Oral route, presumably until 2009-11-08. Instructions: take 200 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-08 00:00:00, ended at 2009-11-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Acute bronchospasm\n- Dyspnea\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-08 00:00:00, ended at 2009-11-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Acute bronchospasm\n- Dyspnea\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-08 10:02:45, ended at 2009-11-08 14:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2009-11-08, presumably until 2009-12-27, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2009-11-08, presumably until 2010-03-26, with quantity of 30.0, with intended 6 refill(s). Instructions: 1 Cap by Inhalation route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-17 00:00:00, ended at 2009-11-17 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dyspnea\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-11-17, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed \n- 14 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2009-11-17, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 13:00:00, ended at 2009-11-17 13:31:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n\n### Condition\n- Marfan's syndrome\n- Dyspnea\n- Acute bronchospasm\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 13:32:00, ended at 2009-11-17 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n\n### Condition\n- Dyspnea\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-20 00:00:00, ended at 2009-11-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Acute bronchospasm\n- Mitral valve disorder\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-20 00:00:00, ended at 2009-11-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-21 00:00:00, ended at 2009-11-21 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n- Tricuspid valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 13:00:00, ended at 2009-12-07 14:23:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Marfan's syndrome\n- Dissection of thoracic aorta\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 14:24:00, ended at 2009-12-07 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Marfan's syndrome\n- Dissection of thoracic aorta\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-08 12:17:00, ended at 2009-12-08 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Mitral valve disorder\n- Marfan's syndrome\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2009-12-08, presumably until 2009-12-08\n- midazolam 1 MG/ML Injectable Solution, started on 2009-12-08, presumably until 2009-12-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-14 00:00:00, ended at 2009-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Dyspnea\n- Acute bronchospasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-14 00:00:00, ended at 2009-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchospasm\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-18 11:49:00, ended at 2009-12-18 14:48:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2009-12-18, presumably until 2009-12-18\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2009-12-18, presumably until 2009-12-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-18 14:49:00, ended at 2009-12-27 14:40:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 24.8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 92 (millimeter mercury column)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 736 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 151 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.5 (ratio)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.07 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 62.4 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 9.8 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.24 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.5 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.4 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 100.8 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Base deficit in Blood: 3.0 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 720 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- Prothrombin time (PT): 35.1 (second)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n\n### Procedure\n- Venous catheterization, not elsewhere classified\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Repair of blood vessel with tissue patch graft\n- Insertion or replacement of epicardial lead [electrode] into epicardium\n- Revision or relocation of cardiac device pocket\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Occupational therapy evaluation\n- Physical therapy evaluation\n- Incision of heart\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Pooling of platelets or other blood products\n- Operative external blood circulation\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Radiologic examination, chest; single view, frontal\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Controlled ventilation procedure and therapy, initiation and management\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Revision of corrective procedure on heart\n\n### Condition\n- Asthma\n- Disorder of lung\n- Gastroesophageal reflux disease\n- Acquired deformity of thoracic structure\n- Adhesive pericarditis\n- Atrial flutter\n- Essential hypertension\n- Obstructive sleep apnea syndrome\n- Pleural effusion\n- Thyrotoxicosis without goiter or other cause\n- Cardiomegaly\n- Complete atrioventricular block\n- Pneumothorax\n- Acute on chronic combined systolic and diastolic heart failure\n- Atrial fibrillation\n- Chronic cor pulmonale\n- Congestive heart failure\n- Osteoporosis\n- Pulmonary congestion and hypostasis\n- Dyspnea\n- Accidental wound during procedure\n- Congenital anomaly of the kidney\n- Mechanical complication due to heart valve prosthesis\n- Scoliosis deformity of spine\n- Urinary tract infectious disease\n- Mitral valve disorder\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2009-12-24, presumably until 2010-03-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day. \n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-24\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2009-12-26\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2010-02-28, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-12-18, presumably until 2009-12-19\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2009-12-27, presumably until 2010-03-26, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Noorani by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2009-12-22, presumably until 2009-12-22\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2009-12-21, presumably until 2009-12-21\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2009-12-18, presumably until 2009-12-21\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-27\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-24, presumably until 2009-12-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-20\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-26\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2009-12-24, presumably until 2009-12-24\n- 24 HR ferrous sulfate 142 MG Extended Release Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-03-26, with quantity of 40.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-23\n- 100 ACTUAT flunisolide 0.25 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-12-25, presumably until 2009-12-27\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-19\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2009-12-21\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2009-12-24\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2009-12-18, presumably until 2009-12-18\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-23\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2009-12-27\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-03-26, with quantity of 80.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-18, presumably until 2010-03-26, with quantity of 40.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2009-12-23\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2009-12-19, presumably until 2009-12-27\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2009-12-18, presumably until 2009-12-27\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-12-18, presumably until 2009-12-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-23\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2009-12-19, presumably until 2009-12-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-12-23, presumably until 2009-12-23\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2009-12-18, presumably until 2009-12-19\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-12-21, presumably until 2009-12-27\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-22, presumably until 2009-12-25\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2009-12-22, presumably until 2009-12-25\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-12-26, presumably until 2009-12-27\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-19\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2009-12-18, presumably until 2009-12-23\n- methylprednisolone 125 MG Injection, started on 2009-12-18, presumably until 2009-12-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-12-24, presumably until 2009-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-19 09:29:21, ended at 2009-12-19 12:55:48\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-11 00:00:00, ended at 2010-01-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Dyspnea\n- Thyrotoxicosis without goiter or other cause\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-29 09:51:00, ended at 2010-01-29 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Other interview and evaluation\n\n### Condition\n- Tricuspid valve disorder\n- Aortic valve disorder\n- Diseases of mitral and aortic valves\n- Chronic cor pulmonale\n- Disorder of pericardium\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-29 12:45:07, ended at 2010-01-29 16:41:34\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-28 00:00:00, ended at 2010-02-28 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2010-02-28, presumably until 2011-02-21, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-26 13:03:29, ended at 2010-03-26 15:05:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Acute bronchospasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-06-13 00:00:00, ended at 2010-06-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized aches and pains\n\n### Drug\n- celecoxib 100 MG Oral Capsule, through Oral route, started on 2010-06-13, presumably until 2010-11-27, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-04 14:25:35, ended at 2010-07-04 14:55:43\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, techni\n- Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-07-26 00:00:00, ended at 2010-07-26 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-07-26, presumably until 2010-11-21, with quantity of 30.0, with intended 11 refill(s). Instructions: take 20 mg by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-12 00:00:00, ended at 2010-11-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-11-12, presumably until 2011-11-12, with quantity of 1.0, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-21 11:00:00, ended at 2010-11-21 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Chronic cor pulmonale\n- Acute bronchospasm\n- Mitral valve disorder\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-21 12:22:57, ended at 2010-11-21 13:09:07\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic cor pulmonale\n- Acute bronchospasm\n\n### Drug\n- sildenafil 20 MG Oral Tablet, through Oral route, started on 2010-11-21, presumably until 2011-03-31, with quantity of 270.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-12, presumably until 2011-11-13. Instructions: take 40 mg by mouth Evening.\n- beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-11-21, presumably until 2011-04-08, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day. \n- loratadine 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-21 12:24:15, ended at 2010-11-21 14:38:01\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-27 00:00:00, ended at 2010-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized aches and pains\n\n### Drug\n- celecoxib 100 MG Oral Capsule, through Oral route, started on 2010-11-27, presumably until 2011-08-21, with quantity of 200.0, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Generic acceptable if available \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-02-18 00:00:00, ended at 2011-02-18 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Marfan's syndrome\n- Thyrotoxicosis without goiter or other cause\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-18 12:42:00, ended at 2011-02-18 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-21 00:00:00, ended at 2011-02-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchospasm\n- Marfan's syndrome\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2011-02-21, presumably until 2011-04-08, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-02-21, presumably until 2011-11-13, with quantity of 1.0, with intended 11 refill(s). Instructions: 1 Cap by Inhalation route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-15 13:00:00, ended at 2011-03-15 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Mitral valve disorder\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2011-03-15, presumably until 2011-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-03-26 00:00:00, ended at 2011-03-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-03-26, presumably until 2011-03-31, with quantity of 10.0, with intended 1 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours. Pt. To take 1 injection 3/24 am and 3/24 pm, and will be given instruction post procedure. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-27 00:00:00, ended at 2011-03-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-11 00:00:00, ended at 2009-07-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Venous varices\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-13 00:00:00, ended at 2009-07-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Venous varices\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-17 00:00:00, ended at 2009-07-17 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-04 00:00:00, ended at 2009-08-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-08-04, presumably until 2009-10-04, with quantity of 10.0, with intended 1 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-22 00:00:00, ended at 2009-08-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-22 00:00:00, ended at 2009-08-22 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-08-22 15:30:00, ended at 2009-08-23 12:23:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.3 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 48.7 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Prothrombin time (PT): 30.9 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Body height: 5' 7.992\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-23\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-22\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-23\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2009-12-27. Instructions: take 100 mg by mouth as needed \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-22\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-08-22, presumably until 2009-08-22. Instructions: take 5 mg by mouth every bedtime as needed \n- alendronic acid 35 MG Oral Tablet, through Oral route, presumably until 2009-08-31. Instructions: take 35 mg by mouth as directed. Every Wed\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-08-23, presumably until 2009-08-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-08-22, presumably until 2009-08-23\n- aspirin 81 MG Oral Tablet, through Oral route, presumably until 2011-11-13. Instructions: take 81 mg by mouth daily. \n- 10 ML furosemide 10 MG/ML Injection, started on 2009-08-22, presumably until 2009-08-22\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, presumably until 2012-07-11. Instructions: take 2.5 mg by mouth as directed. 1 days a week\n- ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet, through Oral route, presumably until 2010-03-26. Instructions: take 2.5 Tabs by mouth daily. Femhrt 2.5 mg once q am\n- diphenhydramine hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2012-07-24. Instructions: take 50 mg by mouth as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-08-23, presumably until 2009-08-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-08-22 16:20:29, ended at 2009-08-22 18:55:55\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-31 00:00:00, ended at 2009-08-31 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.3 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Prothrombin time (PT): 14.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-01 05:28:00, ended at 2009-09-01 16:35:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Varicose veins of lower extremity with inflammation\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2009-09-01, presumably until 2010-02-28, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-10-04 00:00:00, ended at 2009-10-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-10-04, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours. Replace previous order for Atrovent to HFA inhaler \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-04 11:13:37, ended at 2009-10-04 14:56:15\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2009-10-04, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 2 Sprays by Nasal route daily. \n- 100 ACTUAT flunisolide 0.25 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-10-04, presumably until 2010-10-04, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day. \n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-10-04, presumably until 2009-10-04, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours. \n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2009-10-04, presumably until 2010-10-04, with intended 6 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-10-05 00:00:00, ended at 2009-10-05 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-05 12:54:47, ended at 2009-10-05 14:23:56\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-05 14:29:00, ended at 2009-10-05 14:48:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-05 14:49:00, ended at 2009-10-05 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; review and interpretation by a physician \n\n### Condition\n- Conduction disorder of the heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-10-06 00:00:00, ended at 2009-10-06 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Atrial fibrillation\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-25 05:51:00, ended at 2009-10-25 09:07:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Blood: 9.0 (millimole per liter)\n- Body height: 5' 10\" (inch (US))\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n\n### Procedure\n- Other electric countershock of heart\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-10-25, presumably until 2009-10-25\n- dronedarone 400 MG Oral Tablet, through Oral route, presumably until 2009-11-08. Instructions: take 200 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-08 00:00:00, ended at 2009-11-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Acute bronchospasm\n- Dyspnea\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-08 00:00:00, ended at 2009-11-08 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Acute bronchospasm\n- Dyspnea\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-08 10:02:45, ended at 2009-11-08 14:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2009-11-08, presumably until 2009-12-27, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2009-11-08, presumably until 2010-03-26, with quantity of 30.0, with intended 6 refill(s). Instructions: 1 Cap by Inhalation route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-17 00:00:00, ended at 2009-11-17 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dyspnea\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-11-17, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed \n- 14 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2009-11-17, presumably until 2010-03-26, with intended 6 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 13:00:00, ended at 2009-11-17 13:31:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n\n### Condition\n- Marfan's syndrome\n- Dyspnea\n- Acute bronchospasm\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 13:32:00, ended at 2009-11-17 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n\n### Condition\n- Dyspnea\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-20 00:00:00, ended at 2009-11-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Acute bronchospasm\n- Mitral valve disorder\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-20 00:00:00, ended at 2009-11-20 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-21 00:00:00, ended at 2009-11-21 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n- Tricuspid valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 13:00:00, ended at 2009-12-07 14:23:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Marfan's syndrome\n- Dissection of thoracic aorta\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-07 14:24:00, ended at 2009-12-07 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Marfan's syndrome\n- Dissection of thoracic aorta\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-08 12:17:00, ended at 2009-12-08 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Mitral valve disorder\n- Marfan's syndrome\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2009-12-08, presumably until 2009-12-08\n- midazolam 1 MG/ML Injectable Solution, started on 2009-12-08, presumably until 2009-12-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-14 00:00:00, ended at 2009-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mitral valve disorder\n- Dyspnea\n- Acute bronchospasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-14 00:00:00, ended at 2009-12-14 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchospasm\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-18 11:49:00, ended at 2009-12-18 14:48:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2009-12-18, presumably until 2009-12-18\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2009-12-18, presumably until 2009-12-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-18 14:49:00, ended at 2009-12-27 14:40:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 24.8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 92 (millimeter mercury column)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 736 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 151 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.5 (ratio)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.07 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 62.4 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 9.8 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.24 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.5 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.4 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 100.8 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Base deficit in Blood: 3.0 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 720 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- Prothrombin time (PT): 35.1 (second)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n\n### Procedure\n- Venous catheterization, not elsewhere classified\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Repair of blood vessel with tissue patch graft\n- Insertion or replacement of epicardial lead [electrode] into epicardium\n- Revision or relocation of cardiac device pocket\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Occupational therapy evaluation\n- Physical therapy evaluation\n- Incision of heart\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Pooling of platelets or other blood products\n- Operative external blood circulation\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Radiologic examination, chest; single view, frontal\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Controlled ventilation procedure and therapy, initiation and management\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Revision of corrective procedure on heart\n\n### Condition\n- Asthma\n- Disorder of lung\n- Gastroesophageal reflux disease\n- Acquired deformity of thoracic structure\n- Adhesive pericarditis\n- Atrial flutter\n- Essential hypertension\n- Obstructive sleep apnea syndrome\n- Pleural effusion\n- Thyrotoxicosis without goiter or other cause\n- Cardiomegaly\n- Complete atrioventricular block\n- Pneumothorax\n- Acute on chronic combined systolic and diastolic heart failure\n- Atrial fibrillation\n- Chronic cor pulmonale\n- Congestive heart failure\n- Osteoporosis\n- Pulmonary congestion and hypostasis\n- Dyspnea\n- Accidental wound during procedure\n- Congenital anomaly of the kidney\n- Mechanical complication due to heart valve prosthesis\n- Scoliosis deformity of spine\n- Urinary tract infectious disease\n- Mitral valve disorder\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2009-12-24, presumably until 2010-03-26, with quantity of 30.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day. \n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-24\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2009-12-26\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2010-02-28, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-12-18, presumably until 2009-12-19\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2009-12-27, presumably until 2010-03-26, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Noorani by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2009-12-22, presumably until 2009-12-22\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2009-12-21, presumably until 2009-12-21\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2009-12-18, presumably until 2009-12-21\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-27\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-24, presumably until 2009-12-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-20\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-26\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2009-12-24, presumably until 2009-12-24\n- 24 HR ferrous sulfate 142 MG Extended Release Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-03-26, with quantity of 40.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-23\n- 100 ACTUAT flunisolide 0.25 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2009-12-25, presumably until 2009-12-27\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-19\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2009-12-21\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2009-12-24\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2009-12-18, presumably until 2009-12-18\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-23\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2009-12-27\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2010-03-26, with quantity of 80.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-18, presumably until 2010-03-26, with quantity of 40.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2009-12-23\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2009-12-19, presumably until 2009-12-27\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2009-12-18, presumably until 2009-12-27\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-12-18, presumably until 2009-12-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-23\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2009-12-19, presumably until 2009-12-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-12-23, presumably until 2009-12-23\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2009-12-18, presumably until 2009-12-19\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-12-21, presumably until 2009-12-27\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-22, presumably until 2009-12-25\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2009-12-22, presumably until 2009-12-25\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-12-26, presumably until 2009-12-27\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2009-12-18, presumably until 2009-12-19\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2009-12-18, presumably until 2009-12-23\n- methylprednisolone 125 MG Injection, started on 2009-12-18, presumably until 2009-12-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-12-24, presumably until 2009-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-19 09:29:21, ended at 2009-12-19 12:55:48\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-11 00:00:00, ended at 2010-01-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Dyspnea\n- Thyrotoxicosis without goiter or other cause\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-29 09:51:00, ended at 2010-01-29 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Other interview and evaluation\n\n### Condition\n- Tricuspid valve disorder\n- Aortic valve disorder\n- Diseases of mitral and aortic valves\n- Chronic cor pulmonale\n- Disorder of pericardium\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-29 12:45:07, ended at 2010-01-29 16:41:34\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-28 00:00:00, ended at 2010-02-28 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2010-02-28, presumably until 2011-02-21, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-26 13:03:29, ended at 2010-03-26 15:05:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Acute bronchospasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-06-13 00:00:00, ended at 2010-06-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized aches and pains\n\n### Drug\n- celecoxib 100 MG Oral Capsule, through Oral route, started on 2010-06-13, presumably until 2010-11-27, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-04 14:25:35, ended at 2010-07-04 14:55:43\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, techni\n- Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-07-26 00:00:00, ended at 2010-07-26 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2010-07-26, presumably until 2010-11-21, with quantity of 30.0, with intended 11 refill(s). Instructions: take 20 mg by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-12 00:00:00, ended at 2010-11-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchospasm\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-11-12, presumably until 2011-11-12, with quantity of 1.0, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-21 11:00:00, ended at 2010-11-21 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Chronic cor pulmonale\n- Acute bronchospasm\n- Mitral valve disorder\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-21 12:22:57, ended at 2010-11-21 13:09:07\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic cor pulmonale\n- Acute bronchospasm\n\n### Drug\n- sildenafil 20 MG Oral Tablet, through Oral route, started on 2010-11-21, presumably until 2011-03-31, with quantity of 270.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-12, presumably until 2011-11-13. Instructions: take 40 mg by mouth Evening.\n- beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2010-11-21, presumably until 2011-04-08, with intended 6 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day. \n- loratadine 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-21 12:24:15, ended at 2010-11-21 14:38:01\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-27 00:00:00, ended at 2010-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized aches and pains\n\n### Drug\n- celecoxib 100 MG Oral Capsule, through Oral route, started on 2010-11-27, presumably until 2011-08-21, with quantity of 200.0, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Generic acceptable if available \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-02-18 00:00:00, ended at 2011-02-18 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Marfan's syndrome\n- Thyrotoxicosis without goiter or other cause\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-18 12:42:00, ended at 2011-02-18 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-21 00:00:00, ended at 2011-02-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchospasm\n- Marfan's syndrome\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2011-02-21, presumably until 2011-04-08, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- tiotropium 0.018 MG Inhalation Powder, through Inhalation, started on 2011-02-21, presumably until 2011-11-13, with quantity of 1.0, with intended 11 refill(s). Instructions: 1 Cap by Inhalation route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-15 13:00:00, ended at 2011-03-15 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Mitral valve disorder\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2011-03-15, presumably until 2011-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-03-26 00:00:00, ended at 2011-03-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-03-26, presumably until 2011-03-31, with quantity of 10.0, with intended 1 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours. Pt. To take 1 injection 3/24 am and 3/24 pm, and will be given instruction post procedure. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-27 00:00:00, ended at 2011-03-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Marfan's syndrome\n- Mitral valve disorder\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "fe80b4ce1ee285ffa8b26c373cae8821fd7883a07b1cd5f1b040319f95b1c5e5", "prompt_hash": "41c6a662cad32a42256258d3380175a16e5f5a21329f103730f44a20fc145e68", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
{"doc_id": 8, "doc": {"person_id": 115971749, "visit_occurrence_id": 157695016, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2020-04-09 00:00:00", "visit_end_datetime": "2020-04-09 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-09 00:00:00, ended at 2020-04-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-04-09, presumably until 2020-05-11, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n", "approximate_token_count": 126, "patient_first_visit_date": "2016-12-19 00:00:00", "patient_last_visit_date": "2021-10-07 00:00:00", "end_obs_date": "2021-04-09", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 1, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 208, "cumulated_visit_num": 208, "cumulated_approximate_token_count": 35138, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-19 00:00:00, ended at 2016-12-19 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, through Topical route, started on 2016-12-11, presumably until 2017-01-05, with intended 1 refill(s). Instructions: by Topical route APPLY 3 TIMES A DAY\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-11-28, presumably until 2017-01-05, with intended 2 refill(s). Instructions: 2 Sprays daily USE 2 SPRAYS IN EACH NOSTRIL DAILY\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-12-09, presumably until 2017-02-07, with intended 2 refill(s). Instructions: take 20 mg by mouth 2 times a day TAKE ONE TABLET ORALLY TWICE DAILY\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-12-11, presumably until 2017-01-15, with intended 1 refill(s). Instructions: take 5 mg by mouth daily TAKE 1 TABLET ORALLY EVERYDAY\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2016-12-03, presumably until 2017-01-15, with intended 1 refill(s). Instructions: take 200 mg by mouth 2 times a day TAKE ONE CAPSULE TWICE DAILY\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2016-12-09, presumably until 2017-01-05, with intended 2 refill(s). Instructions: take 75 mcg by mouth daily TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-19 14:49:55, ended at 2016-12-19 15:57:10\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 96 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.22 (nanogram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 1.650 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n- Essential hypertension\n- Osteoarthritis\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2017-01-05, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-05 00:00:00, ended at 2017-01-05 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2017-01-05, presumably until 2017-08-06, with intended 6 refill(s). Instructions: APPLY 3 TIMES A DAY\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-01-05, presumably until 2017-08-21, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2017-01-05, presumably until 2017-12-28, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-05 00:00:00, ended at 2017-01-05 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-15 12:53:37, ended at 2017-01-15 13:26:36\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Essential hypertension\n- Hypothyroidism\n- Osteoarthritis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2020-11-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed INSTRUCTED TO HOLD MED UNTIL POST-OP OR MD DISCHARGE INSTRUCTIONS. LAST TAKEN 01/27/2019\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-31 11:18:43, ended at 2017-01-31 12:10:40\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic disposition\n\n### Drug\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, through Intramuscular route, started on 2017-01-31, presumably until 2017-01-31, with intended 1 refill(s). Instructions: inject 0.3 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-07 00:00:00, ended at 2017-02-07 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2018-01-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-06 00:00:00, ended at 2017-08-06 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2017-08-06, presumably until 2018-04-27, with intended 6 refill(s). Instructions: APPLY 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-15 11:12:45, ended at 2017-08-15 12:32:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 1.340 (micro-international unit per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypothyroidism\n- Primary diagnosis: Low back pain\n\n### Drug\n- cyclobenzaprine hydrochloride 5 MG Oral Tablet, started on 2017-08-15, presumably until 2018-02-12, with intended 0 refill(s). Instructions: Take one at night for muscles spasms\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, started on 2017-08-21, presumably until 2018-02-12, with intended 0 refill(s). Instructions: Take one at bedtime for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-08-21, presumably until 2018-03-09, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-23 00:00:00, ended at 2017-08-23 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-08-23, presumably until 2017-08-23, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2017-12-28, presumably until 2018-03-26, with intended 0 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-08 00:00:00, ended at 2018-01-08 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-01-08, presumably until 2018-12-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-09 00:00:00, ended at 2018-01-09 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-01-09, presumably until 2018-01-09, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY - PLEASE CALL72 HOURS AHEAD FOR REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-31 00:00:00, ended at 2018-01-31 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-05-01, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-12 14:18:21, ended at 2018-02-12 15:04:51\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Hypothyroidism\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-09 00:00:00, ended at 2018-03-09 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-03-11, presumably until 2018-05-29, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-26 00:00:00, ended at 2018-03-26 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2018-03-27, presumably until 2019-03-15, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-25 08:17:00, ended at 2018-04-25 08:44:47\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysuria\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2018-04-25, presumably until 2018-05-02, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-26 00:00:00, ended at 2018-04-26 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2018-04-27, presumably until 2019-11-02, with intended 6 refill(s). Instructions: APPLY 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-01 00:00:00, ended at 2018-05-01 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-05-01, presumably until 2019-04-30, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-29 00:00:00, ended at 2018-05-29 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-05-29, presumably until 2019-05-03, with intended 2 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-06-04, presumably until 2018-06-04, with intended 0 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysuria\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2018-09-23, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-11-09 00:00:00, ended at 2018-11-09 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2018-11-09, presumably until 2018-11-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-19 11:24:00, ended at 2018-12-19 12:31:12\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Body height: 5' 2.244\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Acute maxillary sinusitis\n- Hypoxemia\n- Acute bronchitis\n- Essential hypertension\n- Hemoptysis\n- Disorder of mediastinum\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-19, presumably until 2019-01-10, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed for Bronchospasm/Wheezing\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2018-12-19, presumably until 2018-12-19, with intended 0 refill(s). Instructions: 1 mL by Injection route One Time\n- azithromycin 250 MG Oral Tablet, started on 2018-12-19, presumably until 2018-12-25, with intended 0 refill(s). Instructions: 2 tabs po x 1d and then 1 tab po x 4 more days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-19 13:24:47, ended at 2018-12-19 14:51:36\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Hemoptysis\n- Chronic obstructive lung disease\n- Acute bronchitis\n- Inflammatory disorder of mediastinum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-20 00:00:00, ended at 2018-12-20 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-12-20, presumably until 2019-12-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-28 11:27:54, ended at 2018-12-28 13:20:46\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.244\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-12-28, presumably until 2019-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2018-12-28, presumably until 2019-01-06, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2018-12-28, presumably until 2019-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-02 10:44:40, ended at 2019-01-02 12:04:31\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body system\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-06 12:18:22, ended at 2019-01-06 12:45:41\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.244\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n- Anxiety disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-09 14:09:00, ended at 2019-01-09 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bronchitis\n\n### Drug\n- benzonatate 100 MG Oral Capsule, started on 2019-01-10, presumably until 2019-09-03, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH THREE TIMES A DAY AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchitis\n- Hypoxemia\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2019-01-10, presumably until 2019-12-08, with intended 6 refill(s). Instructions: 2 PUFFS BY INHALATION ROUTE EVERY 6 HOURS AS NEEDED FOR BRONCHOSPASM OR WHEEZING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-15 11:32:00, ended at 2019-01-15 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Localized enlarged lymph nodes\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-20 10:31:30, ended at 2019-01-20 11:52:44\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety disorder\n- Dyspnea\n- Hemoptysis\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n- Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-01-20, presumably until 2019-03-11, with intended 1 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed\n- 120 ACTUAT fluticasone propionate 0.11 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-01-20, presumably until 2019-05-08, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-22 00:00:00, ended at 2019-01-22 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-01-22, presumably until 2019-04-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-24 00:00:00, ended at 2019-01-24 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-01-24, presumably until 2019-01-24, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-03 10:47:47, ended at 2019-02-03 11:38:34\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety disorder\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n- Cough\n- Hemoptysis\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0667 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.66 (percent)\n- MCV [Entitic volume] by Automated count: 82.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1648 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.21 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.3962 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.67 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.07 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.61 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 414.9 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-02-14 13:03:00, ended at 2019-02-14 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.59 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.4398 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0526 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.84 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1241 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.26 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.58 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.98 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 10.3 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 33 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-26 00:00:00, ended at 2019-02-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-26 00:00:00, ended at 2019-02-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1009 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0159 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.7 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.21 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.12 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.6797 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.76 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 10:38:28, ended at 2019-03-03 11:14:08\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.01\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Dyspnea\n- Primary malignant neoplasm of respiratory tract\n- Cough\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2019-02-14, presumably until 2019-02-14, with intended 3 refill(s). Instructions: take 8 mg by mouth 3 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.65 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Immature granulocytes/100 leukocytes in Blood: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Synovial fluid by Manual count: 75 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.1 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- MCV [Entitic volume] by Automated count: 79 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-03-11, presumably until 2019-04-28, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.25 (percent)\n- MCH [Entitic mass] by Automated count: 26.7 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.1295 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0855 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.82 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.13 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 363 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 382.1 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Creatinine [Mass/volume] in Urine: 0.64 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2019-03-17, presumably until 2019-05-07, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 00:00:00, ended at 2019-03-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.9 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Synovial fluid by Manual count: 79 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.3 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 00:00:00, ended at 2019-03-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.64 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (international unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-03-25 10:30:00, ended at 2019-03-25 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Unlisted procedure, medical radiation physics, dosimetry and treatment devices, and special services\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-03-26 08:40:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)\n- Therapeutic radiology treatment planning; complex\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-02 09:10:00, ended at 2019-04-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications\n- Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan\n- Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, onl\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.64 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 402.4 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1024 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.58 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.485 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0827 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.28 (percent)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-03 13:38:00, ended at 2019-04-03 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-04 15:09:00, ended at 2019-04-04 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-07 14:58:00, ended at 2019-04-07 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-08 14:45:00, ended at 2019-04-08 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-09 14:54:00, ended at 2019-04-09 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 00:00:00, ended at 2019-04-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.20 (milli-international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 00:00:00, ended at 2019-04-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 00:00:00, ended at 2019-04-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.35 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4045 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0857 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1485 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.19 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.65 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.84 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-10 14:23:00, ended at 2019-04-10 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-11 13:43:00, ended at 2019-04-11 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-14 13:48:00, ended at 2019-04-14 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-15 14:49:00, ended at 2019-04-15 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2019-04-15, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 10 mL by mouth One Time for 1 dose\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-16 00:00:00, ended at 2019-04-16 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-04-16, presumably until 2019-07-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-16 14:00:00, ended at 2019-04-16 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.06 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0689 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 159 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0582 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.83 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-17 14:00:00, ended at 2019-04-17 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-18 13:41:00, ended at 2019-04-18 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-21 13:48:00, ended at 2019-04-21 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-22 14:00:00, ended at 2019-04-22 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-04-22, presumably until 2019-04-29, with intended 0 refill(s). Instructions: take 1 Tab (250 mg total) by mouth daily for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-23 00:00:00, ended at 2019-04-23 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-23 00:00:00, ended at 2019-04-23 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0365 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0413 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.2457 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.73 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.2 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.82 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-23 13:28:00, ended at 2019-04-23 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-24 13:50:00, ended at 2019-04-24 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-25 13:54:00, ended at 2019-04-25 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-28 00:00:00, ended at 2019-04-28 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-04-29, presumably until 2019-06-11, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-28 13:56:00, ended at 2019-04-28 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.27 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.4 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.99 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.40 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.1882 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0381 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0357 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.19 (percent)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 299.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.62 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-29 14:14:00, ended at 2019-04-29 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2019-04-30, presumably until 2020-01-28, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-30 13:57:00, ended at 2019-04-30 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-01 13:58:00, ended at 2019-05-01 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-02 00:00:00, ended at 2019-05-02 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-02 00:00:00, ended at 2019-05-02 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.21 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.55 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.2586 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0486 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.038 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.43 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-02 13:58:00, ended at 2019-05-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-03 00:00:00, ended at 2019-05-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-05-06, presumably until 2020-01-21, with intended 2 refill(s). Instructions: SPRAY 2 SPRAYS INTO EACH NOSTRIL EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0663 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3728 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.2 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.77 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.39 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0402 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.45 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-06 14:44:00, ended at 2019-05-06 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2019-05-07, presumably until 2020-02-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-07 14:03:00, ended at 2019-05-07 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-08 00:00:00, ended at 2019-05-08 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT fluticasone propionate 0.11 MG/ACTUAT Metered Dose Inhaler, started on 2019-05-08, presumably until 2019-06-03, with intended 3 refill(s). Instructions: USE 2 PUFFS BY INHALATION ROUTE 2 TIMES A DAY COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-08 13:56:00, ended at 2019-05-08 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-09 00:00:00, ended at 2019-05-09 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0627 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.8 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0308 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.42 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.17 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.2378 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 2.89 (percent)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-09 13:53:00, ended at 2019-05-09 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-12 14:02:00, ended at 2019-05-12 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.69 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.45 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.2955 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0335 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0239 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.97 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 251.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-13 14:53:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-14 13:55:00, ended at 2019-05-14 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-15 14:01:00, ended at 2019-05-15 16:37:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-05-15 16:38:00, ended at 2019-05-15 17:26:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety disorder\n- Fibromyalgia\n- Essential hypertension\n- Primary malignant neoplasm of respiratory tract\n- Primary diagnosis: Constipation\n- Hyperlipidemia\n- Hypothyroidism\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2019-05-15, presumably until 2019-05-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-20 00:00:00, ended at 2019-05-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-05-20, presumably until 2019-06-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-21 00:00:00, ended at 2019-05-21 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, started on 2019-05-21, presumably until 2021-05-27, with intended 0 refill(s). Instructions: TAKE 10 ML BY MOUTH ONE TIME FOR 1 DOSE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-02 11:18:00, ended at 2019-06-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-03 00:00:00, ended at 2019-06-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2019-06-04, presumably until 2019-09-02, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-03 10:04:50, ended at 2019-06-03 10:49:01\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.01\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cough\n- Primary malignant neoplasm of respiratory tract\n- Dyspnea\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- folic acid 0.4 MG Oral Tablet, started on 2019-02-14, presumably until 2019-07-11, with intended 0 refill(s). Instructions: folic acid 400 mcg tablet\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-06-03, presumably until 2019-09-02, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-06-10, presumably until 2019-12-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-11 00:00:00, ended at 2019-06-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-06-11, presumably until 2019-07-29, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-06-16 12:56:00, ended at 2019-06-16 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2019-06-16, presumably until 2019-11-18, with intended 0 refill(s). Instructions: take 1 Tab (4 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-16 14:02:05, ended at 2019-06-16 16:01:28\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of calcium metabolism\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-19 00:00:00, ended at 2019-06-19 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-23 00:00:00, ended at 2019-06-23 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.63 (nanogram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 1.040 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-27 00:00:00, ended at 2019-06-27 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-10 00:00:00, ended at 2019-07-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Drug-induced neutropenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-10 11:14:55, ended at 2019-07-10 14:00:59\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-11 00:00:00, ended at 2019-07-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-07-11, presumably until 2020-06-28, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-11 00:00:00, ended at 2019-07-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2019-07-13, presumably until 2019-10-04, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-11 00:00:00, ended at 2019-07-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- folic acid 0.4 MG Oral Tablet, started on 2019-07-13, presumably until 2020-01-12, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-24 10:10:00, ended at 2019-07-24 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Localized enlarged lymph nodes\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-07-29, presumably until 2019-09-10, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 11:09:30, ended at 2019-07-29 14:34:36\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-30 00:00:00, ended at 2019-07-30 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-07-30, presumably until 2019-11-25, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily For 3 days and after that take as directed for rash\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-12 00:00:00, ended at 2019-08-12 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter calculated)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.38 (milli-international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-08-26, presumably until 2019-08-26\n- midazolam 1 MG/ML Injectable Solution, started on 2019-08-26, presumably until 2019-08-26\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2019-08-26, presumably until 2019-08-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 15.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-02 10:04:51, ended at 2019-09-02 10:43:03\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dyspnea\n- Wheezing\n- Primary diagnosis: Abnormal breathing\n- Acute exacerbation of chronic obstructive airways disease\n- Cough\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-09-02, presumably until 2019-11-25, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-02 10:53:00, ended at 2019-09-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n\n### Condition\n- Dyspnea\n- Abnormal findings on diagnostic imaging of lung\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-03 00:00:00, ended at 2019-09-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bronchitis\n\n### Drug\n- benzonatate 100 MG Oral Capsule, started on 2019-09-03, presumably until 2020-07-21, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH THREE TIMES A DAY AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-06 00:00:00, ended at 2019-09-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, started on 2019-09-08, presumably until 2019-12-04, with intended 3 refill(s). Instructions: 1 PUFF BY INHALATION ROUTE 2 TIMES A DAY COPD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.23 (milli-international unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.5 (calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 9.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-09 11:47:15, ended at 2019-09-09 13:59:45\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-10 00:00:00, ended at 2019-09-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-09-10, presumably until 2019-11-10, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-16 10:47:20, ended at 2019-09-16 11:37:21\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Wheezing\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Dyspnea\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, through Intra-articular route, started on 2019-09-16, presumably until 2019-09-16, with intended 0 refill(s). Instructions: 3 mL (30 mg total) by Intra-articular route One Time for 1 dose\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-09-16, presumably until 2019-09-21, with intended 0 refill(s). Instructions: take 2 Tabs (500 mg total) by mouth daily for 1 day, THEN 1 Tab (250 mg total) daily for 4 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-22 09:45:54, ended at 2019-09-22 10:12:02\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Wheezing\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-26 00:00:00, ended at 2019-09-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2019-10-06, presumably until 2020-01-06, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-07 11:26:13, ended at 2019-10-07 14:17:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-13 09:57:36, ended at 2019-10-13 10:45:36\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pneumonia\n- Primary diagnosis: Abnormal breathing\n- Primary diagnosis: Dyspnea\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-13, presumably until 2019-11-25, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 11:25:50, ended at 2019-10-21 13:57:59\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n- Hypo-osmolality and or hyponatremia\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2019-10-21, presumably until 2021-05-27, with intended 5 refill(s). Instructions: Apply small amount to skin over PORT and cover with plastic wrap 1 hour prior to chemo start time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-22 00:00:00, ended at 2019-10-22 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2021-09-30, presumably until 2022-03-29, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-22 07:07:00, ended at 2019-10-22 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal breathing\n- Dyspnea\n- Pleural effusion\n- Malignant neoplasm of upper lobe of lung\n- Pneumonia\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-22 07:07:00, ended at 2019-10-22 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-02 00:00:00, ended at 2019-11-02 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2019-11-03, presumably until 2020-06-15, with intended 6 refill(s). Instructions: APPLY THREE TIMES A DAY TO AFFECTED AREA (S)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-04 11:28:40, ended at 2019-11-04 12:40:22\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-05 00:00:00, ended at 2019-11-05 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-11-05, presumably until 2019-11-05, with intended 0 refill(s). Instructions: TAKE 1-2 TABS ORALLY TWICE A DAY AS NEEDED FOR BREAKTHROUGH NAUSEA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-10 00:00:00, ended at 2019-11-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-11-10, presumably until 2019-12-11, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-11 00:00:00, ended at 2019-11-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 24 (millimeter per hour)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Rheumatoid factor [Units/volume] in Serum or Plasma: <10.0 (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Primary diagnosis: Muscle pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-11 10:19:11, ended at 2019-11-11 11:26:45\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pneumonia\n- Wheezing\n- Cough\n- Primary diagnosis: Dyspnea\n- Acute exacerbation of chronic obstructive airways disease\n- Primary diagnosis: Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-13 00:00:00, ended at 2019-11-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 4.700 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.61 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-18 00:00:00, ended at 2019-11-18 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2019-11-18, presumably until 2019-11-23, with intended 0 refill(s). Instructions: take 1 Tab (4 mg total) by mouth daily in the morning with food\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-18 13:28:24, ended at 2019-11-18 15:44:05\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood chemistry abnormal\n- Muscle pain\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-11-25, presumably until 2019-12-02, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily With breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-02 10:34:05, ended at 2019-12-02 12:10:24\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-12-02, presumably until 2019-12-02, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-12-02, presumably until 2020-01-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-12-02, presumably until 2020-01-13, with intended 2 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily With breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, started on 2019-12-04, presumably until 2020-02-09, with intended 3 refill(s). Instructions: 1 PUFF BY INHALATION ROUTE 2 TIMES A DAY COPD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-08 00:00:00, ended at 2019-12-08 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchitis\n- Hypoxemia\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2019-12-08, presumably until 2020-09-06, with intended 6 refill(s). Instructions: 2 PUFFS BY INHALATION ROUTE EVERY 6 HOURS AS NEEDED FOR BRONCHOSPASM OR WHEEZING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-12-11, presumably until 2020-01-12, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-14 00:00:00, ended at 2019-12-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-12-15, presumably until 2020-12-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-16 12:54:08, ended at 2019-12-16 15:22:07\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-01 00:00:00, ended at 2020-01-01 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2020-01-01, presumably until 2020-02-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-06 00:00:00, ended at 2020-01-06 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2020-01-06, presumably until 2020-07-23, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-09 00:00:00, ended at 2020-01-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-01-12, presumably until 2020-02-09, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- folic acid 0.4 MG Oral Tablet, started on 2020-01-12, presumably until 2021-05-27, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-13 10:15:14, ended at 2020-01-13 12:51:25\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-01-13, presumably until 2020-06-22, with intended 3 refill(s). Instructions: take 7 Tabs (7 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-21 13:56:09, ended at 2020-01-21 14:35:28\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Acute exacerbation of chronic obstructive airways disease\n- Drug-induced neutropenia\n- Primary diagnosis: Essential hypertension\n- Anxiety disorder\n- Hypothyroidism\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-21, presumably until 2020-07-14, with intended 2 refill(s). Instructions: SPRAY 2 SPRAYS INTO EACH NOSTRIL EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-25 00:00:00, ended at 2020-01-25 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2020-01-28, presumably until 2020-07-27, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-27 13:53:38, ended at 2020-01-27 14:31:33\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cough\n- Pneumonia\n- Wheezing\n- Primary diagnosis: Abnormal breathing\n- Acute exacerbation of chronic obstructive airways disease\n- Primary diagnosis: Dyspnea\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2020-01-27, presumably until 2020-02-03, with intended 0 refill(s). Instructions: take 1 Tab (250 mg total) by mouth daily for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-02 00:00:00, ended at 2020-02-02 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2020-02-02, presumably until 2020-03-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-02 08:56:00, ended at 2020-02-02 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-05 00:00:00, ended at 2020-02-05 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2020-02-05, presumably until 2020-11-24, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2020-02-09, presumably until 2020-06-03, with intended 3 refill(s). Instructions: 250 mcg by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-03-08, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-03 00:00:00, ended at 2020-03-03 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2020-03-03, presumably until 2020-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-03-08, presumably until 2020-04-09, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-09 00:00:00, ended at 2020-04-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-04-09, presumably until 2020-05-11, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-19 00:00:00, ended at 2016-12-19 00:00:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, through Topical route, started on 2016-12-11, presumably until 2017-01-05, with intended 1 refill(s). Instructions: by Topical route APPLY 3 TIMES A DAY\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-11-28, presumably until 2017-01-05, with intended 2 refill(s). Instructions: 2 Sprays daily USE 2 SPRAYS IN EACH NOSTRIL DAILY\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-12-09, presumably until 2017-02-07, with intended 2 refill(s). Instructions: take 20 mg by mouth 2 times a day TAKE ONE TABLET ORALLY TWICE DAILY\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2016-12-11, presumably until 2017-01-15, with intended 1 refill(s). Instructions: take 5 mg by mouth daily TAKE 1 TABLET ORALLY EVERYDAY\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2016-12-03, presumably until 2017-01-15, with intended 1 refill(s). Instructions: take 200 mg by mouth 2 times a day TAKE ONE CAPSULE TWICE DAILY\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2016-12-09, presumably until 2017-01-05, with intended 2 refill(s). Instructions: take 75 mcg by mouth daily TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-19 14:49:55, ended at 2016-12-19 15:57:10\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 96 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.22 (nanogram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 1.650 (micro-international unit per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n- Essential hypertension\n- Osteoarthritis\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2017-01-05, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-05 00:00:00, ended at 2017-01-05 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2017-01-05, presumably until 2017-08-06, with intended 6 refill(s). Instructions: APPLY 3 TIMES A DAY\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-01-05, presumably until 2017-08-21, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2017-01-05, presumably until 2017-12-28, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-05 00:00:00, ended at 2017-01-05 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-15 12:53:37, ended at 2017-01-15 13:26:36\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Essential hypertension\n- Hypothyroidism\n- Osteoarthritis\n\n### Drug\n- naproxen sodium 220 MG Oral Tablet, through Oral route, presumably until 2020-11-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed INSTRUCTED TO HOLD MED UNTIL POST-OP OR MD DISCHARGE INSTRUCTIONS. LAST TAKEN 01/27/2019\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-31 11:18:43, ended at 2017-01-31 12:10:40\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic disposition\n\n### Drug\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, through Intramuscular route, started on 2017-01-31, presumably until 2017-01-31, with intended 1 refill(s). Instructions: inject 0.3 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-07 00:00:00, ended at 2017-02-07 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2018-01-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-06 00:00:00, ended at 2017-08-06 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2017-08-06, presumably until 2018-04-27, with intended 6 refill(s). Instructions: APPLY 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-15 11:12:45, ended at 2017-08-15 12:32:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 1.340 (micro-international unit per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hypothyroidism\n- Primary diagnosis: Low back pain\n\n### Drug\n- cyclobenzaprine hydrochloride 5 MG Oral Tablet, started on 2017-08-15, presumably until 2018-02-12, with intended 0 refill(s). Instructions: Take one at night for muscles spasms\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, started on 2017-08-21, presumably until 2018-02-12, with intended 0 refill(s). Instructions: Take one at bedtime for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-08-21, presumably until 2018-03-09, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-23 00:00:00, ended at 2017-08-23 00:00:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-08-23, presumably until 2017-08-23, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-28 00:00:00, ended at 2017-12-28 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2017-12-28, presumably until 2018-03-26, with intended 0 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-08 00:00:00, ended at 2018-01-08 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-01-08, presumably until 2018-12-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-09 00:00:00, ended at 2018-01-09 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-01-09, presumably until 2018-01-09, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY - PLEASE CALL72 HOURS AHEAD FOR REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-31 00:00:00, ended at 2018-01-31 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-01-31, presumably until 2018-05-01, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-12 14:18:21, ended at 2018-02-12 15:04:51\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Hypothyroidism\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-09 00:00:00, ended at 2018-03-09 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-03-11, presumably until 2018-05-29, with intended 6 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-26 00:00:00, ended at 2018-03-26 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2018-03-27, presumably until 2019-03-15, with intended 3 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-25 08:17:00, ended at 2018-04-25 08:44:47\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysuria\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2018-04-25, presumably until 2018-05-02, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-26 00:00:00, ended at 2018-04-26 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2018-04-27, presumably until 2019-11-02, with intended 6 refill(s). Instructions: APPLY 3 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-01 00:00:00, ended at 2018-05-01 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2018-05-01, presumably until 2019-04-30, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-29 00:00:00, ended at 2018-05-29 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-05-29, presumably until 2019-05-03, with intended 2 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-06-04, presumably until 2018-06-04, with intended 0 refill(s). Instructions: USE 2 SPRAYS IN EACH NOSTRIL DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysuria\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2018-09-23, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-11-09 00:00:00, ended at 2018-11-09 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2018-11-09, presumably until 2018-11-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-19 11:24:00, ended at 2018-12-19 12:31:12\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Body height: 5' 2.244\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Acute maxillary sinusitis\n- Hypoxemia\n- Acute bronchitis\n- Essential hypertension\n- Hemoptysis\n- Disorder of mediastinum\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-19, presumably until 2019-01-10, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed for Bronchospasm/Wheezing\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2018-12-19, presumably until 2018-12-19, with intended 0 refill(s). Instructions: 1 mL by Injection route One Time\n- azithromycin 250 MG Oral Tablet, started on 2018-12-19, presumably until 2018-12-25, with intended 0 refill(s). Instructions: 2 tabs po x 1d and then 1 tab po x 4 more days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-19 13:24:47, ended at 2018-12-19 14:51:36\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Hemoptysis\n- Chronic obstructive lung disease\n- Acute bronchitis\n- Inflammatory disorder of mediastinum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-20 00:00:00, ended at 2018-12-20 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-12-20, presumably until 2019-12-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-28 11:27:54, ended at 2018-12-28 13:20:46\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.244\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-12-28, presumably until 2019-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2018-12-28, presumably until 2019-01-06, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2018-12-28, presumably until 2019-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-02 10:44:40, ended at 2019-01-02 12:04:31\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.25\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body system\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-06 12:18:22, ended at 2019-01-06 12:45:41\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.244\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n- Anxiety disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-09 14:09:00, ended at 2019-01-09 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bronchitis\n\n### Drug\n- benzonatate 100 MG Oral Capsule, started on 2019-01-10, presumably until 2019-09-03, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH THREE TIMES A DAY AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchitis\n- Hypoxemia\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2019-01-10, presumably until 2019-12-08, with intended 6 refill(s). Instructions: 2 PUFFS BY INHALATION ROUTE EVERY 6 HOURS AS NEEDED FOR BRONCHOSPASM OR WHEEZING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-15 11:32:00, ended at 2019-01-15 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Localized enlarged lymph nodes\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-20 10:31:30, ended at 2019-01-20 11:52:44\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety disorder\n- Dyspnea\n- Hemoptysis\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n- Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-01-20, presumably until 2019-03-11, with intended 1 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed\n- 120 ACTUAT fluticasone propionate 0.11 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-01-20, presumably until 2019-05-08, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-22 00:00:00, ended at 2019-01-22 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-01-22, presumably until 2019-04-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-24 00:00:00, ended at 2019-01-24 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-01-24, presumably until 2019-01-24, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-03 10:47:47, ended at 2019-02-03 11:38:34\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety disorder\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n- Cough\n- Hemoptysis\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0667 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.66 (percent)\n- MCV [Entitic volume] by Automated count: 82.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1648 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.21 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.3962 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.67 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.07 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.61 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 414.9 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-02-14 13:03:00, ended at 2019-02-14 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.59 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Automated count: 0.4398 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0526 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.84 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1241 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.26 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.58 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.98 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 10.3 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 33 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-26 00:00:00, ended at 2019-02-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-26 00:00:00, ended at 2019-02-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1009 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0159 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.7 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.21 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.12 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.6797 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.76 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 10:38:28, ended at 2019-03-03 11:14:08\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.01\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic obstructive lung disease\n- Dyspnea\n- Primary malignant neoplasm of respiratory tract\n- Cough\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2019-02-14, presumably until 2019-02-14, with intended 3 refill(s). Instructions: take 8 mg by mouth 3 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.65 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Immature granulocytes/100 leukocytes in Blood: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Synovial fluid by Manual count: 75 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.1 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- MCV [Entitic volume] by Automated count: 79 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-03-11, presumably until 2019-04-28, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.25 (percent)\n- MCH [Entitic mass] by Automated count: 26.7 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.1295 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0855 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.82 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.13 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 363 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 382.1 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-13 00:00:00, ended at 2019-03-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Creatinine [Mass/volume] in Urine: 0.64 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2019-03-17, presumably until 2019-05-07, with intended 1 refill(s). Instructions: TAKE 1 TABLET ORALLY DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 00:00:00, ended at 2019-03-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.9 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Synovial fluid by Manual count: 79 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.3 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-20 00:00:00, ended at 2019-03-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.64 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (international unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-03-25 10:30:00, ended at 2019-03-25 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Unlisted procedure, medical radiation physics, dosimetry and treatment devices, and special services\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-03-26 08:40:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)\n- Therapeutic radiology treatment planning; complex\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-02 09:10:00, ended at 2019-04-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications\n- Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan\n- Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, onl\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.64 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 402.4 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1024 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.58 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.485 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0827 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.28 (percent)\n- MCV [Entitic volume] by Automated count: 86.6 (femtoliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-03 13:38:00, ended at 2019-04-03 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-04 15:09:00, ended at 2019-04-04 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-07 14:58:00, ended at 2019-04-07 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-08 14:45:00, ended at 2019-04-08 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-09 14:54:00, ended at 2019-04-09 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 00:00:00, ended at 2019-04-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.20 (milli-international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 00:00:00, ended at 2019-04-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 00:00:00, ended at 2019-04-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.35 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4045 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0857 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1485 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.19 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.65 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.84 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-10 14:23:00, ended at 2019-04-10 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-11 13:43:00, ended at 2019-04-11 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-14 13:48:00, ended at 2019-04-14 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-15 14:49:00, ended at 2019-04-15 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2019-04-15, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 10 mL by mouth One Time for 1 dose\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-16 00:00:00, ended at 2019-04-16 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-04-16, presumably until 2019-07-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-16 14:00:00, ended at 2019-04-16 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.06 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0689 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 159 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0582 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.83 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-17 14:00:00, ended at 2019-04-17 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-18 13:41:00, ended at 2019-04-18 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-21 13:48:00, ended at 2019-04-21 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-22 14:00:00, ended at 2019-04-22 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-04-22, presumably until 2019-04-29, with intended 0 refill(s). Instructions: take 1 Tab (250 mg total) by mouth daily for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-23 00:00:00, ended at 2019-04-23 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-23 00:00:00, ended at 2019-04-23 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0365 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0413 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.2457 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.73 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.2 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.82 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-23 13:28:00, ended at 2019-04-23 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-24 13:50:00, ended at 2019-04-24 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-25 13:54:00, ended at 2019-04-25 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-28 00:00:00, ended at 2019-04-28 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-04-29, presumably until 2019-06-11, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-28 13:56:00, ended at 2019-04-28 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.27 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.64 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.4 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.99 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.40 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.1882 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0381 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0357 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.19 (percent)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 299.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.62 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-29 14:14:00, ended at 2019-04-29 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2019-04-30, presumably until 2020-01-28, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-04-30 13:57:00, ended at 2019-04-30 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-01 13:58:00, ended at 2019-05-01 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-02 00:00:00, ended at 2019-05-02 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-02 00:00:00, ended at 2019-05-02 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.21 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.55 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.2586 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0486 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.14 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.038 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.43 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-02 13:58:00, ended at 2019-05-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-03 00:00:00, ended at 2019-05-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-05-06, presumably until 2020-01-21, with intended 2 refill(s). Instructions: SPRAY 2 SPRAYS INTO EACH NOSTRIL EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0663 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3728 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.2 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.77 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.39 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0402 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.45 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-06 14:44:00, ended at 2019-05-06 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2019-05-07, presumably until 2020-02-05, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-07 14:03:00, ended at 2019-05-07 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-08 00:00:00, ended at 2019-05-08 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 120 ACTUAT fluticasone propionate 0.11 MG/ACTUAT Metered Dose Inhaler, started on 2019-05-08, presumably until 2019-06-03, with intended 3 refill(s). Instructions: USE 2 PUFFS BY INHALATION ROUTE 2 TIMES A DAY COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-08 13:56:00, ended at 2019-05-08 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-09 00:00:00, ended at 2019-05-09 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0627 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.8 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0308 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.42 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.17 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.2378 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 2.89 (percent)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-09 13:53:00, ended at 2019-05-09 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-12 14:02:00, ended at 2019-05-12 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.69 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.45 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.75 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.2955 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0335 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0239 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.97 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 251.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-13 14:53:00, ended at 2019-05-13 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Malignant neoplasm of upper lobe of lung\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-14 13:55:00, ended at 2019-05-14 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tobacco dependence in remission\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-15 14:01:00, ended at 2019-05-15 16:37:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Tobacco dependence in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-05-15 16:38:00, ended at 2019-05-15 17:26:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anxiety disorder\n- Fibromyalgia\n- Essential hypertension\n- Primary malignant neoplasm of respiratory tract\n- Primary diagnosis: Constipation\n- Hyperlipidemia\n- Hypothyroidism\n\n### Drug\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2019-05-15, presumably until 2019-05-15, with intended 0 refill(s). Instructions: take 4,000 mL by mouth One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-20 00:00:00, ended at 2019-05-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-05-20, presumably until 2019-06-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-21 00:00:00, ended at 2019-05-21 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, started on 2019-05-21, presumably until 2021-05-27, with intended 0 refill(s). Instructions: TAKE 10 ML BY MOUTH ONE TIME FOR 1 DOSE\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-02 11:18:00, ended at 2019-06-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-03 00:00:00, ended at 2019-06-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2019-06-04, presumably until 2019-09-02, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-03 10:04:50, ended at 2019-06-03 10:49:01\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.01\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cough\n- Primary malignant neoplasm of respiratory tract\n- Dyspnea\n- Primary diagnosis: Chronic obstructive lung disease\n\n### Drug\n- folic acid 0.4 MG Oral Tablet, started on 2019-02-14, presumably until 2019-07-11, with intended 0 refill(s). Instructions: folic acid 400 mcg tablet\n- 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-06-03, presumably until 2019-09-02, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route 2 times a day COPD - J 44.9\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-06-10, presumably until 2019-12-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-11 00:00:00, ended at 2019-06-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-06-11, presumably until 2019-07-29, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-06-16 12:56:00, ended at 2019-06-16 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2019-06-16, presumably until 2019-11-18, with intended 0 refill(s). Instructions: take 1 Tab (4 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-16 14:02:05, ended at 2019-06-16 16:01:28\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of calcium metabolism\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-19 00:00:00, ended at 2019-06-19 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-23 00:00:00, ended at 2019-06-23 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.63 (nanogram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 1.040 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-27 00:00:00, ended at 2019-06-27 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-10 00:00:00, ended at 2019-07-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Drug-induced neutropenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-10 11:14:55, ended at 2019-07-10 14:00:59\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-11 00:00:00, ended at 2019-07-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2019-07-11, presumably until 2020-06-28, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY IN THE MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-11 00:00:00, ended at 2019-07-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2019-07-13, presumably until 2019-10-04, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-11 00:00:00, ended at 2019-07-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- folic acid 0.4 MG Oral Tablet, started on 2019-07-13, presumably until 2020-01-12, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-24 10:10:00, ended at 2019-07-24 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Localized enlarged lymph nodes\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-07-29, presumably until 2019-09-10, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 11:09:30, ended at 2019-07-29 14:34:36\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-30 00:00:00, ended at 2019-07-30 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-07-30, presumably until 2019-11-25, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily For 3 days and after that take as directed for rash\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-12 00:00:00, ended at 2019-08-12 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter calculated)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.38 (milli-international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-08-26, presumably until 2019-08-26\n- midazolam 1 MG/ML Injectable Solution, started on 2019-08-26, presumably until 2019-08-26\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2019-08-26, presumably until 2019-08-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 15.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-02 10:04:51, ended at 2019-09-02 10:43:03\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dyspnea\n- Wheezing\n- Primary diagnosis: Abnormal breathing\n- Acute exacerbation of chronic obstructive airways disease\n- Cough\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-09-02, presumably until 2019-11-25, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-02 10:53:00, ended at 2019-09-02 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n\n### Condition\n- Dyspnea\n- Abnormal findings on diagnostic imaging of lung\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-03 00:00:00, ended at 2019-09-03 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bronchitis\n\n### Drug\n- benzonatate 100 MG Oral Capsule, started on 2019-09-03, presumably until 2020-07-21, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH THREE TIMES A DAY AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-06 00:00:00, ended at 2019-09-06 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, started on 2019-09-08, presumably until 2019-12-04, with intended 3 refill(s). Instructions: 1 PUFF BY INHALATION ROUTE 2 TIMES A DAY COPD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.23 (milli-international unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.5 (calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 9.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-09 11:47:15, ended at 2019-09-09 13:59:45\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-10 00:00:00, ended at 2019-09-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2019-09-10, presumably until 2019-11-10, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-16 10:47:20, ended at 2019-09-16 11:37:21\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Wheezing\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Dyspnea\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, through Intra-articular route, started on 2019-09-16, presumably until 2019-09-16, with intended 0 refill(s). Instructions: 3 mL (30 mg total) by Intra-articular route One Time for 1 dose\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-09-16, presumably until 2019-09-21, with intended 0 refill(s). Instructions: take 2 Tabs (500 mg total) by mouth daily for 1 day, THEN 1 Tab (250 mg total) daily for 4 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-22 09:45:54, ended at 2019-09-22 10:12:02\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n- Wheezing\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-26 00:00:00, ended at 2019-09-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2019-10-06, presumably until 2020-01-06, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-07 11:26:13, ended at 2019-10-07 14:17:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-13 09:57:36, ended at 2019-10-13 10:45:36\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pneumonia\n- Primary diagnosis: Abnormal breathing\n- Primary diagnosis: Dyspnea\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-13, presumably until 2019-11-25, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 11:25:50, ended at 2019-10-21 13:57:59\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n- Hypo-osmolality and or hyponatremia\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2019-10-21, presumably until 2021-05-27, with intended 5 refill(s). Instructions: Apply small amount to skin over PORT and cover with plastic wrap 1 hour prior to chemo start time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-22 00:00:00, ended at 2019-10-22 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2021-09-30, presumably until 2022-03-29, with intended 1 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-22 07:07:00, ended at 2019-10-22 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal breathing\n- Dyspnea\n- Pleural effusion\n- Malignant neoplasm of upper lobe of lung\n- Pneumonia\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-22 07:07:00, ended at 2019-10-22 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-02 00:00:00, ended at 2019-11-02 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2019-11-03, presumably until 2020-06-15, with intended 6 refill(s). Instructions: APPLY THREE TIMES A DAY TO AFFECTED AREA (S)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-04 11:28:40, ended at 2019-11-04 12:40:22\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-05 00:00:00, ended at 2019-11-05 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-11-05, presumably until 2019-11-05, with intended 0 refill(s). Instructions: TAKE 1-2 TABS ORALLY TWICE A DAY AS NEEDED FOR BREAKTHROUGH NAUSEA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-10 00:00:00, ended at 2019-11-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-11-10, presumably until 2019-12-11, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-11 00:00:00, ended at 2019-11-11 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 24 (millimeter per hour)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Rheumatoid factor [Units/volume] in Serum or Plasma: <10.0 (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Primary diagnosis: Muscle pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-11 10:19:11, ended at 2019-11-11 11:26:45\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pneumonia\n- Wheezing\n- Cough\n- Primary diagnosis: Dyspnea\n- Acute exacerbation of chronic obstructive airways disease\n- Primary diagnosis: Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-13 00:00:00, ended at 2019-11-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 4.700 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.61 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-18 00:00:00, ended at 2019-11-18 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2019-11-18, presumably until 2019-11-23, with intended 0 refill(s). Instructions: take 1 Tab (4 mg total) by mouth daily in the morning with food\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-18 13:28:24, ended at 2019-11-18 15:44:05\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood chemistry abnormal\n- Muscle pain\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-11-25, presumably until 2019-12-02, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily With breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-02 10:34:05, ended at 2019-12-02 12:10:24\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-12-02, presumably until 2019-12-02, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-12-02, presumably until 2020-01-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-12-02, presumably until 2020-01-13, with intended 2 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily With breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, started on 2019-12-04, presumably until 2020-02-09, with intended 3 refill(s). Instructions: 1 PUFF BY INHALATION ROUTE 2 TIMES A DAY COPD\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-08 00:00:00, ended at 2019-12-08 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchitis\n- Hypoxemia\n\n### Drug\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2019-12-08, presumably until 2020-09-06, with intended 6 refill(s). Instructions: 2 PUFFS BY INHALATION ROUTE EVERY 6 HOURS AS NEEDED FOR BRONCHOSPASM OR WHEEZING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-12-11, presumably until 2020-01-12, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-14 00:00:00, ended at 2019-12-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-12-15, presumably until 2020-12-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-16 12:54:08, ended at 2019-12-16 15:22:07\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-01 00:00:00, ended at 2020-01-01 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2020-01-01, presumably until 2020-02-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-06 00:00:00, ended at 2020-01-06 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2020-01-06, presumably until 2020-07-23, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-09 00:00:00, ended at 2020-01-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-01-12, presumably until 2020-02-09, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- folic acid 0.4 MG Oral Tablet, started on 2020-01-12, presumably until 2021-05-27, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-13 10:15:14, ended at 2020-01-13 12:51:25\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant neoplasm of upper lobe of lung\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-01-13, presumably until 2020-06-22, with intended 3 refill(s). Instructions: take 7 Tabs (7 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-21 13:56:09, ended at 2020-01-21 14:35:28\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Acute exacerbation of chronic obstructive airways disease\n- Drug-induced neutropenia\n- Primary diagnosis: Essential hypertension\n- Anxiety disorder\n- Hypothyroidism\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-21, presumably until 2020-07-14, with intended 2 refill(s). Instructions: SPRAY 2 SPRAYS INTO EACH NOSTRIL EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-25 00:00:00, ended at 2020-01-25 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- lisinopril 20 MG Oral Tablet, started on 2020-01-28, presumably until 2020-07-27, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-27 13:53:38, ended at 2020-01-27 14:31:33\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.99\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cough\n- Pneumonia\n- Wheezing\n- Primary diagnosis: Abnormal breathing\n- Acute exacerbation of chronic obstructive airways disease\n- Primary diagnosis: Dyspnea\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2020-01-27, presumably until 2020-02-03, with intended 0 refill(s). Instructions: take 1 Tab (250 mg total) by mouth daily for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-02 00:00:00, ended at 2020-02-02 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2020-02-02, presumably until 2020-03-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-02 08:56:00, ended at 2020-02-02 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant neoplasm of upper lobe of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-05 00:00:00, ended at 2020-02-05 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.075 MG Oral Tablet, started on 2020-02-05, presumably until 2020-11-24, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2020-02-09, presumably until 2020-06-03, with intended 3 refill(s). Instructions: 250 mcg by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-09 00:00:00, ended at 2020-02-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-03-08, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-03 00:00:00, ended at 2020-03-03 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2020-03-03, presumably until 2020-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-03-08, presumably until 2020-04-09, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-09 00:00:00, ended at 2020-04-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-04-09, presumably until 2020-05-11, with intended 0 refill(s). Instructions: TAKE 1 TAB (0.5 MG TOTAL) BY MOUTH DAILY AS NEEDED\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "18d3d20c64e1ba6171d0ba012c36c91d7da0b66e638959e7f0af9c304f12e4f0", "prompt_hash": "2d6165977f9454ea6e341f9f9599d3fe1dd2d058a90ecfce86e4d3d756f4058a", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115972500, "visit_occurrence_id": 147389661, "death_date": "2020-10-08", "visit_concept_name": "Emergency Room and Inpatient Visit", "visit_start_datetime": "2019-11-19 17:02:00", "visit_end_datetime": "2019-11-30 13:20:00", "visit_length_in_hours": 260.3, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-11-19 17:02:00, ended at 2019-11-30 13:20:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 37 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Base excess in Arterial blood by calculation: 9.7 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.64 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.39 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 72 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Lactate [Moles/volume] in Serum or Plasma: 0.8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 23.8 (microgram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 24.0 (microgram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 771 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 39.0 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.57 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Radiologic examination, chest; single view\n- Hospital discharge day management; more than 30 minutes\n- Collection of venous blood by venipuncture\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Benign prostatic hyperplasia\n- Chronic pain\n- Claustrophobia\n- Foot ulcer due to type 2 diabetes mellitus\n- Sialoadenitis\n- Ulcer of lower extremity\n- Aortocoronary bypass graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Falls\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Abscess of salivary gland\n- Chronic fatigue syndrome\n- Chronic obstructive lung disease\n- Lumbar spondylosis with myelopathy\n- Atrial fibrillation\n- Backache\n- Chronic atrial fibrillation\n- Pain of right knee joint\n- Peripheral vascular disease\n- Asthenia\n- Extreme obesity with alveolar hypoventilation\n- Hypertensive heart failure\n- Loss of appetite\n- Major depression, single episode\n- Metabolic encephalopathy\n- Neck pain\n- Spasm\n- Acute on chronic hypercapnic respiratory failure\n- Chronic congestive heart failure\n- Drowsy\n- Impacted cerumen\n- Overflow incontinence of urine\n- Pain of left knee region\n- Type 2 diabetes mellitus\n- Atherosclerosis of artery of lower limb\n- Chest pain\n- Generalized anxiety disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Chronic systolic heart failure\n- Chronic ulcer of skin of lower leg\n- Electrocardiogram abnormal\n- Nicotine dependence\n- Pleural effusion\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-11-29, presumably until 2019-11-29\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 1,250 mg by mouth every day \n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-28\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-11-26, presumably until 2019-11-29\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-11-20, presumably until 2019-12-03, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2019-11-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-11-23, presumably until 2019-11-29\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day with meals\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-24\n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-11-19, presumably until 2019-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-11-19, presumably until 2019-12-03, with intended 0 refill(s). Instructions: inject 40 mg subcutaneous (under the skin) daily\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-11-24, presumably until 2019-11-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-11-19, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2019-11-20\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-11-26, presumably until 2019-11-26\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 40 mg by mouth every day \n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-11-29, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 1.25 mg by RT Inhalation route every 6 hours as needed (bronchospasm/wheezing, sob) \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-11-28, presumably until 2019-12-13, with intended 0 refill(s). Instructions: take 25 mg by mouth 2 times a day \n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2019-12-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-11-29, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 500 mcg by Nebulization route every 6 hours as needed (bronchospasm/wheezing) \n- vancomycin 5 MG/ML Injection, through Intravenous route, started on 2019-11-20, presumably until 2019-11-29\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-11-20, presumably until 2019-11-30\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2019-11-22, presumably until 2019-11-22\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2019-11-30\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 0.5 mg by Inhalation route 2 times a day \n- carbamide peroxide 65 MG/ML Otic Solution, through Otic route, started on 2019-11-26, presumably until 2019-11-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-11-24, presumably until 2019-11-28\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-11-22, presumably until 2019-11-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2019-11-19, presumably until 2019-11-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-11-19, presumably until 2019-11-19\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-11-22, presumably until 2019-11-23\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- nystatin 100 UNT/MG Topical Powder, through Topical route, presumably until 2019-12-03, with intended 0 refill(s). Instructions: 1 Application by Topical route 3 times a day \n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-15, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-02-04, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-30\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-19\n\n", "approximate_token_count": 3548, "patient_first_visit_date": "2017-12-20 00:00:00", "patient_last_visit_date": "2020-09-30 13:34:00", "end_obs_date": "2020-10-08", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 140, "cumulated_visit_num": 140, "cumulated_approximate_token_count": 55436, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-20 00:00:00, ended at 2017-12-20 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2017-12-21, presumably until 2018-01-22, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-16 00:00:00, ended at 2018-01-16 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-02-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-20 00:00:00, ended at 2018-01-20 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-01-21, presumably until 2018-01-21, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-08 00:00:00, ended at 2018-02-08 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-02-08, presumably until 2018-03-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-05 15:17:28, ended at 2018-03-05 15:57:41\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Chronic pain\n- Shoulder joint pain\n\n### Drug\n- potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-03-20, presumably until 2018-10-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-05-26, presumably until 2018-04-05, with intended 0 refill(s). Instructions: 1 Spray by Intranasal route 2 times a day\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2017-03-25, presumably until 2018-04-05, with intended 0 refill(s). Instructions: by Topical route 2 times a day\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2017-08-25, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n- acetaminophen 325 MG / dichloralphenazone 100 MG / isometheptene 65 MG Oral Capsule, through Oral route, started on 2018-03-05, presumably until 2018-09-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 4 hours as needed\n- amitriptyline hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-01-01, presumably until 2018-10-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- pregabalin 50 MG Oral Capsule, through Oral route, started on 2018-03-05, presumably until 2018-09-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2018-03-05, presumably until 2018-03-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2017-09-25, presumably until 2018-10-04, with intended 0 refill(s)\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-03-05, presumably until 2019-03-05, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-16 22:27:00, ended at 2018-03-17 00:27:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 136 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Spasm\n- Candidiasis\n- Primary diagnosis: Spasm of back muscles\n- Nicotine dependence\n- Disorder of integument\n\n### Drug\n- clotrimazole 10 MG/ML Topical Cream, started on 2018-03-16, presumably until 2018-04-05, with intended 0 refill(s). Instructions: Wash and dry thoroughly then apply thin film to affected area twice daily.\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2018-03-16, presumably until 2018-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2018-03-10, presumably until 2018-03-19, with intended 0 refill(s)\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2016-05-26, presumably until 2018-03-25, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Oral route, started on 2016-10-15, presumably until 2018-05-20, with intended 0 refill(s). Instructions: take by mouth\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-03-16, presumably until 2018-04-05, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-19 00:00:00, ended at 2018-03-19 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-03-19, presumably until 2018-03-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-19 00:46:00, ended at 2018-03-19 03:21:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Backache\n- Spasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-19 07:39:00, ended at 2018-03-19 08:33:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spasm\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-03-19, presumably until 2018-03-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-03-25 00:00:00, ended at 2018-03-25 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-03-25, presumably until 2018-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-25 16:08:00, ended at 2018-03-25 18:04:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Primary diagnosis: Pain in left foot\n- Spasm\n- Primary diagnosis: Pain in right foot\n- Chronic pain syndrome\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-07-31, presumably until 2018-04-16, with intended 0 refill(s). Instructions: as needed\n- alprazolam 1 MG Oral Tablet, started on 2017-10-23, presumably until 2018-04-05, with intended 0 refill(s). Instructions: 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-26 15:26:51, ended at 2018-03-26 15:50:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Pain in right lower limb\n- Pain in left lower limb\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-03-26, presumably until 2018-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-03 05:37:00, ended at 2018-04-03 06:52:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Muscle strain\n- Shoulder joint pain\n- Primary diagnosis: Sprain of upper extremity\n- Injury of muscle and tendon at thorax level\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2018-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-04-03, presumably until 2018-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-05 10:00:54, ended at 2018-04-05 11:19:56\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Laceration of hand\n- Psychophysiologic insomnia\n- Primary diagnosis: Shoulder joint pain\n- Hernia of anterior abdominal wall\n\n### Drug\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2018-04-05, presumably until 2018-10-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n- 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe, through Intramuscular route, started on 2018-04-05, presumably until 2018-04-05, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2018-04-05, presumably until 2018-04-14, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-04-12, presumably until 2018-05-21, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-12 04:36:00, ended at 2018-04-12 05:44:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bacteria [Presence] in Urine sediment by Light microscopy: None (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 5 - 10 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: >100 (per high power field)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Microscopic hematuria\n- Dysuria\n- Ureteric stone\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-04-12, presumably until 2018-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-14 15:09:49, ended at 2018-04-14 15:48:36\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Psychophysiologic insomnia\n- Primary diagnosis: Urogenital finding\n- Lumbago with sciatica\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2018-04-14, presumably until 2018-05-14, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-16 00:00:00, ended at 2018-04-16 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-04-16, presumably until 2018-10-10, with intended 0 refill(s). Instructions: Use one spray in each nostril one time daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-20 17:13:00, ended at 2018-04-20 20:29:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Specimen source identified: 10.4 (femtoliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.99 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 5 - 10 (per high power field)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Bacteria [Presence] in Urine sediment by Light microscopy: Few (per high power field)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.2 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Hematuria syndrome\n- Dysuria\n- Nicotine dependence\n- Abdominal pain\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-04-20\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2018-04-20, presumably until 2018-05-20, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n- phenazopyridine hydrochloride 200 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-04-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-30 12:52:00, ended at 2018-04-30 14:18:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eye region\n- Acute conjunctivitis\n- Injury of conjunctiva\n- Corneal abrasion\n- Nicotine dependence\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Conjunctivitis\n\n### Drug\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2018-04-30, presumably until 2018-04-30\n- sulfacetamide sodium 100 MG/ML Ophthalmic Solution, through Intraocular route, started on 2018-04-30, presumably until 2018-10-04, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes every 2 hours while awake\n- fluorescein dilaurate, through Intraocular route, started on 2018-04-30, presumably until 2018-04-30\n- fluorescein, through Intraocular route, started on 2018-04-30, presumably until 2018-04-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-06 20:43:00, ended at 2018-05-06 23:24:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eye region\n- Nicotine dependence\n- Primary diagnosis: Acute conjunctivitis\n\n### Drug\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2018-05-06, presumably until 2018-05-06\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2018-05-06, presumably until 2018-05-06\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-05-06, presumably until 2018-05-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-10 23:19:00, ended at 2018-05-11 00:53:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in eye\n- Primary diagnosis: Blepharitis\n- Nicotine dependence\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-05-11, presumably until 2018-05-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2018-05-11, presumably until 2018-05-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-20 00:00:00, ended at 2018-05-20 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-05-20, presumably until 2018-06-08, with intended 0 refill(s). Instructions: 1 Puff by Inhalation route every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-20 18:53:00, ended at 2018-05-20 19:30:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy\n- Pain in lower limb\n- Exacerbation of moderate persistent asthma\n- Nicotine dependence\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-05-20, presumably until 2018-06-08, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-21 00:00:00, ended at 2018-05-21 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-05-21, presumably until 2018-07-19, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-02 04:45:00, ended at 2018-06-02 07:55:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.74 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 8\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 156 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 47.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.72 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Chromatin IgG Ab [Units/volume] in Serum or Plasma: 0.72 (microgram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.85 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Specimen source identified: 10.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Chest pain\n- Essential hypertension\n- Spasm\n- Atrial premature complex\n- Chronic obstructive lung disease\n- Aortocoronary bypass graft present\n- Nicotine dependence\n- Chronic pain\n- Disorder of eye region\n- Anesthesia of skin\n- Chronic pulmonary edema\n- Dyspnea\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2018-06-02, presumably until 2018-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-08 00:13:00, ended at 2018-06-08 02:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Heartburn\n- Major depression, single episode\n- Chronic pain\n- Congenital heart disease\n- Conjunctivitis\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Pain in left lower limb\n- Pain in right lower limb\n- Chronic conjunctivitis\n- Dyspnea\n- Cough\n- Essential hypertension\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2018-06-08, presumably until 2018-06-08\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-06-08, presumably until 2018-11-04, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n- dexamethasone 0.001 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment, through Intraocular route, started on 2018-06-08, presumably until 2018-10-04, with intended 0 refill(s). Instructions: instill to right eye 4 times a day\n- azithromycin 250 MG Oral Tablet, started on 2018-06-08, presumably until 2018-06-13, with intended 0 refill(s). Instructions: Take 2 tablets now, then one tablet daily until gone.\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2018-06-08, presumably until 2018-06-13, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-06-08, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-16 16:13:20, ended at 2018-06-16 17:02:35\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paresthesia\n- Abrasion, knee\n- Pleuritic pain\n- Wrist joint pain\n- Primary diagnosis: Anesthesia of skin\n\n### Drug\n- alprazolam 1 MG Disintegrating Oral Tablet, started on 2018-06-16, presumably until 2018-07-19, with intended 0 refill(s). Instructions: 1 tablet 2 or 3 times daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-16 16:35:00, ended at 2018-06-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; 2 views\n\n### Condition\n- Injury of upper extremity\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-07-14 04:51:00, ended at 2018-07-14 06:18:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Specimen source identified: 10.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.5 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.9 (percent)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 288 (picogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.48 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 221 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pain in right lower limb\n- Primary diagnosis: Cellulitis of right lower limb\n- Aortocoronary bypass graft present\n- Cellulitis of left lower limb\n- Nicotine dependence\n\n### Drug\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2018-07-14, presumably until 2018-07-15, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-07-15 17:47:00, ended at 2018-07-15 19:10:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Essential hypertension\n- Localized edema\n- Primary diagnosis: Cellulitis of right lower limb\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-15, presumably until 2018-07-15\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-07-15, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2018-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-07-19 00:00:00, ended at 2018-07-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-23 00:00:00, ended at 2018-07-23 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-07-26, presumably until 2018-08-18, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH 2 TO 3 TIMES DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-07-23 00:46:00, ended at 2018-07-23 04:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views\n\n### Condition\n- Primary diagnosis: Injury of muscle and tendon at neck level\n- Neck pain\n- Contusion of hip\n- Hip pain\n- Primary diagnosis: Muscle strain\n- Nicotine dependence\n\n### Drug\n- 1 ML morphine sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-07-23, presumably until 2018-07-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-07-23, presumably until 2018-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-26 13:30:44, ended at 2018-07-26 14:06:38\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Backache\n- Shoulder joint pain\n- Primary diagnosis: Chronic pain\n- Neck pain\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-07-26, presumably until 2018-08-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-28 08:21:58, ended at 2018-07-28 08:48:26\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Shoulder joint pain\n- Chronic pain\n- Backache\n- Primary diagnosis: Neck pain\n- Musculoskeletal finding\n- Spasm\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-07-28, presumably until 2018-09-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth as needed\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-07-28, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed (pain)\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-07-28, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-08-11 00:24:00, ended at 2018-08-11 04:32:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.18 (thousand per microliter)\n- Specimen source identified: 10.7 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Cellulitis of left lower limb\n- Strain of muscle and/or tendon of thigh\n- Thigh pain\n- Nicotine dependence\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2018-08-11, presumably until 2018-08-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-18 15:19:14, ended at 2018-08-18 16:07:33\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Neck pain\n- Primary diagnosis: Musculoskeletal finding\n- Paresthesia\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-08-18, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- alprazolam 1 MG Oral Tablet, started on 2018-08-18, presumably until 2018-09-07, with intended 0 refill(s). Instructions: 1 tablet 3 times daily\n- tadalafil 20 MG Oral Tablet, started on 2018-08-18, presumably until 2018-09-07, with intended 1 refill(s). Instructions: 1 tablet once a week as needed for erectile dysfunction\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-19 00:00:00, ended at 2018-08-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2018-08-19, presumably until 2018-08-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 10 days\n- hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension, through Otic route, started on 2018-08-19, presumably until 2018-10-04, with intended 0 refill(s). Instructions: instill 3 Drops to right ear 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-08-26 22:49:00, ended at 2018-08-27 02:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Specimen source identified: 10.5 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.9 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Pain of left knee region\n- Nicotine dependence\n- Thigh pain\n- Dyspnea\n- Polyneuropathy\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-08-27, presumably until 2018-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-07 11:25:00, ended at 2018-09-07 11:55:10\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Laceration of hand\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth as needed\n- alprazolam 1 MG Oral Tablet, started on 2018-09-07, presumably until 2018-09-07, with intended 0 refill(s). Instructions: 1 tablet 3 times daily\n- 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe, through Intramuscular route, started on 2018-09-07, presumably until 2018-09-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-09-07, presumably until 2018-10-20, with intended 2 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-09 07:14:00, ended at 2018-09-09 10:20:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, elbow; complete, minimum of 3 views\n\n### Condition\n- Abrasion of nose\n- Nicotine dependence\n- Elbow joint pain\n- Contusion of elbow\n- Primary diagnosis: Injury of head\n- Laceration of upper arm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-30 09:48:45, ended at 2018-09-30 10:55:08\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Generalized anxiety disorder\n- Primary diagnosis: Musculoskeletal finding\n- Backache\n- Paresthesia\n- Anesthesia of skin\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-09-30, presumably until 2018-10-21, with intended 4 refill(s). Instructions: take 1 Tab by mouth as needed\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-09-30, presumably until 2018-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-09-30, presumably until 2018-10-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-10-04, presumably until 2018-10-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-04 19:42:00, ended at 2018-10-04 22:06:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic obstructive lung disease\n- Nausea\n- Essential hypertension\n- Backache\n- Nicotine dependence\n- Chronic pain\n- Primary diagnosis: Palpitations\n- Chest pain\n- Neck pain\n- Major depression, single episode\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-06 00:00:00, ended at 2018-10-06 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-10-06, presumably until 2018-11-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-11, presumably until 2019-03-03, with intended 0 refill(s). Instructions: USE ONE SPRAY IN EACH NOSTRIL ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-13 23:18:00, ended at 2018-10-14 07:49:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination; forearm, 2 views\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Injury of muscle and tendon at neck level\n- Lumbar sprain\n- Arthralgia of the ankle and/or foot\n- Chronic pain\n- Nicotine dependence\n- Wrist joint pain\n- Primary diagnosis: Injury of head\n- Injury of muscle and tendon of abdomen, lower back and pelvis\n- Major depression, single episode\n- Essential hypertension\n- Chronic obstructive lung disease\n- Low back pain\n- Pain in forearm\n- Injury of forearm\n- Muscle strain\n\n### Drug\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-14, presumably until 2018-10-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-20 10:26:02, ended at 2018-10-20 11:47:08\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Metabolic encephalopathy\n- Pain in left arm\n- Neck pain\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2018-10-20, presumably until 2018-12-08, with intended 0 refill(s). Instructions: Take one tab 30 min before his MRI, many repeat in 30 min PRN for the MRI\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-21 00:00:00, ended at 2018-10-21 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-10-22, presumably until 2018-11-04, with intended 4 refill(s). Instructions: take 1 Tab by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-21 15:12:00, ended at 2018-10-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Cerebral ischemia\n- Metabolic encephalopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-02 21:48:00, ended at 2018-11-03 01:44:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 49.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Specimen source identified: 11.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.98 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Bacteria [Presence] in Urine sediment by Light microscopy: Few (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.1 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Electrocardiogram abnormal\n- Essential hypertension\n- Kidney stone\n- Low back pain\n- Coronary artery graft present\n- Primary diagnosis: Abdominal pain\n- Atherosclerosis of coronary artery without angina pectoris\n- Nicotine dependence\n- Chronic obstructive lung disease\n- Major depression, single episode\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-04 09:42:00, ended at 2018-11-04 10:52:30\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Low back pain\n- Cough\n- Neck pain\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-11-04, presumably until 2019-02-15, with intended 4 refill(s). Instructions: take 1 Tab by mouth as needed\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2018-11-04, presumably until 2018-12-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- alprazolam 1 MG Oral Tablet, started on 2018-11-04, presumably until 2018-12-06, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-11-04, presumably until 2018-12-08, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-05 14:27:00, ended at 2018-11-05 15:02:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Puncture wound of foot\n- Low back pain\n- Metal nail puncture wound of skin\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Nicotine dependence\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-11-05, presumably until 2018-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-11-05, presumably until 2018-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-09 02:32:00, ended at 2018-11-09 07:07:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 6.5 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Specimen source identified: 11.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chromatin IgG Ab [Units/volume] in Serum or Plasma: 0.69 (microgram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 233 (picogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 225 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 49.0 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Neck pain\n- Backache\n- Chronic obstructive lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Pain in left arm\n- Major depression, single episode\n- Chronic pain\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-11-09, presumably until 2018-11-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-19 18:30:00, ended at 2018-11-19 19:40:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Essential hypertension\n- Primary diagnosis: Sprain of knee\n- Nicotine dependence\n- Wrist joint pain\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-11-19, presumably until 2018-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-24 23:24:00, ended at 2018-11-25 01:38:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n\n### Condition\n- Asthenia\n- Cough\n- Urinary incontinence\n- Chronic pain\n- Nicotine dependence\n- Primary diagnosis: Disorder of bladder\n- Major depression, single episode\n- Neck pain\n- Acute exacerbation of chronic obstructive airways disease\n- Essential hypertension\n- Backache\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2018-11-25, presumably until 2018-11-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-25 12:10:42, ended at 2018-11-25 13:50:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary incontinence\n- Disorder of sleep-wake cycle\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-26 00:53:00, ended at 2018-11-26 03:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Few (per low powered field)\n- Bacteria [Presence] in Urine sediment by Light microscopy: None (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: >100 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication associated with genitourinary device\n- Major depression, single episode\n- Chronic pain\n- Essential hypertension\n- Nicotine dependence\n- Complication of urinary catheter\n- Chronic obstructive lung disease\n- Pain due to internal prosthetic device\n- Urinary incontinence\n- Primary diagnosis: Dysuria\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, started on 2018-11-26, presumably until 2018-11-26\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-11-26, presumably until 2018-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2018-11-26, presumably until 2018-11-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-01 10:12:00, ended at 2018-12-01 12:13:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Primary diagnosis: Contusion of knee\n- Injury of muscle and tendon at ankle and foot level\n- Pain of left knee region\n- Arthralgia of the ankle and/or foot\n- Chronic pain\n- Essential hypertension\n- Nicotine dependence\n- Disorder of soft tissue\n- Muscle strain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-02 07:59:00, ended at 2018-12-02 08:34:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Chronic obstructive lung disease\n- Chronic pain\n- Essential hypertension\n- Major depression, single episode\n- Neck pain\n- Urinary incontinence\n- Primary diagnosis: Complication associated with genitourinary device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-06 00:00:00, ended at 2018-12-06 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-12-06, presumably until 2018-12-08, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-12-13, presumably until 2018-12-13, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-08 14:07:15, ended at 2018-12-08 15:17:52\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Chronic obstructive lung disease\n- Tinea cruris\n- Primary diagnosis: Cellulitis of right lower limb\n\n### Drug\n- nystatin 100000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream, through Topical route, started on 2018-12-08, presumably until 2019-02-15, with intended 0 refill(s). Instructions: by Topical route 4 times a day X 7 days topically\n- alprazolam 1 MG Oral Tablet, started on 2018-12-08, presumably until 2018-12-14, with intended 0 refill(s). Instructions: TAKE 1/2 TAB TID PRN PO\n- cephalexin 500 MG Oral Capsule, started on 2018-12-08, presumably until 2018-12-14, with intended 0 refill(s). Instructions: Take 1 tid x 10 days\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-08, presumably until 2019-02-28, with intended 2 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-08 22:28:00, ended at 2018-12-08 23:43:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eruption\n- Urinary incontinence\n- Chronic pain\n- Major depression, single episode\n- Essential hypertension\n- Chronic obstructive lung disease\n- Nicotine dependence\n- Neck pain\n\n### Drug\n- clotrimazole 10 MG/ML Topical Cream, started on 2018-12-08, presumably until 2019-01-07, with intended 0 refill(s). Instructions: Wash and dry thoroughly then apply thin film to affected area twice daily.\n- hydrocortisone 25 MG/ML Topical Cream, started on 2018-12-08, presumably until 2019-01-07, with intended 0 refill(s). Instructions: Apply sparingly to the affected area twice daily for duration of the flare.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-14 13:23:58, ended at 2018-12-14 13:45:11\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Primary diagnosis: Pain in left lower limb\n- Polyneuropathy\n- Chronic pain\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-12-14, presumably until 2019-01-20, with intended 0 refill(s). Instructions: TAKE 1 po 3 times daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-19 21:29:00, ended at 2018-12-19 23:04:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Chronic pain\n- Chronic obstructive lung disease\n- Primary diagnosis: Contusion of knee\n- Low back pain\n- Pain of left knee region\n- Contusion of trunk\n- Nicotine dependence\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2018-12-19, presumably until 2018-12-19\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2018-12-19, presumably until 2019-01-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-22 03:44:00, ended at 2018-12-22 05:34:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.9 (femtoliter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.86 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 217 (picogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Specimen source identified: 10.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest; single view\n\n### Condition\n- Primary diagnosis: Chest pain\n- Abnormal findings on diagnostic imaging of lung\n- Atrial premature complex\n- Chronic pain\n- Essential hypertension\n- Cellulitis of right lower limb\n- Atherosclerosis of coronary artery without angina pectoris\n- Anxiety disorder\n- Chronic obstructive lung disease\n- Electrocardiogram abnormal\n- Nicotine dependence\n- Aortocoronary bypass graft present\n\n### Drug\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2018-12-22, presumably until 2018-12-22\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-12-22, presumably until 2018-12-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-03 03:14:00, ended at 2019-01-03 04:17:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Radiologic examination, wrist; 2 views\n\n### Condition\n- Shoulder joint pain\n- Wrist joint pain\n- Pain of left knee region\n- Neck pain\n- Major depression, single episode\n- Chronic obstructive lung disease\n- Essential hypertension\n- Urinary incontinence\n- Primary diagnosis: Muscle pain\n- Chronic pain\n- Nicotine dependence\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-01-03, presumably until 2019-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-09 18:34:00, ended at 2019-01-09 20:46:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Primary diagnosis: Pain in left lower limb\n- Essential hypertension\n- Chronic obstructive lung disease\n- Nicotine dependence\n\n### Drug\n- nabumetone 500 MG Oral Tablet, through Oral route, started on 2019-01-09, presumably until 2019-02-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-20 09:57:19, ended at 2019-01-20 11:37:02\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Late effect of accidental fall\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n- alprazolam 1 MG Oral Tablet, started on 2019-01-20, presumably until 2019-02-15, with intended 0 refill(s). Instructions: TAKE 1 po 3 times daily as needed\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-28 06:04:00, ended at 2019-01-28 09:19:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Spasm\n- Nicotine dependence\n- Wrist joint pain\n- Essential hypertension\n- Primary diagnosis: Sprain of wrist\n- Chronic obstructive lung disease\n- Major depression, single episode\n\n### Drug\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2019-01-28, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-04 03:27:00, ended at 2019-02-04 05:25:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Major depression, single episode\n- Essential hypertension\n- Pain in left lower limb\n- Primary diagnosis: Spasm\n- Chronic obstructive lung disease\n- Chronic pain\n- Nicotine dependence\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-02-04, presumably until 2019-02-04\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2019-02-04, presumably until 2019-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-06 21:20:00, ended at 2019-02-06 23:41:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, femur; minimum 2 views\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Thigh pain\n- Major depression, single episode\n- Chronic pain\n- Nicotine dependence\n- Pain in left foot\n- Chronic obstructive lung disease\n- Essential hypertension\n- Primary diagnosis: Pain in left lower limb\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, started on 2019-02-06, presumably until 2019-02-06\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2019-02-06, presumably until 2019-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-08 13:27:00, ended at 2019-02-08 14:34:28\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Localized edema\n- Primary diagnosis: Pain in left lower limb\n- Lumbago with sciatica\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-02-08, presumably until 2019-09-18, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2019-02-08, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-02-08, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-09 20:12:00, ended at 2019-02-10 00:49:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.83 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bacteria [Presence] in Urine sediment by Light microscopy: Few (per high power field)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.64 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.4 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 193 (thousand per microliter)\n\n### Procedure\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n\n### Condition\n- Lumbar radiculopathy\n- Major depression, single episode\n- Nicotine dependence\n- Chronic obstructive pulmonary disease with acute lower respiratory infection\n- Primary diagnosis: Pain in left lower limb\n- Chronic pain\n- Left lower quadrant pain\n- Pneumonia\n- Benign prostatic hyperplasia with outflow obstruction\n- Essential hypertension\n- Lobar pneumonia\n- Urinary incontinence\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-02-09, presumably until 2019-02-09\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-02-10, presumably until 2019-02-10\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-02-09, presumably until 2019-02-09\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2019-02-09, presumably until 2019-02-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-02-09, presumably until 2019-02-09\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-02-09, presumably until 2019-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-12 00:36:00, ended at 2019-02-12 01:08:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left lower limb\n- Primary diagnosis: Chronic pain syndrome\n- Nicotine dependence\n- Essential hypertension\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-02-12, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-14 16:18:24, ended at 2019-02-14 16:58:50\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n- Primary diagnosis: Pain in right lower limb\n- Primary diagnosis: Pain in right foot\n- Primary diagnosis: Pain in left lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-15 10:22:51, ended at 2019-02-15 11:33:37\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Low back pain\n- Degeneration of lumbar intervertebral disc\n- Disorder of musculoskeletal system\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-09-18, with intended 5 refill(s). Instructions: take 1 Tab by mouth as needed\n- alprazolam 1 MG Oral Tablet, started on 2019-02-15, presumably until 2019-03-03, with intended 0 refill(s). Instructions: TAKE 1 po 3 times daily as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-16 07:21:00, ended at 2019-02-16 11:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n- Major depression, single episode\n- Chronic obstructive lung disease\n- Essential hypertension\n- Nicotine dependence\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-02-16, presumably until 2019-02-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-21 11:30:00, ended at 2019-02-21 12:11:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Major depression, single episode\n- Chronic obstructive lung disease\n- Primary diagnosis: Chest pain\n- Essential hypertension\n- Nicotine dependence\n- Chronic pain\n- Urinary incontinence\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-02-21, presumably until 2019-02-21\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-02-21, presumably until 2019-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-21 12:34:00, ended at 2019-02-21 14:32:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.03 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.61 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.1 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-24 18:40:00, ended at 2019-02-24 19:17:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Urinary incontinence\n- Chronic obstructive lung disease\n- Primary diagnosis: Diaper rash\n- Eruption\n- Nicotine dependence\n\n### Drug\n- hydrocortisone 10 MG/ML Topical Cream, started on 2019-02-24, presumably until 2019-03-26, with intended 0 refill(s). Instructions: Wash and dry thoroughly then apply thin film to affected area. 2-4 times daily as needed for flare up of rash\n- clotrimazole 10 MG/ML Topical Cream, started on 2019-02-24, presumably until 2019-09-18, with intended 0 refill(s). Instructions: Apply to affected areas or redness covered by  diaper\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-26 19:06:00, ended at 2019-02-26 23:55:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.5 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.0 (percent)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.93 (million per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.98 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.46 (thousand per microliter)\n- Bacteria [Presence] in Urine sediment by Light microscopy: None (per high power field)\n- Eosinophils [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.66 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Nicotine dependence\n- Spinal stenosis of lumbar region\n- Chronic obstructive lung disease\n- Major depression, single episode\n- Urinary incontinence\n- Chronic pain\n- Essential hypertension\n- Primary diagnosis: Right lower quadrant pain\n- Pain in left lower limb\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-02-26, presumably until 2019-02-26\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2019-02-26, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-02-26, presumably until 2019-02-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-02-28, presumably until 2019-03-03, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-03 00:00:00, ended at 2019-03-03 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2019-03-03, presumably until 2019-05-22, with intended 1 refill(s). Instructions: inhale 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-03 00:00:00, ended at 2019-03-03 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-03-03, presumably until 2019-05-11, with intended 0 refill(s). Instructions: 1 Spray by Nasal route daily\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-03-03, presumably until 2019-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-07 03:20:00, ended at 2019-03-07 05:25:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Lumbago with sciatica\n- Asthenia\n- Chronic obstructive lung disease\n- Nicotine dependence\n- Essential hypertension\n- Pain in left lower limb\n- Major depression, single episode\n- Primary diagnosis: Sciatica\n- Chronic pain\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-03-07, presumably until 2019-03-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-08 04:58:00, ended at 2019-03-08 06:40:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.6 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic pain\n- Major depression, single episode\n- Pain in left lower limb\n- Chronic obstructive lung disease\n- Essential hypertension\n- Thigh pain\n- Nicotine dependence\n- Pain of left knee region\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-03-08, presumably until 2019-03-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-10 02:35:00, ended at 2019-03-10 05:15:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Major depression, single episode\n- Primary diagnosis: Contusion of knee\n- Nicotine dependence\n- Pain in left lower limb\n- Sprain of upper extremity\n- Chronic pain\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-03-10, presumably until 2019-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-15, presumably until 2019-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-15 02:48:00, ended at 2019-03-15 05:37:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Neck pain\n- Aortocoronary bypass graft present\n- Chronic pain\n- Injury of head\n- Severe recurrent major depression without psychotic features\n- Essential hypertension\n- Muscle strain\n- Chronic obstructive lung disease\n- Gastroesophageal reflux disease without esophagitis\n- Generalized anxiety disorder\n- Injury of muscle and tendon at neck level\n- Falls\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-03-15, presumably until 2019-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-15 13:24:03, ended at 2019-03-15 14:21:06\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2018-12-24, presumably until 2019-09-18, with intended 0 refill(s). Instructions:   0 Refill(s)\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-15, presumably until 2019-03-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-03-15, presumably until 2019-05-24, with intended 2 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2018-12-24, presumably until 2019-06-28, with intended 0 refill(s). Instructions:   0 Refill(s)\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-15, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-19 03:56:00, ended at 2019-03-19 08:55:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Sprain of upper extremity\n- Aortocoronary bypass graft present\n- Neck pain\n- Primary diagnosis: Pain of left knee region\n- Chronic obstructive lung disease\n- Chronic pain\n- Major depression, single episode\n- Shoulder joint pain\n- Essential hypertension\n- Nicotine dependence\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-19, presumably until 2019-03-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-25 23:40:00, ended at 2019-03-26 02:45:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.94 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.68 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.32 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.0 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Aortocoronary bypass graft present\n- Atrial premature complex\n- Acquired absence of organ\n- Major depression, single episode\n- Essential hypertension\n- Primary diagnosis: Chest pain\n- Nicotine dependence\n- Chronic pain\n- Electrocardiogram abnormal\n- Absence of toe\n- Chronic obstructive lung disease\n- Pain in left lower limb\n- Pain in right lower limb\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-26, presumably until 2019-03-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-29 03:14:00, ended at 2019-03-29 06:15:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views\n\n### Condition\n- Chronic obstructive lung disease\n- Absence of toe\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Severe recurrent major depression without psychotic features\n- Primary diagnosis: Drowsy\n- Neck pain\n- Pain of right knee joint\n- Sleep disorder\n- Nicotine dependence\n- Chronic pain\n- Generalized anxiety disorder\n- Pain of left knee region\n- Acquired absence of organ\n- Hip pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-04-01 20:59:00, ended at 2019-04-02 00:44:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-04-02 16:28:00, ended at 2019-04-02 18:20:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Low back pain\n- Nicotine dependence\n- Wrist joint pain\n- Primary diagnosis: Injury of shoulder and upper arm\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-04-02, presumably until 2019-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-18 00:00:00, ended at 2019-04-18 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2019-04-19, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tablet  by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-05-01 19:44:00, ended at 2019-05-01 20:28:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Chest pain\n- Chronic obstructive lung disease\n- Dyspnea\n- Nicotine dependence\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-05-01, presumably until 2019-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-11 00:00:00, ended at 2019-05-11 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-05-12, presumably until 2019-05-24, with intended 0 refill(s). Instructions: 1 Spray by Nasal route daily\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-05-12, presumably until 2019-06-10, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-05-17 02:55:00, ended at 2019-05-17 06:03:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Essential hypertension\n- Aortocoronary bypass graft present\n- Asthenia\n- Major depression, single episode\n- Acquired absence of organ\n- Chronic pain\n- Absence of toe\n- Pain in right foot\n- Callosity\n- Chronic obstructive lung disease\n- Nicotine dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-22 00:00:00, ended at 2019-05-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-05-23, presumably until 2019-06-28, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-24 11:13:01, ended at 2019-05-24 11:38:47\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Chronic obstructive lung disease\n- Degeneration of lumbar intervertebral disc\n- Chronic pain\n- Musculoskeletal finding\n- Disorder of musculoskeletal system\n- Low back pain\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2019-05-24, presumably until 2019-06-03, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 10 days\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-05-24, presumably until 2019-06-28, with intended 1 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-05-24, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-05-24, presumably until 2019-09-18, with intended 2 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-01 03:24:00, ended at 2019-06-01 05:50:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Asthenia\n- Backache\n- Wrist joint pain\n- Spinal stenosis in cervical region\n- Nicotine dependence\n- Primary diagnosis: Chest pain\n- Aortocoronary bypass graft present\n- Chronic pain\n- Essential hypertension\n- Pleuritic pain\n- Chronic obstructive lung disease\n- Major depression, single episode\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-06-01, presumably until 2019-06-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2019-06-12, presumably until 2019-07-07, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-15 21:03:00, ended at 2019-06-15 23:47:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Aortocoronary bypass graft present\n- Nicotine dependence\n- Backache\n- Chronic obstructive lung disease\n- Chronic pulmonary edema\n- Pain in right lower limb\n- Cardiomegaly\n- Essential hypertension\n- Chronic pain\n- Primary diagnosis: Localized edema\n- Major depression, single episode\n- Pain in left lower limb\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-06-15, presumably until 2019-06-15\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2019-06-15, presumably until 2019-06-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-19 02:49:00, ended at 2019-06-19 06:21:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Base excess in Arterial blood by calculation: 3.4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 51.0 (millimeter mercury column)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 29.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 175 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.6 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 59.9 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.00 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Radiologic examination, chest; single view\n- Arterial puncture, withdrawal of blood for diagnosis\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Hypoxemia\n- Abnormal breathing\n- Acquired absence of organ\n- Cardiomegaly\n- Chronic pulmonary edema\n- Hypertensive heart failure\n- Lumbar spondylosis with myelopathy\n- Aortocoronary bypass graft present\n- Joint pain\n- Primary diagnosis: Pain of right knee joint\n- Chronic pain\n- Heart failure\n- Nicotine dependence\n- Backache\n- Major depression, single episode\n- Absence of toe\n- Chronic obstructive lung disease\n- Cardiomyopathy\n- Benign prostatic hyperplasia with outflow obstruction\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-06-19, presumably until 2019-06-19\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-06-19, presumably until 2019-06-19\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-06-19, presumably until 2019-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-28 01:39:00, ended at 2019-06-28 04:05:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, spine; thoracic, 3 views\n\n### Condition\n- Aortocoronary bypass graft present\n- Primary diagnosis: Neck pain\n- Essential hypertension\n- Pain of left knee region\n- Falls\n- Nicotine dependence\n- Acute exacerbation of chronic obstructive airways disease\n- Asthenia\n- Chronic pain\n- Contusion of chest\n- Pain in thoracic spine\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-06-28, presumably until 2019-06-28\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2019-06-28, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every 4 hours as needed\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-06-28, presumably until 2019-07-28, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route daily\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-06-28, presumably until 2019-06-28\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-06-28, presumably until 2019-07-27, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-01 00:00:00, ended at 2019-07-01 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2019-07-01, presumably until 2019-07-01, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-07-08, presumably until 2019-09-17, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-07 13:28:04, ended at 2019-07-07 14:01:38\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lumbar radiculopathy\n- Generalized anxiety disorder\n- Musculoskeletal finding\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-07-07, presumably until 2019-08-22, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-07-21 21:47:00, ended at 2019-07-21 22:38:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Primary diagnosis: Chronic ulcer of foot\n- Aortocoronary bypass graft present\n- Pain in right foot\n- Chronic obstructive lung disease\n- Essential hypertension\n- Nicotine dependence\n- Benign prostatic hyperplasia\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-07-21, presumably until 2019-07-27, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 7 days\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-07-21, presumably until 2019-07-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-27 00:00:00, ended at 2019-07-27 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-07-27, presumably until 2019-08-03, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 7 days\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-07-27, presumably until 2019-08-22, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-22 00:00:00, ended at 2019-08-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-08-22, presumably until 2019-09-18, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-08-22, presumably until 2019-09-18, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-03 03:09:00, ended at 2019-09-03 04:11:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Chronic pain\n- Nicotine dependence\n- Aortocoronary bypass graft present\n- Primary diagnosis: Dyspnea\n- Generalized anxiety disorder\n- Wrist joint pain\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-11 13:46:00, ended at 2019-09-11 19:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Chronic obstructive lung disease\n- Arthralgia of the ankle and/or foot\n- Nicotine dependence\n- Aortocoronary bypass graft present\n- Sprain of ankle\n- Pain of left knee region\n- Generalized anxiety disorder\n- Primary diagnosis: Sprain of knee\n- Chronic pain\n- Essential hypertension\n- Osteoarthritis of knee\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-09-11, presumably until 2019-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-15 22:59:00, ended at 2019-09-16 01:25:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Aortocoronary bypass graft present\n- Chronic obstructive lung disease\n- Generalized anxiety disorder\n- Nicotine dependence\n- Open wound of elbow\n- Open wound of forearm\n- Primary diagnosis: Cellulitis of left upper limb\n- Chronic pain\n- Essential hypertension\n- Open wound of wrist\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-09-15, presumably until 2019-09-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-09-16, presumably until 2019-09-16\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-09-16, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 2 times a day for 10 days\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2019-09-16, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-09-17 02:59:00, ended at 2019-09-18 18:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Base excess in Arterial blood by calculation: 7.6 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 197 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.7 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Left ventricular Ejection fraction: 54.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.9 (milliequivalent per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.7 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 205 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- Lactate [Moles/volume] in Serum or Plasma: 1.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 74.4 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 394 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 65.2 (millimeter mercury column)\n- Prothrombin time (PT): 13.6 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination \n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, knee; 3 views\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Radiologic examination, chest; single view\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n\n### Condition\n- Aortocoronary bypass graft present\n- Hypoxemia\n- Chronic obstructive pulmonary disease with acute lower respiratory infection\n- Essential hypertension\n- Pain of left knee region\n- Pneumonia\n- Primary diagnosis: Dyspnea\n- Nicotine dependence\n- Obstructive sleep apnea syndrome\n- Acute on chronic hypoxemic respiratory failure\n- Acute on chronic hypercapnic respiratory failure\n- Atelectasis\n- Benign prostatic hyperplasia\n- Fatigue\n- Generalized anxiety disorder\n- Abnormal findings on diagnostic imaging of lung\n- Acute exacerbation of chronic obstructive airways disease\n- Hyperglycemia\n- Metabolic encephalopathy\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 250 ML moxifloxacin 1.6 MG/ML Injection, through Intravenous route, started on 2019-09-17, presumably until 2019-09-17\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-11-20, with intended 0 refill(s). Instructions: 1 Spray by Nasal route 3 times a day as needed (for allergies) \n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-09-17, presumably until 2019-09-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-09-17, presumably until 2019-09-18\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-09-17, presumably until 2019-09-18\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-09-17, presumably until 2019-09-18\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-09-17, presumably until 2019-09-18\n- methylprednisolone 125 MG Injection, started on 2019-09-17, presumably until 2019-09-18\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-09-18, presumably until 2019-09-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-18 20:39:00, ended at 2019-09-18 22:56:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-21 16:18:00, ended at 2019-09-21 18:45:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.5 (femtoliter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 5.1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 31.3 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Prothrombin time (PT): 14.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: 5.1 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1760 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n\n### Procedure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest; single view\n\n### Condition\n- Asthenia\n- Bilateral inguinal hernia\n- Cellulitis of right lower limb\n- Dyspnea\n- Primary diagnosis: Atrial fibrillation\n- Chronic obstructive lung disease\n- Chronic pain\n- Essential hypertension\n- Electrocardiogram abnormal\n- Generalized anxiety disorder\n- Nicotine dependence\n- Obstructive sleep apnea syndrome\n- Aortocoronary bypass graft present\n- Lumbar spondylosis with myelopathy\n- Falls\n- Tinea cruris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-22 22:59:00, ended at 2019-09-23 02:28:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Nicotine dependence\n- Aortocoronary bypass graft present\n- Primary diagnosis: Closed fracture scapula, neck\n- Generalized anxiety disorder\n- Pain of left knee region\n- Shoulder joint pain\n- Pain in lower limb\n- Chronic pain\n- Primary diagnosis: Closed fracture scapula, glenoid\n- Atrial fibrillation\n- Contusion of knee\n- Essential hypertension\n- Sprain of shoulder\n- Chronic obstructive lung disease\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-09-23, presumably until 2019-09-23\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-24 00:00:00, ended at 2019-09-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-09-27, presumably until 2019-10-07, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-09-26 05:31:00, ended at 2019-09-30 09:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 34.1 (milliequivalent per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Catecholamines [Interpretation] in Plasma Narrative: 57.5 (femtoliter)\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1627 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Left ventricular Ejection fraction: 49.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.56 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Base excess in Arterial blood by calculation: 5.6 (milliequivalent per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 71.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.61 (million per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 91.4 (millimeter mercury column)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n\n### Procedure\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Arterial puncture, withdrawal of blood for diagnosis\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, foot; complete, minimum of 3 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Radiologic examination, chest; single view\n\n### Condition\n- Acute exacerbation of chronic obstructive airways disease\n- Chronic pain\n- Chronic ulcer of foot\n- Difficulty walking\n- Falls\n- Generalized anxiety disorder\n- Hypoxemia\n- Persistent atrial fibrillation\n- Backache\n- Chronic pulmonary edema\n- Acute on chronic hypercapnic respiratory failure\n- Aortocoronary bypass graft present\n- Benign prostatic hyperplasia\n- Cardiomegaly\n- Disorder of sleep-wake cycle\n- Mixed acid-base balance disorder\n- Anxiety disorder\n- Primary diagnosis: Atrial fibrillation\n- Benign prostatic hyperplasia with outflow obstruction\n- Chronic obstructive lung disease\n- Acute on chronic systolic heart failure\n- Extreme obesity with alveolar hypoventilation\n- Stricture of artery\n- Tachycardia\n- Acute on chronic hypoxemic respiratory failure\n- Hypertensive heart failure\n- Atherosclerosis of artery of lower limb\n- Atherosclerosis of coronary artery without angina pectoris\n- Congestive heart failure\n- Dyspnea\n- Pain of left knee region\n- Cardiomyopathy\n- Pain of right knee joint\n- Abnormal findings on diagnostic imaging of lung\n- Nicotine dependence\n\n### Drug\n- methylprednisolone 40 MG Injection, started on 2019-09-28, presumably until 2019-09-30\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-09-27, presumably until 2019-09-29\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-09-27, presumably until 2019-09-29\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-09-26, presumably until 2019-09-29\n- alprazolam 1 MG Oral Tablet, through Oral route, presumably until 2019-09-30, with intended 0 refill(s). Instructions: take 1 mg by mouth 3 times a day as needed (for anxiety) \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2019-09-26, presumably until 2019-09-30\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-09-26, presumably until 2019-09-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-09-29, presumably until 2019-09-29\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2019-09-29, presumably until 2019-09-30\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-09-28, presumably until 2019-09-30\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2019-10-07, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed for Bronchospasm/Wheezing\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2019-10-07, with intended 0 refill(s). Instructions: take 81 mg by mouth daily SUPPOSED TO TAKE, BUT HAS BEEN OFF FOR 1-2 MONTHS\n- levalbuterol 0.21 MG/ML Inhalation Solution, through Inhalation, started on 2019-09-27, presumably until 2019-09-28\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2019-09-29, presumably until 2019-09-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-09-28, presumably until 2019-09-29\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-09-26, presumably until 2019-09-26\n- cadexomer iodine 0.009 MG/MG Topical Gel, through Topical route, started on 2019-09-29, presumably until 2019-09-30\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2019-09-27, presumably until 2019-09-27\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-09-27, presumably until 2019-11-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed (for shoulder pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 09:47:46, ended at 2019-09-30 11:23:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-09-30, presumably until 2019-10-12, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed (for anxiety)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-06 00:00:00, ended at 2019-10-06 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lumbar radiculopathy\n- Primary diagnosis: Musculoskeletal finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-07 00:00:00, ended at 2019-10-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-10-07, presumably until 2019-10-09, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-10-07, presumably until 2019-10-09, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-10-07 18:54:00, ended at 2019-10-08 00:39:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.66 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.19 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.2 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.99 (micro-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 25.3 (milliequivalent per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 58.2 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 5 - 10 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Arterial blood by calculation: -0.8 (milliequivalent per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Aortocoronary bypass graft present\n- Primary diagnosis: Atrial fibrillation\n- Chronic pain\n- Dizziness and giddiness\n- Acute exacerbation of chronic obstructive airways disease\n- Asthenia\n- Essential hypertension\n- Loss of consciousness\n- Nicotine dependence\n- Chronic pulmonary edema\n- Major depression, single episode\n- Generalized anxiety disorder\n- Pain of left knee region\n\n### Drug\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-10-07, presumably until 2019-10-12, with intended 0 refill(s). Instructions: take 1 Tab (60 mg total) by mouth 4 times a day\n- diltiazem hydrochloride 30 MG Oral Tablet, through Oral route, started on 2019-10-07, presumably until 2019-10-07\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-10-07, presumably until 2019-10-12, with intended 1 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed for Bronchospasm/Wheezing\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-10-07, presumably until 2019-11-20, with intended 1 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily SUPPOSED TO TAKE, BUT HAS BEEN OFF FOR 1-2 MONTHS\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-07, presumably until 2019-10-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-10-08 22:45:00, ended at 2019-10-10 16:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 769 (picogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Base excess in Arterial blood by calculation: 3.2 (milliequivalent per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.4 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Body height: 5' 8.11\" (inch (US))\n- Carbon dioxide [Partial pressure] in Arterial blood: 68.7 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.80 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 32.0 (milliequivalent per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 78.5 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.2 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.7 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Arterial puncture, withdrawal of blood for diagnosis\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Hospital discharge day management; 30 minutes or less\n- Collection of venous blood by venipuncture\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Radiologic examination, chest; single view\n\n### Condition\n- Acute on chronic hypoxemic respiratory failure\n- Chronic obstructive lung disease\n- Major depression, single episode\n- Acidosis\n- Hypercapnic respiratory failure\n- Obesity\n- Atherosclerosis of coronary artery without angina pectoris\n- Paroxysmal atrial fibrillation\n- Atrial fibrillation\n- Dyspnea\n- Falls\n- Injury of head\n- Urinary tract infectious disease\n- Acute on chronic hypercapnic respiratory failure\n- Anxiety disorder\n- Aortocoronary bypass graft present\n- Asthenia\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Tinea cruris\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Generalized anxiety disorder\n- Neck pain\n- Nicotine dependence\n- Chronic kidney disease stage 1\n- Metabolic encephalopathy\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-09, presumably until 2019-10-10\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-10-09, presumably until 2019-10-09\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-10-10, presumably until 2019-10-10\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-10-09, presumably until 2019-10-10\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-09, presumably until 2019-10-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-10-09, presumably until 2019-10-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-10-10, presumably until 2019-10-10\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-09, presumably until 2019-10-09\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-09, presumably until 2019-10-10\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-10-10, presumably until 2019-10-10\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-10-10, presumably until 2019-10-10\n- methylprednisolone 125 MG Injection, started on 2019-10-09, presumably until 2019-10-10\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-10-09, presumably until 2019-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2019-10-13, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day as needed (for anxiety)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-10-12 00:22:00, ended at 2019-10-12 04:24:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.1 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 1.2 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.36 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.54 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Base excess in Arterial blood by calculation: 3.7 (milliequivalent per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1837 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Body height: 5' 10\" (inch (US))\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n\n### Procedure\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest; single view\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n\n### Condition\n- Primary diagnosis: Acute on chronic hypercapnic respiratory failure\n- Radiology result abnormal\n- Abnormal findings on diagnostic imaging of lung\n- Chronic pulmonary edema\n- Ventricular premature complex\n- Atrial fibrillation\n- Acute exacerbation of chronic obstructive airways disease\n\n### Drug\n- 250 ML moxifloxacin 1.6 MG/ML Injection, through Intravenous route, started on 2019-10-12, presumably until 2019-10-12\n- moxifloxacin 400 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2019-10-14, with intended 0 refill(s). Instructions: take 1 Tab (400 mg total) by mouth daily for 7 days\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-12, presumably until 2019-10-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-10-12, presumably until 2019-10-12\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-10-12, presumably until 2019-11-20, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-12, presumably until 2019-10-14, with intended 0 refill(s). Instructions: take 1 Cap (240 mg total) by mouth daily\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-12, presumably until 2019-10-12\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-12, presumably until 2019-10-12\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2019-10-14, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth 3 times a day\n- methylprednisolone 125 MG Injection, started on 2019-10-12, presumably until 2019-10-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-13 00:00:00, ended at 2019-10-13 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-10-13, presumably until 2019-11-20, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed for Anxiety (for anxiety)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-10-14 04:02:00, ended at 2019-10-29 16:40:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Base excess in Arterial blood by calculation: 9.5 (milliequivalent per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.23 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 50.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.83 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 75.7 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Body height: 5' 8.11\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 38 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.6 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 98 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.41 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 80 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 148 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 93.2 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 65.9 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 151 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 39.1 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.1 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 136 (milligram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 2.0 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.71 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 927 (picogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach\n- Noninvasive ear or pulse oximetry for oxygen saturation; multiple determinations (eg, during exercise)\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Radiologic examination, chest; single view\n- Insertion of Infusion Device into Left Femoral Vein, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Arterial puncture, withdrawal of blood for diagnosis\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Collection of venous blood by venipuncture\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n\n### Condition\n- Hyperglycemia\n- Hypertensive heart failure\n- Neck pain\n- Respiratory failure\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Acute hypoxemic respiratory failure\n- Acute on chronic hypoxemic respiratory failure\n- Atrial fibrillation\n- Disorder of lung\n- Benign prostatic hyperplasia\n- Paroxysmal atrial fibrillation\n- Stimulant dependence\n- Atherosclerosis of coronary artery without angina pectoris\n- Acute renal failure syndrome\n- Chronic congestive heart failure\n- Chronic pain\n- Chronic pulmonary edema\n- Abnormal findings diagnostic imaging heart+coronary circulat\n- Acidosis\n- Acute exacerbation of chronic obstructive airways disease\n- Acute on chronic hypercapnic respiratory failure\n- Disorder of male genital organ\n- Metabolic encephalopathy\n- Nicotine dependence\n- Pleural effusion\n- Primary diagnosis: Acute hypercapnic respiratory failure\n- Aortocoronary bypass graft present\n- Chronic systolic heart failure\n- Electrocardiogram abnormal\n- Localized edema\n- Backache\n- Dyspnea\n- Fatigue\n- Generalized anxiety disorder\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-14, presumably until 2019-10-14\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-10-20, presumably until 2019-10-29\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-10-14, presumably until 2019-10-14\n- methylprednisolone 40 MG Injection, started on 2019-10-14, presumably until 2019-10-29\n- 250 ML moxifloxacin 1.6 MG/ML Injection, through Intravenous route, started on 2019-10-14, presumably until 2019-10-14\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-10-14, presumably until 2019-10-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-10-26, presumably until 2019-10-28\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2019-10-20, presumably until 2019-10-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-10-24, presumably until 2019-10-24\n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-10-15, presumably until 2019-10-29\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-10-14, presumably until 2019-10-29\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-10-20, presumably until 2019-10-29\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-14, presumably until 2019-10-17\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2019-10-16, presumably until 2019-10-22\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-10-29\n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-17, presumably until 2019-10-29\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2019-10-22, presumably until 2019-10-26\n- acetazolamide 500 MG Injection, started on 2019-10-16, presumably until 2019-10-16\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2019-10-29\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-10-14, presumably until 2019-10-28\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2019-10-14, presumably until 2019-10-15\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-14, presumably until 2019-10-29\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-10-24, presumably until 2019-10-29\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-17, presumably until 2019-10-18\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-18, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 180 mg by mouth 2 times a day \n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-10-19, presumably until 2019-10-25\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-14, presumably until 2019-10-17\n- 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2019-10-16, presumably until 2019-10-16\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2019-10-28, presumably until 2019-10-29\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-10-16, presumably until 2019-10-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-29\n- methylprednisolone 125 MG Injection, started on 2019-10-14, presumably until 2019-10-25\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-10-15, presumably until 2019-10-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2019-10-29 17:23:00, ended at 2019-11-19 16:20:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.11\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 56.5 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.59 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 193 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.1 (femtoliter)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n\n### Condition\n- Qualitative platelet disorder\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Aortocoronary bypass graft present\n- Pain in left arm\n- Cellulitis and abscess of face\n- Essential hypertension\n- Hyperglycemia\n- Neck pain\n- Nicotine dependence\n- Primary diagnosis: Backache\n- Primary diagnosis: Chronic pain\n- Chronic ulcer of foot\n- Disorder of male genital organ\n- Localized swelling, mass and lump, neck\n- Stimulant dependence\n- Acute exacerbation of chronic obstructive airways disease\n- Atherosclerosis of artery of lower limb\n- Localized edema\n- Urinary incontinence\n- Acute on chronic hypercapnic respiratory failure\n- Spasm\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-03, presumably until 2019-11-05\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-11-06, presumably until 2019-11-20\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-20\n- amoxicillin 250 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-11-03\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-10-30, presumably until 2019-11-20\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-31, presumably until 2019-11-16\n- hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension, through Otic route, started on 2019-11-09, presumably until 2019-11-15\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-11-01, presumably until 2019-11-01\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-09, presumably until 2019-11-20\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-11-12\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-10-30, presumably until 2019-11-20\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-19\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-20\n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-30, presumably until 2019-11-20\n- purified protein derivative of tuberculin 50 UNT/ML Injectable Solution, through Intradermal route, started on 2019-10-31, presumably until 2019-11-07\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2019-11-04, presumably until 2019-11-20\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-10-30\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-11-20\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-30, presumably until 2019-11-20\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-10-29, presumably until 2019-11-20\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-11-09, presumably until 2019-11-09\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2019-10-30, presumably until 2019-11-20\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2019-11-08, presumably until 2019-11-20\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-20\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-03 08:07:00, ended at 2019-11-03 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation\n\n### Condition\n- Swelling / lump finding\n- Disorder of head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-11-09 04:01:00, ended at 2019-11-09 05:57:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Otalgia\n- Chronic obstructive lung disease\n- Aortocoronary bypass graft present\n- Atrial fibrillation\n- Essential hypertension\n- Generalized anxiety disorder\n- Primary diagnosis: Injury of ear\n- Nicotine dependence\n\n### Drug\n- ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension, started on 2019-11-09, presumably until 2019-11-16, with intended 0 refill(s). Instructions: Instill 4 drops into affected ear 4 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-19 09:30:00, ended at 2019-11-19 17:01:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, soft tissue neck; with contrast material(s)\n\n### Condition\n- Localized swelling, mass and lump, neck\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-11-19 17:02:00, ended at 2019-11-30 13:20:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 37 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Base excess in Arterial blood by calculation: 9.7 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.64 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.39 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 72 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Lactate [Moles/volume] in Serum or Plasma: 0.8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 23.8 (microgram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 24.0 (microgram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 771 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 39.0 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.57 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Radiologic examination, chest; single view\n- Hospital discharge day management; more than 30 minutes\n- Collection of venous blood by venipuncture\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Benign prostatic hyperplasia\n- Chronic pain\n- Claustrophobia\n- Foot ulcer due to type 2 diabetes mellitus\n- Sialoadenitis\n- Ulcer of lower extremity\n- Aortocoronary bypass graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Falls\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Abscess of salivary gland\n- Chronic fatigue syndrome\n- Chronic obstructive lung disease\n- Lumbar spondylosis with myelopathy\n- Atrial fibrillation\n- Backache\n- Chronic atrial fibrillation\n- Pain of right knee joint\n- Peripheral vascular disease\n- Asthenia\n- Extreme obesity with alveolar hypoventilation\n- Hypertensive heart failure\n- Loss of appetite\n- Major depression, single episode\n- Metabolic encephalopathy\n- Neck pain\n- Spasm\n- Acute on chronic hypercapnic respiratory failure\n- Chronic congestive heart failure\n- Drowsy\n- Impacted cerumen\n- Overflow incontinence of urine\n- Pain of left knee region\n- Type 2 diabetes mellitus\n- Atherosclerosis of artery of lower limb\n- Chest pain\n- Generalized anxiety disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Chronic systolic heart failure\n- Chronic ulcer of skin of lower leg\n- Electrocardiogram abnormal\n- Nicotine dependence\n- Pleural effusion\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-11-29, presumably until 2019-11-29\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 1,250 mg by mouth every day \n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-28\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-11-26, presumably until 2019-11-29\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-11-20, presumably until 2019-12-03, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2019-11-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-11-23, presumably until 2019-11-29\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day with meals\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-24\n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-11-19, presumably until 2019-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-11-19, presumably until 2019-12-03, with intended 0 refill(s). Instructions: inject 40 mg subcutaneous (under the skin) daily\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-11-24, presumably until 2019-11-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-11-19, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2019-11-20\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-11-26, presumably until 2019-11-26\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 40 mg by mouth every day \n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-11-29, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 1.25 mg by RT Inhalation route every 6 hours as needed (bronchospasm/wheezing, sob) \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-11-28, presumably until 2019-12-13, with intended 0 refill(s). Instructions: take 25 mg by mouth 2 times a day \n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2019-12-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-11-29, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 500 mcg by Nebulization route every 6 hours as needed (bronchospasm/wheezing) \n- vancomycin 5 MG/ML Injection, through Intravenous route, started on 2019-11-20, presumably until 2019-11-29\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-11-20, presumably until 2019-11-30\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2019-11-22, presumably until 2019-11-22\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2019-11-30\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 0.5 mg by Inhalation route 2 times a day \n- carbamide peroxide 65 MG/ML Otic Solution, through Otic route, started on 2019-11-26, presumably until 2019-11-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-11-24, presumably until 2019-11-28\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-11-22, presumably until 2019-11-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2019-11-19, presumably until 2019-11-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-11-19, presumably until 2019-11-19\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-11-22, presumably until 2019-11-23\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- nystatin 100 UNT/MG Topical Powder, through Topical route, presumably until 2019-12-03, with intended 0 refill(s). Instructions: 1 Application by Topical route 3 times a day \n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-15, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-02-04, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-30\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-19\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Asthma within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-20 00:00:00, ended at 2017-12-20 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2017-12-21, presumably until 2018-01-22, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-16 00:00:00, ended at 2018-01-16 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-01-18, presumably until 2018-02-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-20 00:00:00, ended at 2018-01-20 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-01-21, presumably until 2018-01-21, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-08 00:00:00, ended at 2018-02-08 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-02-08, presumably until 2018-03-05, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-05 15:17:28, ended at 2018-03-05 15:57:41\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Chronic pain\n- Shoulder joint pain\n\n### Drug\n- potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-03-20, presumably until 2018-10-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-05-26, presumably until 2018-04-05, with intended 0 refill(s). Instructions: 1 Spray by Intranasal route 2 times a day\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2017-03-25, presumably until 2018-04-05, with intended 0 refill(s). Instructions: by Topical route 2 times a day\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2017-08-25, presumably until 2018-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n- acetaminophen 325 MG / dichloralphenazone 100 MG / isometheptene 65 MG Oral Capsule, through Oral route, started on 2018-03-05, presumably until 2018-09-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 4 hours as needed\n- amitriptyline hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-01-01, presumably until 2018-10-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- pregabalin 50 MG Oral Capsule, through Oral route, started on 2018-03-05, presumably until 2018-09-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2018-03-05, presumably until 2018-03-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2017-09-25, presumably until 2018-10-04, with intended 0 refill(s)\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-03-05, presumably until 2019-03-05, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-16 22:27:00, ended at 2018-03-17 00:27:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 136 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Spasm\n- Candidiasis\n- Primary diagnosis: Spasm of back muscles\n- Nicotine dependence\n- Disorder of integument\n\n### Drug\n- clotrimazole 10 MG/ML Topical Cream, started on 2018-03-16, presumably until 2018-04-05, with intended 0 refill(s). Instructions: Wash and dry thoroughly then apply thin film to affected area twice daily.\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2018-03-16, presumably until 2018-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- tramadol hydrochloride 50 MG Oral Tablet, started on 2018-03-10, presumably until 2018-03-19, with intended 0 refill(s)\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2016-05-26, presumably until 2018-03-25, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Oral route, started on 2016-10-15, presumably until 2018-05-20, with intended 0 refill(s). Instructions: take by mouth\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-03-16, presumably until 2018-04-05, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-19 00:00:00, ended at 2018-03-19 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-03-19, presumably until 2018-03-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-19 00:46:00, ended at 2018-03-19 03:21:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Backache\n- Spasm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-19 07:39:00, ended at 2018-03-19 08:33:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spasm\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-03-19, presumably until 2018-03-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-03-25 00:00:00, ended at 2018-03-25 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-03-25, presumably until 2018-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-03-25 16:08:00, ended at 2018-03-25 18:04:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Primary diagnosis: Pain in left foot\n- Spasm\n- Primary diagnosis: Pain in right foot\n- Chronic pain syndrome\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2017-07-31, presumably until 2018-04-16, with intended 0 refill(s). Instructions: as needed\n- alprazolam 1 MG Oral Tablet, started on 2017-10-23, presumably until 2018-04-05, with intended 0 refill(s). Instructions: 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-26 15:26:51, ended at 2018-03-26 15:50:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Pain in right foot\n- Pain in right lower limb\n- Pain in left lower limb\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-03-26, presumably until 2018-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-03 05:37:00, ended at 2018-04-03 06:52:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Muscle strain\n- Shoulder joint pain\n- Primary diagnosis: Sprain of upper extremity\n- Injury of muscle and tendon at thorax level\n\n### Drug\n- carisoprodol 350 MG Oral Tablet, through Oral route, started on 2018-04-03, presumably until 2018-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-04-03, presumably until 2018-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-05 10:00:54, ended at 2018-04-05 11:19:56\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Laceration of hand\n- Psychophysiologic insomnia\n- Primary diagnosis: Shoulder joint pain\n- Hernia of anterior abdominal wall\n\n### Drug\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2018-04-05, presumably until 2018-10-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n- 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe, through Intramuscular route, started on 2018-04-05, presumably until 2018-04-05, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2018-04-05, presumably until 2018-04-14, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-04-12, presumably until 2018-05-21, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-12 04:36:00, ended at 2018-04-12 05:44:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bacteria [Presence] in Urine sediment by Light microscopy: None (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 5 - 10 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: >100 (per high power field)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Microscopic hematuria\n- Dysuria\n- Ureteric stone\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-04-12, presumably until 2018-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-14 15:09:49, ended at 2018-04-14 15:48:36\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Psychophysiologic insomnia\n- Primary diagnosis: Urogenital finding\n- Lumbago with sciatica\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2018-04-14, presumably until 2018-05-14, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-16 00:00:00, ended at 2018-04-16 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-04-16, presumably until 2018-10-10, with intended 0 refill(s). Instructions: Use one spray in each nostril one time daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-20 17:13:00, ended at 2018-04-20 20:29:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Specimen source identified: 10.4 (femtoliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.99 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 5 - 10 (per high power field)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Bacteria [Presence] in Urine sediment by Light microscopy: Few (per high power field)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.2 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Hematuria syndrome\n- Dysuria\n- Nicotine dependence\n- Abdominal pain\n- Primary diagnosis: Urinary tract infectious disease\n\n### Drug\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-04-20\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2018-04-20, presumably until 2018-05-20, with intended 0 refill(s). Instructions: Apply 1 patch to pain area for up to 12 hours in any 24 hour period.\n- phenazopyridine hydrochloride 200 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-04-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-04-30 12:52:00, ended at 2018-04-30 14:18:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eye region\n- Acute conjunctivitis\n- Injury of conjunctiva\n- Corneal abrasion\n- Nicotine dependence\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Conjunctivitis\n\n### Drug\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2018-04-30, presumably until 2018-04-30\n- sulfacetamide sodium 100 MG/ML Ophthalmic Solution, through Intraocular route, started on 2018-04-30, presumably until 2018-10-04, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes every 2 hours while awake\n- fluorescein dilaurate, through Intraocular route, started on 2018-04-30, presumably until 2018-04-30\n- fluorescein, through Intraocular route, started on 2018-04-30, presumably until 2018-04-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-06 20:43:00, ended at 2018-05-06 23:24:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eye region\n- Nicotine dependence\n- Primary diagnosis: Acute conjunctivitis\n\n### Drug\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2018-05-06, presumably until 2018-05-06\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2018-05-06, presumably until 2018-05-06\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-05-06, presumably until 2018-05-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-10 23:19:00, ended at 2018-05-11 00:53:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in eye\n- Primary diagnosis: Blepharitis\n- Nicotine dependence\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-05-11, presumably until 2018-05-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2018-05-11, presumably until 2018-05-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-20 00:00:00, ended at 2018-05-20 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-05-20, presumably until 2018-06-08, with intended 0 refill(s). Instructions: 1 Puff by Inhalation route every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-05-20 18:53:00, ended at 2018-05-20 19:30:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy\n- Pain in lower limb\n- Exacerbation of moderate persistent asthma\n- Nicotine dependence\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-05-20, presumably until 2018-06-08, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-21 00:00:00, ended at 2018-05-21 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-05-21, presumably until 2018-07-19, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-02 04:45:00, ended at 2018-06-02 07:55:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.74 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 8\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 156 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 47.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.72 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Chromatin IgG Ab [Units/volume] in Serum or Plasma: 0.72 (microgram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.85 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Specimen source identified: 10.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Chest pain\n- Essential hypertension\n- Spasm\n- Atrial premature complex\n- Chronic obstructive lung disease\n- Aortocoronary bypass graft present\n- Nicotine dependence\n- Chronic pain\n- Disorder of eye region\n- Anesthesia of skin\n- Chronic pulmonary edema\n- Dyspnea\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2018-06-02, presumably until 2018-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-06-08 00:13:00, ended at 2018-06-08 02:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Heartburn\n- Major depression, single episode\n- Chronic pain\n- Congenital heart disease\n- Conjunctivitis\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Pain in left lower limb\n- Pain in right lower limb\n- Chronic conjunctivitis\n- Dyspnea\n- Cough\n- Essential hypertension\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2018-06-08, presumably until 2018-06-08\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-06-08, presumably until 2018-11-04, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n- dexamethasone 0.001 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment, through Intraocular route, started on 2018-06-08, presumably until 2018-10-04, with intended 0 refill(s). Instructions: instill to right eye 4 times a day\n- azithromycin 250 MG Oral Tablet, started on 2018-06-08, presumably until 2018-06-13, with intended 0 refill(s). Instructions: Take 2 tablets now, then one tablet daily until gone.\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2018-06-08, presumably until 2018-06-13, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-06-08, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-16 16:13:20, ended at 2018-06-16 17:02:35\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Paresthesia\n- Abrasion, knee\n- Pleuritic pain\n- Wrist joint pain\n- Primary diagnosis: Anesthesia of skin\n\n### Drug\n- alprazolam 1 MG Disintegrating Oral Tablet, started on 2018-06-16, presumably until 2018-07-19, with intended 0 refill(s). Instructions: 1 tablet 2 or 3 times daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-16 16:35:00, ended at 2018-06-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; 2 views\n\n### Condition\n- Injury of upper extremity\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-07-14 04:51:00, ended at 2018-07-14 06:18:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Specimen source identified: 10.6 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.5 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.9 (percent)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 288 (picogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.48 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 221 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pain in right lower limb\n- Primary diagnosis: Cellulitis of right lower limb\n- Aortocoronary bypass graft present\n- Cellulitis of left lower limb\n- Nicotine dependence\n\n### Drug\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2018-07-14, presumably until 2018-07-15, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-07-15 17:47:00, ended at 2018-07-15 19:10:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Essential hypertension\n- Localized edema\n- Primary diagnosis: Cellulitis of right lower limb\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-15, presumably until 2018-07-15\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-07-15, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2018-07-15, presumably until 2018-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-07-19 00:00:00, ended at 2018-07-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-07-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-23 00:00:00, ended at 2018-07-23 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-07-26, presumably until 2018-08-18, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH 2 TO 3 TIMES DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-07-23 00:46:00, ended at 2018-07-23 04:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views\n\n### Condition\n- Primary diagnosis: Injury of muscle and tendon at neck level\n- Neck pain\n- Contusion of hip\n- Hip pain\n- Primary diagnosis: Muscle strain\n- Nicotine dependence\n\n### Drug\n- 1 ML morphine sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-07-23, presumably until 2018-07-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-07-23, presumably until 2018-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-26 13:30:44, ended at 2018-07-26 14:06:38\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Backache\n- Shoulder joint pain\n- Primary diagnosis: Chronic pain\n- Neck pain\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-07-26, presumably until 2018-08-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-28 08:21:58, ended at 2018-07-28 08:48:26\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Shoulder joint pain\n- Chronic pain\n- Backache\n- Primary diagnosis: Neck pain\n- Musculoskeletal finding\n- Spasm\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-07-28, presumably until 2018-09-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth as needed\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-07-28, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed (pain)\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-07-28, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-08-11 00:24:00, ended at 2018-08-11 04:32:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.18 (thousand per microliter)\n- Specimen source identified: 10.7 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Cellulitis of left lower limb\n- Strain of muscle and/or tendon of thigh\n- Thigh pain\n- Nicotine dependence\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2018-08-11, presumably until 2018-08-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-08-11, presumably until 2018-08-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-18 15:19:14, ended at 2018-08-18 16:07:33\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Neck pain\n- Primary diagnosis: Musculoskeletal finding\n- Paresthesia\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-08-18, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- alprazolam 1 MG Oral Tablet, started on 2018-08-18, presumably until 2018-09-07, with intended 0 refill(s). Instructions: 1 tablet 3 times daily\n- tadalafil 20 MG Oral Tablet, started on 2018-08-18, presumably until 2018-09-07, with intended 1 refill(s). Instructions: 1 tablet once a week as needed for erectile dysfunction\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-19 00:00:00, ended at 2018-08-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2018-08-19, presumably until 2018-08-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day for 10 days\n- hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension, through Otic route, started on 2018-08-19, presumably until 2018-10-04, with intended 0 refill(s). Instructions: instill 3 Drops to right ear 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-08-26 22:49:00, ended at 2018-08-27 02:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Specimen source identified: 10.5 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.9 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Pain of left knee region\n- Nicotine dependence\n- Thigh pain\n- Dyspnea\n- Polyneuropathy\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-08-27, presumably until 2018-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-07 11:25:00, ended at 2018-09-07 11:55:10\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Laceration of hand\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth as needed\n- alprazolam 1 MG Oral Tablet, started on 2018-09-07, presumably until 2018-09-07, with intended 0 refill(s). Instructions: 1 tablet 3 times daily\n- 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe, through Intramuscular route, started on 2018-09-07, presumably until 2018-09-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-09-07, presumably until 2018-10-20, with intended 2 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-09-09 07:14:00, ended at 2018-09-09 10:20:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, elbow; complete, minimum of 3 views\n\n### Condition\n- Abrasion of nose\n- Nicotine dependence\n- Elbow joint pain\n- Contusion of elbow\n- Primary diagnosis: Injury of head\n- Laceration of upper arm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-30 09:48:45, ended at 2018-09-30 10:55:08\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Generalized anxiety disorder\n- Primary diagnosis: Musculoskeletal finding\n- Backache\n- Paresthesia\n- Anesthesia of skin\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-09-30, presumably until 2018-10-21, with intended 4 refill(s). Instructions: take 1 Tab by mouth as needed\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-09-30, presumably until 2018-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2018-09-30, presumably until 2018-10-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-10-04, presumably until 2018-10-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-04 19:42:00, ended at 2018-10-04 22:06:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic obstructive lung disease\n- Nausea\n- Essential hypertension\n- Backache\n- Nicotine dependence\n- Chronic pain\n- Primary diagnosis: Palpitations\n- Chest pain\n- Neck pain\n- Major depression, single episode\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-06 00:00:00, ended at 2018-10-06 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-10-06, presumably until 2018-11-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-11, presumably until 2019-03-03, with intended 0 refill(s). Instructions: USE ONE SPRAY IN EACH NOSTRIL ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-10-13 23:18:00, ended at 2018-10-14 07:49:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination; forearm, 2 views\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Injury of muscle and tendon at neck level\n- Lumbar sprain\n- Arthralgia of the ankle and/or foot\n- Chronic pain\n- Nicotine dependence\n- Wrist joint pain\n- Primary diagnosis: Injury of head\n- Injury of muscle and tendon of abdomen, lower back and pelvis\n- Major depression, single episode\n- Essential hypertension\n- Chronic obstructive lung disease\n- Low back pain\n- Pain in forearm\n- Injury of forearm\n- Muscle strain\n\n### Drug\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2018-10-14, presumably until 2018-10-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-20 10:26:02, ended at 2018-10-20 11:47:08\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Metabolic encephalopathy\n- Pain in left arm\n- Neck pain\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2018-10-20, presumably until 2018-12-08, with intended 0 refill(s). Instructions: Take one tab 30 min before his MRI, many repeat in 30 min PRN for the MRI\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-21 00:00:00, ended at 2018-10-21 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-10-22, presumably until 2018-11-04, with intended 4 refill(s). Instructions: take 1 Tab by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-21 15:12:00, ended at 2018-10-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Cerebral ischemia\n- Metabolic encephalopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-02 21:48:00, ended at 2018-11-03 01:44:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 49.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Specimen source identified: 11.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.98 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Bacteria [Presence] in Urine sediment by Light microscopy: Few (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.1 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Electrocardiogram abnormal\n- Essential hypertension\n- Kidney stone\n- Low back pain\n- Coronary artery graft present\n- Primary diagnosis: Abdominal pain\n- Atherosclerosis of coronary artery without angina pectoris\n- Nicotine dependence\n- Chronic obstructive lung disease\n- Major depression, single episode\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-04 09:42:00, ended at 2018-11-04 10:52:30\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Low back pain\n- Cough\n- Neck pain\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2018-11-04, presumably until 2019-02-15, with intended 4 refill(s). Instructions: take 1 Tab by mouth as needed\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2018-11-04, presumably until 2018-12-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- alprazolam 1 MG Oral Tablet, started on 2018-11-04, presumably until 2018-12-06, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-11-04, presumably until 2018-12-08, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-05 14:27:00, ended at 2018-11-05 15:02:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Puncture wound of foot\n- Low back pain\n- Metal nail puncture wound of skin\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n- Nicotine dependence\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-11-05, presumably until 2018-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-11-05, presumably until 2018-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-09 02:32:00, ended at 2018-11-09 07:07:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 6.5 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Specimen source identified: 11.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chromatin IgG Ab [Units/volume] in Serum or Plasma: 0.69 (microgram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 233 (picogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 225 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 49.0 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Neck pain\n- Backache\n- Chronic obstructive lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Pain in left arm\n- Major depression, single episode\n- Chronic pain\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-11-09, presumably until 2018-11-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-19 18:30:00, ended at 2018-11-19 19:40:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Essential hypertension\n- Primary diagnosis: Sprain of knee\n- Nicotine dependence\n- Wrist joint pain\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2018-11-19, presumably until 2018-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-24 23:24:00, ended at 2018-11-25 01:38:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n\n### Condition\n- Asthenia\n- Cough\n- Urinary incontinence\n- Chronic pain\n- Nicotine dependence\n- Primary diagnosis: Disorder of bladder\n- Major depression, single episode\n- Neck pain\n- Acute exacerbation of chronic obstructive airways disease\n- Essential hypertension\n- Backache\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2018-11-25, presumably until 2018-11-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-25 12:10:42, ended at 2018-11-25 13:50:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary incontinence\n- Disorder of sleep-wake cycle\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-11-26 00:53:00, ended at 2018-11-26 03:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Few (per low powered field)\n- Bacteria [Presence] in Urine sediment by Light microscopy: None (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: >100 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication associated with genitourinary device\n- Major depression, single episode\n- Chronic pain\n- Essential hypertension\n- Nicotine dependence\n- Complication of urinary catheter\n- Chronic obstructive lung disease\n- Pain due to internal prosthetic device\n- Urinary incontinence\n- Primary diagnosis: Dysuria\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, started on 2018-11-26, presumably until 2018-11-26\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-11-26, presumably until 2018-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2018-11-26, presumably until 2018-11-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-01 10:12:00, ended at 2018-12-01 12:13:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, ankle; complete, minimum of 3 views\n\n### Condition\n- Primary diagnosis: Contusion of knee\n- Injury of muscle and tendon at ankle and foot level\n- Pain of left knee region\n- Arthralgia of the ankle and/or foot\n- Chronic pain\n- Essential hypertension\n- Nicotine dependence\n- Disorder of soft tissue\n- Muscle strain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-02 07:59:00, ended at 2018-12-02 08:34:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Chronic obstructive lung disease\n- Chronic pain\n- Essential hypertension\n- Major depression, single episode\n- Neck pain\n- Urinary incontinence\n- Primary diagnosis: Complication associated with genitourinary device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-06 00:00:00, ended at 2018-12-06 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-12-06, presumably until 2018-12-08, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-12-13, presumably until 2018-12-13, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-08 14:07:15, ended at 2018-12-08 15:17:52\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n- Chronic obstructive lung disease\n- Tinea cruris\n- Primary diagnosis: Cellulitis of right lower limb\n\n### Drug\n- nystatin 100000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream, through Topical route, started on 2018-12-08, presumably until 2019-02-15, with intended 0 refill(s). Instructions: by Topical route 4 times a day X 7 days topically\n- alprazolam 1 MG Oral Tablet, started on 2018-12-08, presumably until 2018-12-14, with intended 0 refill(s). Instructions: TAKE 1/2 TAB TID PRN PO\n- cephalexin 500 MG Oral Capsule, started on 2018-12-08, presumably until 2018-12-14, with intended 0 refill(s). Instructions: Take 1 tid x 10 days\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-08, presumably until 2019-02-28, with intended 2 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-08 22:28:00, ended at 2018-12-08 23:43:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eruption\n- Urinary incontinence\n- Chronic pain\n- Major depression, single episode\n- Essential hypertension\n- Chronic obstructive lung disease\n- Nicotine dependence\n- Neck pain\n\n### Drug\n- clotrimazole 10 MG/ML Topical Cream, started on 2018-12-08, presumably until 2019-01-07, with intended 0 refill(s). Instructions: Wash and dry thoroughly then apply thin film to affected area twice daily.\n- hydrocortisone 25 MG/ML Topical Cream, started on 2018-12-08, presumably until 2019-01-07, with intended 0 refill(s). Instructions: Apply sparingly to the affected area twice daily for duration of the flare.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-14 13:23:58, ended at 2018-12-14 13:45:11\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Primary diagnosis: Pain in left lower limb\n- Polyneuropathy\n- Chronic pain\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2018-12-14, presumably until 2019-01-20, with intended 0 refill(s). Instructions: TAKE 1 po 3 times daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-19 21:29:00, ended at 2018-12-19 23:04:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Chronic pain\n- Chronic obstructive lung disease\n- Primary diagnosis: Contusion of knee\n- Low back pain\n- Pain of left knee region\n- Contusion of trunk\n- Nicotine dependence\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2018-12-19, presumably until 2018-12-19\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2018-12-19, presumably until 2019-01-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-12-22 03:44:00, ended at 2018-12-22 05:34:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.9 (femtoliter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.86 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.8 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 217 (picogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Specimen source identified: 10.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest; single view\n\n### Condition\n- Primary diagnosis: Chest pain\n- Abnormal findings on diagnostic imaging of lung\n- Atrial premature complex\n- Chronic pain\n- Essential hypertension\n- Cellulitis of right lower limb\n- Atherosclerosis of coronary artery without angina pectoris\n- Anxiety disorder\n- Chronic obstructive lung disease\n- Electrocardiogram abnormal\n- Nicotine dependence\n- Aortocoronary bypass graft present\n\n### Drug\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2018-12-22, presumably until 2018-12-22\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-12-22, presumably until 2018-12-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-03 03:14:00, ended at 2019-01-03 04:17:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Radiologic examination, wrist; 2 views\n\n### Condition\n- Shoulder joint pain\n- Wrist joint pain\n- Pain of left knee region\n- Neck pain\n- Major depression, single episode\n- Chronic obstructive lung disease\n- Essential hypertension\n- Urinary incontinence\n- Primary diagnosis: Muscle pain\n- Chronic pain\n- Nicotine dependence\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-01-03, presumably until 2019-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-09 18:34:00, ended at 2019-01-09 20:46:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Primary diagnosis: Pain in left lower limb\n- Essential hypertension\n- Chronic obstructive lung disease\n- Nicotine dependence\n\n### Drug\n- nabumetone 500 MG Oral Tablet, through Oral route, started on 2019-01-09, presumably until 2019-02-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-20 09:57:19, ended at 2019-01-20 11:37:02\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Late effect of accidental fall\n\n### Drug\n- atenolol 25 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n- alprazolam 1 MG Oral Tablet, started on 2019-01-20, presumably until 2019-02-15, with intended 0 refill(s). Instructions: TAKE 1 po 3 times daily as needed\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-01-28 06:04:00, ended at 2019-01-28 09:19:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Spasm\n- Nicotine dependence\n- Wrist joint pain\n- Essential hypertension\n- Primary diagnosis: Sprain of wrist\n- Chronic obstructive lung disease\n- Major depression, single episode\n\n### Drug\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2019-01-28, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-04 03:27:00, ended at 2019-02-04 05:25:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Major depression, single episode\n- Essential hypertension\n- Pain in left lower limb\n- Primary diagnosis: Spasm\n- Chronic obstructive lung disease\n- Chronic pain\n- Nicotine dependence\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-02-04, presumably until 2019-02-04\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2019-02-04, presumably until 2019-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-06 21:20:00, ended at 2019-02-06 23:41:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, femur; minimum 2 views\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Thigh pain\n- Major depression, single episode\n- Chronic pain\n- Nicotine dependence\n- Pain in left foot\n- Chronic obstructive lung disease\n- Essential hypertension\n- Primary diagnosis: Pain in left lower limb\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, started on 2019-02-06, presumably until 2019-02-06\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2019-02-06, presumably until 2019-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-08 13:27:00, ended at 2019-02-08 14:34:28\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Localized edema\n- Primary diagnosis: Pain in left lower limb\n- Lumbago with sciatica\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-02-08, presumably until 2019-09-18, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2019-02-08, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-02-08, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-09 20:12:00, ended at 2019-02-10 00:49:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.83 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bacteria [Presence] in Urine sediment by Light microscopy: Few (per high power field)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.64 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.4 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 193 (thousand per microliter)\n\n### Procedure\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n\n### Condition\n- Lumbar radiculopathy\n- Major depression, single episode\n- Nicotine dependence\n- Chronic obstructive pulmonary disease with acute lower respiratory infection\n- Primary diagnosis: Pain in left lower limb\n- Chronic pain\n- Left lower quadrant pain\n- Pneumonia\n- Benign prostatic hyperplasia with outflow obstruction\n- Essential hypertension\n- Lobar pneumonia\n- Urinary incontinence\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-02-09, presumably until 2019-02-09\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-02-10, presumably until 2019-02-10\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-02-09, presumably until 2019-02-09\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2019-02-09, presumably until 2019-02-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-02-09, presumably until 2019-02-09\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2019-02-09, presumably until 2019-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-12 00:36:00, ended at 2019-02-12 01:08:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left lower limb\n- Primary diagnosis: Chronic pain syndrome\n- Nicotine dependence\n- Essential hypertension\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-02-12, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-14 16:18:24, ended at 2019-02-14 16:58:50\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n- Primary diagnosis: Pain in right lower limb\n- Primary diagnosis: Pain in right foot\n- Primary diagnosis: Pain in left lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-15 10:22:51, ended at 2019-02-15 11:33:37\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Low back pain\n- Degeneration of lumbar intervertebral disc\n- Disorder of musculoskeletal system\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-09-18, with intended 5 refill(s). Instructions: take 1 Tab by mouth as needed\n- alprazolam 1 MG Oral Tablet, started on 2019-02-15, presumably until 2019-03-03, with intended 0 refill(s). Instructions: TAKE 1 po 3 times daily as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-16 07:21:00, ended at 2019-02-16 11:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain syndrome\n- Major depression, single episode\n- Chronic obstructive lung disease\n- Essential hypertension\n- Nicotine dependence\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-02-16, presumably until 2019-02-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-21 11:30:00, ended at 2019-02-21 12:11:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Major depression, single episode\n- Chronic obstructive lung disease\n- Primary diagnosis: Chest pain\n- Essential hypertension\n- Nicotine dependence\n- Chronic pain\n- Urinary incontinence\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-02-21, presumably until 2019-02-21\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-02-21, presumably until 2019-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-21 12:34:00, ended at 2019-02-21 14:32:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.03 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.61 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.1 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-24 18:40:00, ended at 2019-02-24 19:17:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Urinary incontinence\n- Chronic obstructive lung disease\n- Primary diagnosis: Diaper rash\n- Eruption\n- Nicotine dependence\n\n### Drug\n- hydrocortisone 10 MG/ML Topical Cream, started on 2019-02-24, presumably until 2019-03-26, with intended 0 refill(s). Instructions: Wash and dry thoroughly then apply thin film to affected area. 2-4 times daily as needed for flare up of rash\n- clotrimazole 10 MG/ML Topical Cream, started on 2019-02-24, presumably until 2019-09-18, with intended 0 refill(s). Instructions: Apply to affected areas or redness covered by  diaper\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-26 19:06:00, ended at 2019-02-26 23:55:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.5 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.0 (percent)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: Moderate (per low powered field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.93 (million per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.98 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.46 (thousand per microliter)\n- Bacteria [Presence] in Urine sediment by Light microscopy: None (per high power field)\n- Eosinophils [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.66 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Nicotine dependence\n- Spinal stenosis of lumbar region\n- Chronic obstructive lung disease\n- Major depression, single episode\n- Urinary incontinence\n- Chronic pain\n- Essential hypertension\n- Primary diagnosis: Right lower quadrant pain\n- Pain in left lower limb\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-02-26, presumably until 2019-02-26\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2019-02-26, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-02-26, presumably until 2019-02-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-02-28, presumably until 2019-03-03, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-03 00:00:00, ended at 2019-03-03 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2019-03-03, presumably until 2019-05-22, with intended 1 refill(s). Instructions: inhale 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-03 00:00:00, ended at 2019-03-03 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-03-03, presumably until 2019-05-11, with intended 0 refill(s). Instructions: 1 Spray by Nasal route daily\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-03-03, presumably until 2019-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-07 03:20:00, ended at 2019-03-07 05:25:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Lumbago with sciatica\n- Asthenia\n- Chronic obstructive lung disease\n- Nicotine dependence\n- Essential hypertension\n- Pain in left lower limb\n- Major depression, single episode\n- Primary diagnosis: Sciatica\n- Chronic pain\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-03-07, presumably until 2019-03-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-08 04:58:00, ended at 2019-03-08 06:40:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.6 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic pain\n- Major depression, single episode\n- Pain in left lower limb\n- Chronic obstructive lung disease\n- Essential hypertension\n- Thigh pain\n- Nicotine dependence\n- Pain of left knee region\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-03-08, presumably until 2019-03-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-10 02:35:00, ended at 2019-03-10 05:15:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Major depression, single episode\n- Primary diagnosis: Contusion of knee\n- Nicotine dependence\n- Pain in left lower limb\n- Sprain of upper extremity\n- Chronic pain\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-03-10, presumably until 2019-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-15, presumably until 2019-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-15 02:48:00, ended at 2019-03-15 05:37:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n\n### Condition\n- Neck pain\n- Aortocoronary bypass graft present\n- Chronic pain\n- Injury of head\n- Severe recurrent major depression without psychotic features\n- Essential hypertension\n- Muscle strain\n- Chronic obstructive lung disease\n- Gastroesophageal reflux disease without esophagitis\n- Generalized anxiety disorder\n- Injury of muscle and tendon at neck level\n- Falls\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-03-15, presumably until 2019-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-15 13:24:03, ended at 2019-03-15 14:21:06\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2018-12-24, presumably until 2019-09-18, with intended 0 refill(s). Instructions:   0 Refill(s)\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-03-15, presumably until 2019-03-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-03-15, presumably until 2019-05-24, with intended 2 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2018-12-24, presumably until 2019-06-28, with intended 0 refill(s). Instructions:   0 Refill(s)\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-15, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-19 03:56:00, ended at 2019-03-19 08:55:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Sprain of upper extremity\n- Aortocoronary bypass graft present\n- Neck pain\n- Primary diagnosis: Pain of left knee region\n- Chronic obstructive lung disease\n- Chronic pain\n- Major depression, single episode\n- Shoulder joint pain\n- Essential hypertension\n- Nicotine dependence\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-19, presumably until 2019-03-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-25 23:40:00, ended at 2019-03-26 02:45:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.94 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 181 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.68 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.32 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.0 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Aortocoronary bypass graft present\n- Atrial premature complex\n- Acquired absence of organ\n- Major depression, single episode\n- Essential hypertension\n- Primary diagnosis: Chest pain\n- Nicotine dependence\n- Chronic pain\n- Electrocardiogram abnormal\n- Absence of toe\n- Chronic obstructive lung disease\n- Pain in left lower limb\n- Pain in right lower limb\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-03-26, presumably until 2019-03-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-03-29 03:14:00, ended at 2019-03-29 06:15:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral, with pelvis when performed; 2-3 views\n\n### Condition\n- Chronic obstructive lung disease\n- Absence of toe\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Severe recurrent major depression without psychotic features\n- Primary diagnosis: Drowsy\n- Neck pain\n- Pain of right knee joint\n- Sleep disorder\n- Nicotine dependence\n- Chronic pain\n- Generalized anxiety disorder\n- Pain of left knee region\n- Acquired absence of organ\n- Hip pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-04-01 20:59:00, ended at 2019-04-02 00:44:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-04-02 16:28:00, ended at 2019-04-02 18:20:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Low back pain\n- Nicotine dependence\n- Wrist joint pain\n- Primary diagnosis: Injury of shoulder and upper arm\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-04-02, presumably until 2019-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-18 00:00:00, ended at 2019-04-18 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2019-04-19, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tablet  by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-05-01 19:44:00, ended at 2019-05-01 20:28:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Chest pain\n- Chronic obstructive lung disease\n- Dyspnea\n- Nicotine dependence\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-05-01, presumably until 2019-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-11 00:00:00, ended at 2019-05-11 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-05-12, presumably until 2019-05-24, with intended 0 refill(s). Instructions: 1 Spray by Nasal route daily\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-05-12, presumably until 2019-06-10, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-05-17 02:55:00, ended at 2019-05-17 06:03:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in left foot\n- Essential hypertension\n- Aortocoronary bypass graft present\n- Asthenia\n- Major depression, single episode\n- Acquired absence of organ\n- Chronic pain\n- Absence of toe\n- Pain in right foot\n- Callosity\n- Chronic obstructive lung disease\n- Nicotine dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-22 00:00:00, ended at 2019-05-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-05-23, presumably until 2019-06-28, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-24 11:13:01, ended at 2019-05-24 11:38:47\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Chronic obstructive lung disease\n- Degeneration of lumbar intervertebral disc\n- Chronic pain\n- Musculoskeletal finding\n- Disorder of musculoskeletal system\n- Low back pain\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2019-05-24, presumably until 2019-06-03, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 10 days\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-05-24, presumably until 2019-06-28, with intended 1 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-05-24, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-05-24, presumably until 2019-09-18, with intended 2 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-01 03:24:00, ended at 2019-06-01 05:50:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Asthenia\n- Backache\n- Wrist joint pain\n- Spinal stenosis in cervical region\n- Nicotine dependence\n- Primary diagnosis: Chest pain\n- Aortocoronary bypass graft present\n- Chronic pain\n- Essential hypertension\n- Pleuritic pain\n- Chronic obstructive lung disease\n- Major depression, single episode\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-06-01, presumably until 2019-06-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2019-06-12, presumably until 2019-07-07, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY AS NEEDED \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-15 21:03:00, ended at 2019-06-15 23:47:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Aortocoronary bypass graft present\n- Nicotine dependence\n- Backache\n- Chronic obstructive lung disease\n- Chronic pulmonary edema\n- Pain in right lower limb\n- Cardiomegaly\n- Essential hypertension\n- Chronic pain\n- Primary diagnosis: Localized edema\n- Major depression, single episode\n- Pain in left lower limb\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-06-15, presumably until 2019-06-15\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2019-06-15, presumably until 2019-06-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-19 02:49:00, ended at 2019-06-19 06:21:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Base excess in Arterial blood by calculation: 3.4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 51.0 (millimeter mercury column)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 29.6 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 175 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.6 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 59.9 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.00 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Radiologic examination, chest; single view\n- Arterial puncture, withdrawal of blood for diagnosis\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Hypoxemia\n- Abnormal breathing\n- Acquired absence of organ\n- Cardiomegaly\n- Chronic pulmonary edema\n- Hypertensive heart failure\n- Lumbar spondylosis with myelopathy\n- Aortocoronary bypass graft present\n- Joint pain\n- Primary diagnosis: Pain of right knee joint\n- Chronic pain\n- Heart failure\n- Nicotine dependence\n- Backache\n- Major depression, single episode\n- Absence of toe\n- Chronic obstructive lung disease\n- Cardiomyopathy\n- Benign prostatic hyperplasia with outflow obstruction\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-06-19, presumably until 2019-06-19\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-06-19, presumably until 2019-06-19\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-06-19, presumably until 2019-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-28 01:39:00, ended at 2019-06-28 04:05:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, spine; thoracic, 3 views\n\n### Condition\n- Aortocoronary bypass graft present\n- Primary diagnosis: Neck pain\n- Essential hypertension\n- Pain of left knee region\n- Falls\n- Nicotine dependence\n- Acute exacerbation of chronic obstructive airways disease\n- Asthenia\n- Chronic pain\n- Contusion of chest\n- Pain in thoracic spine\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-06-28, presumably until 2019-06-28\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2019-06-28, presumably until 2019-07-07, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every 4 hours as needed\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-06-28, presumably until 2019-07-28, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route daily\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-06-28, presumably until 2019-06-28\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-06-28, presumably until 2019-07-27, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-01 00:00:00, ended at 2019-07-01 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, started on 2019-07-01, presumably until 2019-07-01, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-07-08, presumably until 2019-09-17, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-07 13:28:04, ended at 2019-07-07 14:01:38\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lumbar radiculopathy\n- Generalized anxiety disorder\n- Musculoskeletal finding\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-07-07, presumably until 2019-08-22, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-07-21 21:47:00, ended at 2019-07-21 22:38:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Primary diagnosis: Chronic ulcer of foot\n- Aortocoronary bypass graft present\n- Pain in right foot\n- Chronic obstructive lung disease\n- Essential hypertension\n- Nicotine dependence\n- Benign prostatic hyperplasia\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-07-21, presumably until 2019-07-27, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 7 days\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-07-21, presumably until 2019-07-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-27 00:00:00, ended at 2019-07-27 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-07-27, presumably until 2019-08-03, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 3 times a day for 7 days\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-07-27, presumably until 2019-08-22, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-22 00:00:00, ended at 2019-08-22 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-08-22, presumably until 2019-09-18, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-08-22, presumably until 2019-09-18, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-03 03:09:00, ended at 2019-09-03 04:11:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic obstructive lung disease\n- Chronic pain\n- Nicotine dependence\n- Aortocoronary bypass graft present\n- Primary diagnosis: Dyspnea\n- Generalized anxiety disorder\n- Wrist joint pain\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-11 13:46:00, ended at 2019-09-11 19:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Chronic obstructive lung disease\n- Arthralgia of the ankle and/or foot\n- Nicotine dependence\n- Aortocoronary bypass graft present\n- Sprain of ankle\n- Pain of left knee region\n- Generalized anxiety disorder\n- Primary diagnosis: Sprain of knee\n- Chronic pain\n- Essential hypertension\n- Osteoarthritis of knee\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-09-11, presumably until 2019-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-15 22:59:00, ended at 2019-09-16 01:25:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Aortocoronary bypass graft present\n- Chronic obstructive lung disease\n- Generalized anxiety disorder\n- Nicotine dependence\n- Open wound of elbow\n- Open wound of forearm\n- Primary diagnosis: Cellulitis of left upper limb\n- Chronic pain\n- Essential hypertension\n- Open wound of wrist\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-09-15, presumably until 2019-09-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-09-16, presumably until 2019-09-16\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2019-09-16, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Cap (500 mg total) by mouth 2 times a day for 10 days\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2019-09-16, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-09-17 02:59:00, ended at 2019-09-18 18:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.6 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Base excess in Arterial blood by calculation: 7.6 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 197 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 50.7 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Left ventricular Ejection fraction: 54.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.9 (milliequivalent per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.7 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 205 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.9 (percent)\n- Lactate [Moles/volume] in Serum or Plasma: 1.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 74.4 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 394 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 65.2 (millimeter mercury column)\n- Prothrombin time (PT): 13.6 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination \n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, knee; 3 views\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Radiologic examination, chest; single view\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n\n### Condition\n- Aortocoronary bypass graft present\n- Hypoxemia\n- Chronic obstructive pulmonary disease with acute lower respiratory infection\n- Essential hypertension\n- Pain of left knee region\n- Pneumonia\n- Primary diagnosis: Dyspnea\n- Nicotine dependence\n- Obstructive sleep apnea syndrome\n- Acute on chronic hypoxemic respiratory failure\n- Acute on chronic hypercapnic respiratory failure\n- Atelectasis\n- Benign prostatic hyperplasia\n- Fatigue\n- Generalized anxiety disorder\n- Abnormal findings on diagnostic imaging of lung\n- Acute exacerbation of chronic obstructive airways disease\n- Hyperglycemia\n- Metabolic encephalopathy\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 250 ML moxifloxacin 1.6 MG/ML Injection, through Intravenous route, started on 2019-09-17, presumably until 2019-09-17\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-11-20, with intended 0 refill(s). Instructions: 1 Spray by Nasal route 3 times a day as needed (for allergies) \n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-09-17, presumably until 2019-09-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-09-17, presumably until 2019-09-18\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-09-17, presumably until 2019-09-18\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-09-17, presumably until 2019-09-18\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-09-17, presumably until 2019-09-18\n- methylprednisolone 125 MG Injection, started on 2019-09-17, presumably until 2019-09-18\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-09-18, presumably until 2019-09-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-18 20:39:00, ended at 2019-09-18 22:56:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-21 16:18:00, ended at 2019-09-21 18:45:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Catecholamines [Interpretation] in Plasma Narrative: 51.5 (femtoliter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 5.1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 31.3 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Prothrombin time (PT): 14.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: 5.1 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1760 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n\n### Procedure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest; single view\n\n### Condition\n- Asthenia\n- Bilateral inguinal hernia\n- Cellulitis of right lower limb\n- Dyspnea\n- Primary diagnosis: Atrial fibrillation\n- Chronic obstructive lung disease\n- Chronic pain\n- Essential hypertension\n- Electrocardiogram abnormal\n- Generalized anxiety disorder\n- Nicotine dependence\n- Obstructive sleep apnea syndrome\n- Aortocoronary bypass graft present\n- Lumbar spondylosis with myelopathy\n- Falls\n- Tinea cruris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-09-22 22:59:00, ended at 2019-09-23 02:28:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Nicotine dependence\n- Aortocoronary bypass graft present\n- Primary diagnosis: Closed fracture scapula, neck\n- Generalized anxiety disorder\n- Pain of left knee region\n- Shoulder joint pain\n- Pain in lower limb\n- Chronic pain\n- Primary diagnosis: Closed fracture scapula, glenoid\n- Atrial fibrillation\n- Contusion of knee\n- Essential hypertension\n- Sprain of shoulder\n- Chronic obstructive lung disease\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-09-23, presumably until 2019-09-23\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-09-23, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-09-26, presumably until 2019-09-26, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed for Anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-24 00:00:00, ended at 2019-09-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-09-27, presumably until 2019-10-07, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-09-26 05:31:00, ended at 2019-09-30 09:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 34.1 (milliequivalent per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Catecholamines [Interpretation] in Plasma Narrative: 57.5 (femtoliter)\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1627 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Left ventricular Ejection fraction: 49.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.56 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Base excess in Arterial blood by calculation: 5.6 (milliequivalent per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 71.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.61 (million per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 91.4 (millimeter mercury column)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n\n### Procedure\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Arterial puncture, withdrawal of blood for diagnosis\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination, foot; complete, minimum of 3 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Radiologic examination, chest; single view\n\n### Condition\n- Acute exacerbation of chronic obstructive airways disease\n- Chronic pain\n- Chronic ulcer of foot\n- Difficulty walking\n- Falls\n- Generalized anxiety disorder\n- Hypoxemia\n- Persistent atrial fibrillation\n- Backache\n- Chronic pulmonary edema\n- Acute on chronic hypercapnic respiratory failure\n- Aortocoronary bypass graft present\n- Benign prostatic hyperplasia\n- Cardiomegaly\n- Disorder of sleep-wake cycle\n- Mixed acid-base balance disorder\n- Anxiety disorder\n- Primary diagnosis: Atrial fibrillation\n- Benign prostatic hyperplasia with outflow obstruction\n- Chronic obstructive lung disease\n- Acute on chronic systolic heart failure\n- Extreme obesity with alveolar hypoventilation\n- Stricture of artery\n- Tachycardia\n- Acute on chronic hypoxemic respiratory failure\n- Hypertensive heart failure\n- Atherosclerosis of artery of lower limb\n- Atherosclerosis of coronary artery without angina pectoris\n- Congestive heart failure\n- Dyspnea\n- Pain of left knee region\n- Cardiomyopathy\n- Pain of right knee joint\n- Abnormal findings on diagnostic imaging of lung\n- Nicotine dependence\n\n### Drug\n- methylprednisolone 40 MG Injection, started on 2019-09-28, presumably until 2019-09-30\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-09-27, presumably until 2019-09-29\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-09-27, presumably until 2019-09-29\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-09-26, presumably until 2019-09-29\n- alprazolam 1 MG Oral Tablet, through Oral route, presumably until 2019-09-30, with intended 0 refill(s). Instructions: take 1 mg by mouth 3 times a day as needed (for anxiety) \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2019-09-26, presumably until 2019-09-30\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-09-26, presumably until 2019-09-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-09-29, presumably until 2019-09-29\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2019-09-29, presumably until 2019-09-30\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-09-28, presumably until 2019-09-30\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2019-10-07, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed for Bronchospasm/Wheezing\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2019-10-07, with intended 0 refill(s). Instructions: take 81 mg by mouth daily SUPPOSED TO TAKE, BUT HAS BEEN OFF FOR 1-2 MONTHS\n- levalbuterol 0.21 MG/ML Inhalation Solution, through Inhalation, started on 2019-09-27, presumably until 2019-09-28\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2019-09-29, presumably until 2019-09-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-09-28, presumably until 2019-09-29\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-09-26, presumably until 2019-09-26\n- cadexomer iodine 0.009 MG/MG Topical Gel, through Topical route, started on 2019-09-29, presumably until 2019-09-30\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2019-09-27, presumably until 2019-09-27\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-09-27, presumably until 2019-11-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed (for shoulder pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 09:47:46, ended at 2019-09-30 11:23:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-09-30, presumably until 2019-10-12, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed (for anxiety)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-06 00:00:00, ended at 2019-10-06 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lumbar radiculopathy\n- Primary diagnosis: Musculoskeletal finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-07 00:00:00, ended at 2019-10-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-10-07, presumably until 2019-10-09, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-10-07, presumably until 2019-10-09, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-10-07 18:54:00, ended at 2019-10-08 00:39:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.66 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.19 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.2 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.99 (micro-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 25.3 (milliequivalent per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 58.2 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 5 - 10 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Arterial blood by calculation: -0.8 (milliequivalent per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Aortocoronary bypass graft present\n- Primary diagnosis: Atrial fibrillation\n- Chronic pain\n- Dizziness and giddiness\n- Acute exacerbation of chronic obstructive airways disease\n- Asthenia\n- Essential hypertension\n- Loss of consciousness\n- Nicotine dependence\n- Chronic pulmonary edema\n- Major depression, single episode\n- Generalized anxiety disorder\n- Pain of left knee region\n\n### Drug\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-10-07, presumably until 2019-10-12, with intended 0 refill(s). Instructions: take 1 Tab (60 mg total) by mouth 4 times a day\n- diltiazem hydrochloride 30 MG Oral Tablet, through Oral route, started on 2019-10-07, presumably until 2019-10-07\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-10-07, presumably until 2019-10-12, with intended 1 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed for Bronchospasm/Wheezing\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-10-07, presumably until 2019-11-20, with intended 1 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily SUPPOSED TO TAKE, BUT HAS BEEN OFF FOR 1-2 MONTHS\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-07, presumably until 2019-10-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-10-08 22:45:00, ended at 2019-10-10 16:30:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 769 (picogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Base excess in Arterial blood by calculation: 3.2 (milliequivalent per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Body fluid: <0.013 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.4 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Body height: 5' 8.11\" (inch (US))\n- Carbon dioxide [Partial pressure] in Arterial blood: 68.7 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 7.80 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 32.0 (milliequivalent per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 78.5 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.2 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.30 (million per microliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.7 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Arterial puncture, withdrawal of blood for diagnosis\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Hospital discharge day management; 30 minutes or less\n- Collection of venous blood by venipuncture\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Radiologic examination, chest; single view\n\n### Condition\n- Acute on chronic hypoxemic respiratory failure\n- Chronic obstructive lung disease\n- Major depression, single episode\n- Acidosis\n- Hypercapnic respiratory failure\n- Obesity\n- Atherosclerosis of coronary artery without angina pectoris\n- Paroxysmal atrial fibrillation\n- Atrial fibrillation\n- Dyspnea\n- Falls\n- Injury of head\n- Urinary tract infectious disease\n- Acute on chronic hypercapnic respiratory failure\n- Anxiety disorder\n- Aortocoronary bypass graft present\n- Asthenia\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Tinea cruris\n- Primary diagnosis: Acute exacerbation of chronic obstructive airways disease\n- Generalized anxiety disorder\n- Neck pain\n- Nicotine dependence\n- Chronic kidney disease stage 1\n- Metabolic encephalopathy\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-09, presumably until 2019-10-10\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-10-09, presumably until 2019-10-09\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-10-10, presumably until 2019-10-10\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-10-09, presumably until 2019-10-10\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-09, presumably until 2019-10-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-10-09, presumably until 2019-10-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-10-10, presumably until 2019-10-10\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-09, presumably until 2019-10-09\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-09, presumably until 2019-10-10\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-10-10, presumably until 2019-10-10\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-10-10, presumably until 2019-10-10\n- methylprednisolone 125 MG Injection, started on 2019-10-09, presumably until 2019-10-10\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-10-09, presumably until 2019-10-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2019-10-13, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day as needed (for anxiety)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-10-12 00:22:00, ended at 2019-10-12 04:24:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.1 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 1.2 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.36 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.54 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Base excess in Arterial blood by calculation: 3.7 (milliequivalent per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1837 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Body height: 5' 10\" (inch (US))\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n\n### Procedure\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest; single view\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n\n### Condition\n- Primary diagnosis: Acute on chronic hypercapnic respiratory failure\n- Radiology result abnormal\n- Abnormal findings on diagnostic imaging of lung\n- Chronic pulmonary edema\n- Ventricular premature complex\n- Atrial fibrillation\n- Acute exacerbation of chronic obstructive airways disease\n\n### Drug\n- 250 ML moxifloxacin 1.6 MG/ML Injection, through Intravenous route, started on 2019-10-12, presumably until 2019-10-12\n- moxifloxacin 400 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2019-10-14, with intended 0 refill(s). Instructions: take 1 Tab (400 mg total) by mouth daily for 7 days\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-12, presumably until 2019-10-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-10-12, presumably until 2019-10-12\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-10-12, presumably until 2019-11-20, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (wheezing, shortness of breath)\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-12, presumably until 2019-10-14, with intended 0 refill(s). Instructions: take 1 Cap (240 mg total) by mouth daily\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-12, presumably until 2019-10-12\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-12, presumably until 2019-10-12\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2019-10-14, with intended 0 refill(s). Instructions: take 1 Tab (20 mg total) by mouth 3 times a day\n- methylprednisolone 125 MG Injection, started on 2019-10-12, presumably until 2019-10-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-13 00:00:00, ended at 2019-10-13 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-10-13, presumably until 2019-11-20, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 3 times a day as needed for Anxiety (for anxiety)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-10-14 04:02:00, ended at 2019-10-29 16:40:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Base excess in Arterial blood by calculation: 9.5 (milliequivalent per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.23 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 50.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.83 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 75.7 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.8 (millimole per liter)\n- Body height: 5' 8.11\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 38 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Creatine kinase.MB [Mass/volume] in Serum or Plasma: 3.6 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 98 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.41 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 80 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 148 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 93.2 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 65.9 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 151 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 39.1 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.1 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 136 (milligram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 2.0 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.71 (thousand per microliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 927 (picogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach\n- Noninvasive ear or pulse oximetry for oxygen saturation; multiple determinations (eg, during exercise)\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Radiologic examination, chest; single view\n- Insertion of Infusion Device into Left Femoral Vein, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Arterial puncture, withdrawal of blood for diagnosis\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Collection of venous blood by venipuncture\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n\n### Condition\n- Hyperglycemia\n- Hypertensive heart failure\n- Neck pain\n- Respiratory failure\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Acute hypoxemic respiratory failure\n- Acute on chronic hypoxemic respiratory failure\n- Atrial fibrillation\n- Disorder of lung\n- Benign prostatic hyperplasia\n- Paroxysmal atrial fibrillation\n- Stimulant dependence\n- Atherosclerosis of coronary artery without angina pectoris\n- Acute renal failure syndrome\n- Chronic congestive heart failure\n- Chronic pain\n- Chronic pulmonary edema\n- Abnormal findings diagnostic imaging heart+coronary circulat\n- Acidosis\n- Acute exacerbation of chronic obstructive airways disease\n- Acute on chronic hypercapnic respiratory failure\n- Disorder of male genital organ\n- Metabolic encephalopathy\n- Nicotine dependence\n- Pleural effusion\n- Primary diagnosis: Acute hypercapnic respiratory failure\n- Aortocoronary bypass graft present\n- Chronic systolic heart failure\n- Electrocardiogram abnormal\n- Localized edema\n- Backache\n- Dyspnea\n- Fatigue\n- Generalized anxiety disorder\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-10-14, presumably until 2019-10-14\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-10-20, presumably until 2019-10-29\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2019-10-14, presumably until 2019-10-14\n- methylprednisolone 40 MG Injection, started on 2019-10-14, presumably until 2019-10-29\n- 250 ML moxifloxacin 1.6 MG/ML Injection, through Intravenous route, started on 2019-10-14, presumably until 2019-10-14\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-10-14, presumably until 2019-10-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-10-26, presumably until 2019-10-28\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2019-10-20, presumably until 2019-10-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-10-24, presumably until 2019-10-24\n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-10-15, presumably until 2019-10-29\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-10-14, presumably until 2019-10-29\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-10-20, presumably until 2019-10-29\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-14, presumably until 2019-10-17\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2019-10-16, presumably until 2019-10-22\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-10-29\n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-17, presumably until 2019-10-29\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2019-10-22, presumably until 2019-10-26\n- acetazolamide 500 MG Injection, started on 2019-10-16, presumably until 2019-10-16\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2019-10-29\n- 10 ML furosemide 10 MG/ML Injection, started on 2019-10-14, presumably until 2019-10-28\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2019-10-14, presumably until 2019-10-15\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-14, presumably until 2019-10-29\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-10-24, presumably until 2019-10-29\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-17, presumably until 2019-10-18\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-18, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 180 mg by mouth 2 times a day \n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-10-19, presumably until 2019-10-25\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-10-14, presumably until 2019-10-17\n- 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2019-10-16, presumably until 2019-10-16\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2019-10-28, presumably until 2019-10-29\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-10-16, presumably until 2019-10-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-17, presumably until 2019-10-29\n- methylprednisolone 125 MG Injection, started on 2019-10-14, presumably until 2019-10-25\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-10-15, presumably until 2019-10-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2019-10-29 17:23:00, ended at 2019-11-19 16:20:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.11\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 56.5 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.59 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 193 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.1 (femtoliter)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n\n### Condition\n- Qualitative platelet disorder\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial fibrillation\n- Aortocoronary bypass graft present\n- Pain in left arm\n- Cellulitis and abscess of face\n- Essential hypertension\n- Hyperglycemia\n- Neck pain\n- Nicotine dependence\n- Primary diagnosis: Backache\n- Primary diagnosis: Chronic pain\n- Chronic ulcer of foot\n- Disorder of male genital organ\n- Localized swelling, mass and lump, neck\n- Stimulant dependence\n- Acute exacerbation of chronic obstructive airways disease\n- Atherosclerosis of artery of lower limb\n- Localized edema\n- Urinary incontinence\n- Acute on chronic hypercapnic respiratory failure\n- Spasm\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-03, presumably until 2019-11-05\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-11-06, presumably until 2019-11-20\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-20\n- amoxicillin 250 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-11-03\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-10-30, presumably until 2019-11-20\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-31, presumably until 2019-11-16\n- hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension, through Otic route, started on 2019-11-09, presumably until 2019-11-15\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2019-11-01, presumably until 2019-11-01\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-09, presumably until 2019-11-20\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-11-12\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-10-30, presumably until 2019-11-20\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-19\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-20\n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-30, presumably until 2019-11-20\n- purified protein derivative of tuberculin 50 UNT/ML Injectable Solution, through Intradermal route, started on 2019-10-31, presumably until 2019-11-07\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2019-11-04, presumably until 2019-11-20\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-10-30\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-11-20\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-10-30, presumably until 2019-11-20\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-10-29, presumably until 2019-11-20\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-11-09, presumably until 2019-11-09\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2019-10-30, presumably until 2019-11-20\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2019-11-08, presumably until 2019-11-20\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2019-11-20\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-20\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-10-30, presumably until 2019-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-03 08:07:00, ended at 2019-11-03 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation\n\n### Condition\n- Swelling / lump finding\n- Disorder of head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-11-09 04:01:00, ended at 2019-11-09 05:57:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Otalgia\n- Chronic obstructive lung disease\n- Aortocoronary bypass graft present\n- Atrial fibrillation\n- Essential hypertension\n- Generalized anxiety disorder\n- Primary diagnosis: Injury of ear\n- Nicotine dependence\n\n### Drug\n- ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension, started on 2019-11-09, presumably until 2019-11-16, with intended 0 refill(s). Instructions: Instill 4 drops into affected ear 4 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-19 09:30:00, ended at 2019-11-19 17:01:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, soft tissue neck; with contrast material(s)\n\n### Condition\n- Localized swelling, mass and lump, neck\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-11-19 17:02:00, ended at 2019-11-30 13:20:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 8\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 37 (millimole per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 59.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Base excess in Arterial blood by calculation: 9.7 (milliequivalent per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.64 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.39 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 72 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Lactate [Moles/volume] in Serum or Plasma: 0.8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 23.8 (microgram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 24.0 (microgram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 771 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 39.0 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.57 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Noninvasive ear or pulse oximetry for oxygen saturation; single determination\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Radiologic examination, chest; single view\n- Hospital discharge day management; more than 30 minutes\n- Collection of venous blood by venipuncture\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry eit\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Benign prostatic hyperplasia\n- Chronic pain\n- Claustrophobia\n- Foot ulcer due to type 2 diabetes mellitus\n- Sialoadenitis\n- Ulcer of lower extremity\n- Aortocoronary bypass graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Falls\n- Abnormal findings on diagnostic imaging of lung\n- Primary diagnosis: Abscess of salivary gland\n- Chronic fatigue syndrome\n- Chronic obstructive lung disease\n- Lumbar spondylosis with myelopathy\n- Atrial fibrillation\n- Backache\n- Chronic atrial fibrillation\n- Pain of right knee joint\n- Peripheral vascular disease\n- Asthenia\n- Extreme obesity with alveolar hypoventilation\n- Hypertensive heart failure\n- Loss of appetite\n- Major depression, single episode\n- Metabolic encephalopathy\n- Neck pain\n- Spasm\n- Acute on chronic hypercapnic respiratory failure\n- Chronic congestive heart failure\n- Drowsy\n- Impacted cerumen\n- Overflow incontinence of urine\n- Pain of left knee region\n- Type 2 diabetes mellitus\n- Atherosclerosis of artery of lower limb\n- Chest pain\n- Generalized anxiety disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n- Peripheral circulatory disorder due to type 2 diabetes mellitus\n- Chronic systolic heart failure\n- Chronic ulcer of skin of lower leg\n- Electrocardiogram abnormal\n- Nicotine dependence\n- Pleural effusion\n\n### Drug\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2019-11-29, presumably until 2019-11-29\n- calcium polycarbophil 625 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 1,250 mg by mouth every day \n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-28\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2019-11-26, presumably until 2019-11-29\n- 24 HR nicotine 0.875 MG/HR Transdermal System, through Transdermal route, started on 2019-11-20, presumably until 2019-12-03, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2019-11-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2019-11-23, presumably until 2019-11-29\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day with meals\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-24\n- sodium chloride 9 MG/ML Injectable Solution, started on 2019-11-19, presumably until 2019-11-30\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2019-11-19, presumably until 2019-12-03, with intended 0 refill(s). Instructions: inject 40 mg subcutaneous (under the skin) daily\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-11-24, presumably until 2019-11-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2019-11-19, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- alprazolam 1 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2019-11-20\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2019-11-26, presumably until 2019-11-26\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take 40 mg by mouth every day \n- levalbuterol 2.5 MG/ML Inhalation Solution, through Inhalation, started on 2019-11-29, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 1.25 mg by RT Inhalation route every 6 hours as needed (bronchospasm/wheezing, sob) \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2019-11-28, presumably until 2019-12-13, with intended 0 refill(s). Instructions: take 25 mg by mouth 2 times a day \n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2019-12-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for pain\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2019-11-29, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 500 mcg by Nebulization route every 6 hours as needed (bronchospasm/wheezing) \n- vancomycin 5 MG/ML Injection, through Intravenous route, started on 2019-11-20, presumably until 2019-11-29\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-11-20, presumably until 2019-11-30\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2019-11-22, presumably until 2019-11-22\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2019-11-30\n- budesonide 0.25 MG/ML Inhalation Suspension, through Inhalation, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: 0.5 mg by Inhalation route 2 times a day \n- carbamide peroxide 65 MG/ML Otic Solution, through Otic route, started on 2019-11-26, presumably until 2019-11-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-11-24, presumably until 2019-11-28\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2019-11-22, presumably until 2019-11-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2019-11-19, presumably until 2019-11-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2019-11-19, presumably until 2019-11-19\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2019-11-22, presumably until 2019-11-23\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2019-11-20, presumably until 2020-01-25, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- nystatin 100 UNT/MG Topical Powder, through Topical route, presumably until 2019-12-03, with intended 0 refill(s). Instructions: 1 Application by Topical route 3 times a day \n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-11-20, presumably until 2020-01-15, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-02-04, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-30\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2019-11-19, presumably until 2019-11-19\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Asthma within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of asthma means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8fd1210936eef79fdf9dacb9992129e5df5610f78f97ade16733aad10a715e5d", "prompt_hash": "b87c75c570de89d42b6eac48e86e813008bdd93d9443c81cf0663ff06fc1a53d", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
